0001546380-22-000035 | 10-K | XBRL Viewer

Print Document View Excel Document

Cover - USD ($)	12 Months Ended
Cover - USD ($)	Sep. 30, 2022	Nov. 18, 2022	Apr. 01, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Sep. 30, 2022
Current Fiscal Year End Date	--09-30
Document Transition Report	false
Entity File Number	001-11593
Entity Registrant Name	Scotts Miracle-Gro Co
Entity Central Index Key	0000825542
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	31-1414921
Entity Address, Address Line One	14111 Scottslawn Road,
Entity Address, City or Town	Marysville,
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43041
City Area Code	937
Local Phone Number	644-0011
Title of 12(b) Security	Common Shares, $0.01 stated value
Trading Symbol	SMG
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 5,115,863,599
Entity Common Stock, Shares Outstanding		55,464,721
Documents Incorporated by Reference	Portions of the definitive Proxy Statement for the registrant’s 2023 Annual Meeting of Shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K. Such Proxy Statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended September 30, 2022.

Audit Information	12 Months Ended
Audit Information	Sep. 30, 2022
Audit Information [Abstract]
Auditor Firm ID	34
Auditor Location	Columbus, Ohio
Auditor Name	DELOITTE & TOUCHE LLP

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net sales	$ 3,924.1	$ 4,925.0	$ 4,131.6
Cost of sales	2,891.1	3,431.3	2,768.6
Cost of sales—impairment, restructuring and other	160.1	24.7	16.0
Gross margin	872.9	1,469.0	1,347.0
Operating expenses:
Selling, general and administrative	613.0	743.5	757.8
Impairment, restructuring and other	693.1	4.3	0.8
Other (income) expense, net	0.8	(1.8)	3.2
Income (loss) from operations	(434.0)	723.0	585.2
Equity in (income) loss of unconsolidated affiliates	12.9	(14.4)	0.0
Costs related to refinancing	0.0	0.0	15.1
Interest expense	118.1	78.9	79.6
Other non-operating income, net	(6.9)	(18.6)	(20.1)
Income (loss) from continuing operations before income taxes	(558.1)	677.1	510.6
Income tax expense (benefit) from continuing operations	(120.6)	159.8	123.7
Income (loss) from continuing operations	(437.5)	517.3	386.9
Income (loss) from discontinued operations, net of tax	0.0	(3.9)	1.7
Net income (loss)	(437.5)	513.4	388.6
Net income attributable to noncontrolling interest	0.0	(0.9)	(1.2)
Net income (loss) attributable to controlling interest	$ (437.5)	$ 512.5	$ 387.4
Basic income (loss) per common share:
Income from continuing operations (USD per share)	$ (7.88)	$ 9.27	$ 6.92
Income (loss) from discontinued operations (USD per share)	0	(0.07)	0.04
Basic net income (loss) per common share (USD per share)	(7.88)	9.20	6.96
Diluted income (loss) per common share:
Income from continuing operations (USD per share)	(7.88)	9.03	6.78
Income (loss) from discontinued operations (USD per share)	0	(0.07)	0.03
Diluted net income (loss) per common share (USD per share)	$ (7.88)	$ 8.96	$ 6.81

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (437.5)	$ 513.4	$ 388.6
Other comprehensive income (loss):
Net foreign currency translation adjustment	(27.2)	4.5	11.3
Net unrealized gain (loss) on derivative instruments, net of tax	29.9	19.8	(14.6)
Reclassification of net unrealized (gains) losses on derivative instruments to net income, net of tax	(6.8)	5.4	7.5
Net unrealized loss on securities, net of tax	(77.4)	(2.3)	0.0
Net unrealized gain (loss) in pension and other post-retirement benefits, net of tax	(5.4)	5.1	(9.6)
Pension and other post-retirement benefit adjustments, net of tax	8.7	0.3	0.2
Total other comprehensive income (loss)	(78.2)	32.8	(5.2)
Comprehensive income (loss)	(515.7)	546.2	383.4
Comprehensive income attributable to noncontrolling interest	0.0	(0.9)	(1.2)
Comprehensive income (loss) attributable to controlling interest	$ (515.7)	$ 545.3	$ 382.2

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
OPERATING ACTIVITIES
Net income (loss)	$ (437.5)	$ 513.4	$ 388.6
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Impairment, restructuring and other	666.8	0.0	0.0
Costs related to refinancing	0.0	0.0	15.1
Share-based compensation expense	34.3	40.6	57.9
Depreciation	68.1	62.9	62.2
Amortization	37.1	30.9	32.5
Deferred taxes	(182.8)	22.5	(11.1)
Equity in (income) loss of unconsolidated affiliates, net of distributions	12.9	(2.6)	0.0
Other, net	1.1	(10.8)	4.2
Changes in assets and liabilities, net of acquisitions:
Accounts receivable	102.8	15.5	(188.1)
Inventories	(203.8)	(496.5)	(80.6)
Prepaid and other assets	(3.3)	(76.5)	(19.4)
Accounts payable	(171.2)	202.5	172.2
Other current liabilities	(68.4)	(21.6)	148.6
Other non-current items	20.1	(10.1)	(24.8)
Other, net	(5.2)	1.3	0.7
Net cash (used in) provided by operating activities	(129.0)	271.5	558.0
INVESTING ACTIVITIES
Proceeds from sale of long-lived assets	63.3	0.2	0.4
Investments in property, plant and equipment	(113.5)	(106.9)	(62.7)
Investments in loans receivable	0.0	0.0	(3.4)
Proceeds from sale of brand extension assets	0.0	0.0	115.5
Investments in unconsolidated affiliates	0.0	(102.3)	0.0
Payment for acquisitions, net of cash acquired	(237.3)	(127.8)	0.0
Purchase of convertible debt investments	(25.0)	(193.1)	0.0
Other investing, net	29.3	(8.7)	(2.9)
Net cash (used in) provided by investing activities	(283.2)	(538.6)	46.9
FINANCING ACTIVITIES
Borrowings under revolving and bank lines of credit and term loans	3,617.4	1,243.2	1,222.7
Repayments under revolving and bank lines of credit and term loans	(2,937.3)	(1,361.5)	(1,413.8)
Financing and issuance fees	(9.6)	(13.1)	(18.7)
Dividends paid	(166.2)	(143.0)	(411.2)
Purchase of Common Shares	(257.9)	(129.3)	(53.2)
Payments on seller notes	0.0	0.0	(0.5)
Cash received from exercise of stock options	3.3	15.2	17.6
Acquisition of noncontrolling interests	0.0	(17.5)	0.0
Other financing, net	5.6	0.0	0.0
Net cash provided by (used in) financing activities	255.3	494.0	(607.1)
Effect of exchange rate changes on cash	(0.4)	0.6	0.0
Net increase (decrease) in cash and cash equivalents	(157.3)	227.5	(2.2)
Cash and cash equivalents at beginning of year	244.1	16.6	18.8
Cash and cash equivalents at end of year	86.8	244.1	16.6
Senior Notes due 2031 – 4.000%
FINANCING ACTIVITIES
Proceeds from Issuance of Senior Notes	0.0	500.0	0.0
Senior Notes due 2032 – 4.375%
FINANCING ACTIVITIES
Proceeds from Issuance of Senior Notes	0.0	400.0	0.0
4.500% Senior Notes
FINANCING ACTIVITIES
Proceeds from Issuance of Senior Notes	0.0	0.0	450.0
6.000% Senior Notes
FINANCING ACTIVITIES
Repayment of Senior Notes	$ 0.0	$ 0.0	$ (400.0)

Consolidated Statements of Cash Flows (Parenthetical) - Senior Notes	Sep. 30, 2021
Senior Notes due 2031 – 4.000%
Interest rate (percent)	4.00%
Senior Notes due 2032 – 4.375%
Interest rate (percent)	4.375%
4.500% Senior Notes
Interest rate (percent)	4.50%
6.000% Senior Notes
Interest rate (percent)	6.00%

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Current assets:
Cash and cash equivalents	$ 86.8	$ 244.1
Accounts receivable, less allowances of $14.4 in 2022 and $16.8 in 2021	299.0	483.4
Accounts receivable pledged	79.8	0.0
Inventories	1,343.5	1,126.6
Prepaid and other current assets	172.8	169.9
Total current assets	1,981.9	2,024.0
Investment in unconsolidated affiliates	193.8	207.0
Property, plant and equipment, net	606.0	622.2
Goodwill	254.0	605.2
Intangible assets, net	580.2	709.6
Other assets	680.9	632.0
Total assets	4,296.8	4,800.0
Current liabilities:
Current portion of debt	144.3	57.8
Accounts payable	422.6	609.4
Other current liabilities	397.0	473.2
Total current liabilities	963.9	1,140.4
Long-term debt	2,826.2	2,236.7
Other liabilities	359.0	409.6
Total liabilities	4,149.1	3,786.7
Commitments and contingencies (Notes 18, 19 and 20)
Equity:
Common shares and capital in excess of $0.01 stated value per share; shares outstanding of 55.5 and 55.6, respectively	364.0	477.0
Retained earnings	1,020.1	1,605.1
Treasury shares, at cost; 12.8 and 12.6 shares, respectively	(1,091.8)	(1,002.4)
Accumulated other comprehensive loss	(144.6)	(66.4)
Total equity	147.7	1,013.3
Total liabilities and equity	$ 4,296.8	$ 4,800.0

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Statement of Financial Position [Abstract]
Accounts receivable, allowances	$ 14.4	$ 16.8
Common shares, stated value per share (USD per share)	$ 0.01	$ 0.01
Common shares outstanding (in shares)	55.5	55.6
Treasury shares, at cost (in shares)	12.8	12.6

Consolidated Statements of Shareholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Shares	Capital in Excess of Stated Value	Retained Earnings	Treasury Shares	Accumulated Other Comprehensive Income (Loss)	Parent	Non-controlling Interest
Equity beginning balance (in shares) at Sep. 30, 2019		68.1
Equity beginning balance at Sep. 30, 2019		$ 0.3	$ 441.9	$ 1,274.7	$ (904.3)	$ (93.9)	$ 718.7
Treasury shares, beginning balance (in shares) at Sep. 30, 2019					12.4
Noncontrolling interest, beginning balance at Sep. 30, 2019								$ 4.5
Total equity, beginning balance at Sep. 30, 2019	$ 723.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	388.6			387.4			387.4	1.2
Other comprehensive income (loss)	(5.2)					(5.2)	(5.2)
Share-based compensation	57.9		57.9				57.9
Dividends declared	(426.5)			(426.5)			(426.5)
Treasury share purchases (in shares)					0.4
Treasury share purchases	(53.2)				$ (53.2)		(53.2)
Treasury share issuances (in shares)					(0.4)
Treasury share issuances	18.1		(17.6)		$ 35.7		18.1
Equity ending balance (in shares) at Sep. 30, 2020		68.1
Equity ending balance at Sep. 30, 2020		$ 0.3	482.2	1,235.6	$ (921.8)	(99.1)	697.2
Treasury shares, ending balance (in shares) at Sep. 30, 2020					12.4
Noncontrolling interest, ending balance at Sep. 30, 2020								5.7
Total equity, ending balance at Sep. 30, 2020	702.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	513.4			512.5			512.5	0.9
Other comprehensive income (loss)	32.8					32.8	32.8
Share-based compensation	40.6		40.6				40.6
Dividends declared	(143.0)			(143.0)			(143.0)
Treasury share purchases (in shares)					0.7
Treasury share purchases	(129.3)				$ (129.3)		(129.3)
Treasury share issuances (in shares)					(0.5)
Treasury share issuances	16.1		(32.6)		$ 48.7		16.1
Acquisition of remaining noncontrolling interest in AeroGrow	(20.1)		(13.4)				(13.4)	(6.7)
Equity ending balance (in shares) at Sep. 30, 2021		68.1
Equity ending balance at Sep. 30, 2021		$ 0.3	476.7	1,605.1	$ (1,002.4)	(66.4)	1,013.3
Treasury shares, ending balance (in shares) at Sep. 30, 2021					12.6
Noncontrolling interest, ending balance at Sep. 30, 2021								0.0
Total equity, ending balance at Sep. 30, 2021	1,013.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(437.5)			(437.5)			(437.5)	0.0
Other comprehensive income (loss)	(78.2)					(78.2)	(78.2)
Share-based compensation	30.3		30.3				30.3
Dividends declared	(147.5)			(147.5)			(147.5)
Treasury share purchases (in shares)					1.7
Treasury share purchases	(257.9)				$ (257.9)		(257.9)
Treasury share issuances (in shares)					(1.5)
Treasury share issuances	25.1		(143.3)		$ 168.4		25.1
Equity ending balance (in shares) at Sep. 30, 2022		68.1
Equity ending balance at Sep. 30, 2022		$ 0.3	$ 363.7	$ 1,020.1	$ (1,091.8)	$ (144.6)	$ 147.7
Treasury shares, ending balance (in shares) at Sep. 30, 2022					12.8
Noncontrolling interest, ending balance at Sep. 30, 2022								$ 0.0
Total equity, ending balance at Sep. 30, 2022	$ 147.7

Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares				12 Months Ended
	Jul. 30, 2021	Jul. 27, 2020	Jul. 30, 2019	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Statement of Stockholders' Equity [Abstract]
Dividends declared (USD per share)	$ 0.66	$ 0.62	$ 0.58	$ 2.64	$ 2.52	$ 7.36

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

The Scotts Miracle-Gro Company (“Scotts Miracle-Gro” or “Parent”) and its subsidiaries (collectively, together with Scotts Miracle-Gro, the “Company”) are engaged in the manufacturing, marketing and sale of products for lawn and garden care and indoor and hydroponic gardening. The Company’s products are sold in North America, Europe and Asia.

The Company’s North America consumer lawn and garden business is highly seasonal, with approximately 75% of its annual net sales occurring in the second and third fiscal quarters. For the Company’s Hawthorne segment, sales are also impacted by seasonal patterns for certain product categories due to the timing of outdoor growing in North America during the second and third fiscal quarters, and the timing of certain controlled agricultural lighting project sales during the third and fourth fiscal quarters.

Organization and Basis of Presentation

The Company’s consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. On February 26, 2021, the Company acquired the remaining outstanding shares of AeroGrow International, Inc. (“AeroGrow”). Prior to this date, the equity owned by other shareholders was shown as noncontrolling interest in the Consolidated Balance Sheets, and the other shareholders’ portion of net earnings and other comprehensive income was shown as net (income) loss or comprehensive (income) loss attributable to noncontrolling interest in the Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income (Loss), respectively. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and related disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.

Advertising

Advertising costs incurred during the year are expensed to interim periods in relation to revenues. All advertising costs, except for external production costs, are expensed within the fiscal year in which such costs are incurred. External production costs for advertising programs are deferred until the period in which the advertising is first aired. Costs deferred at September 30, 2022 and 2021 were not material. Advertising expenses were $120.3, $165.7 and $147.4 for fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

Research and Development

Costs associated with research and development are generally charged to expense as incurred. Expenses for fiscal 2022, fiscal 2021 and fiscal 2020 were $45.3, $45.4 and $39.7, respectively, including product registration costs of $13.0, $12.3 and $11.0, respectively.

Environmental Costs

The Company recognizes environmental liabilities when conditions requiring remediation are probable and the amounts can be reasonably estimated. Expenditures which extend the life of the related property or mitigate or prevent future environmental contamination are capitalized. Environmental liabilities are not discounted or reduced for possible recoveries from insurance carriers.

Earnings per Common Share

Basic income (loss) per common share of Scotts Miracle-Gro (“Common Share”) is computed by dividing income (loss) attributable to controlling interest from continuing operations, income (loss) from discontinued operations or net income (loss) attributable to controlling interest by the weighted average number of Common Shares outstanding each period. Diluted income (loss) per Common Share is computed by dividing income (loss) attributable to controlling interest from continuing operations, income (loss) from discontinued operations or net income (loss) attributable to controlling interest by the weighted

average number of Common Shares outstanding plus all dilutive potential Common Shares (stock options, restricted stock units, deferred stock units and performance-based award units) outstanding each period.

Share-Based Compensation Awards

Scotts Miracle-Gro grants share-based awards annually to officers and certain other employees and to the non-employee directors of Scotts Miracle-Gro. The share-based awards have consisted of stock options, restricted stock units, deferred stock units and performance-based award units. All of these share-based awards have been made under plans approved by the shareholders. The fair value of awards is expensed over the requisite service period which is typically the vesting period, generally three to five years for awards granted to officers and other employees and one year for awards granted to non-employee directors.

For restricted stock units, deferred stock units and performance-based award units, the fair value of each award is estimated on the date of grant based on the current market price of the Common Shares. The grant date fair value of stock option awards is estimated using a binomial model. Expected market price volatility is based on implied volatilities from traded options on Common Shares and historical volatility specific to the Common Shares. Historical data, including demographic factors impacting historical exercise behavior, is used to estimate stock option exercises and employee terminations within the valuation model. The risk-free rate for periods within the contractual life of the stock option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life of stock options is based on historical experience and expectations for grants outstanding.

Vesting of performance-based award units depends on service and achievement of specified performance targets. Based on the extent to which the targets are achieved, vested shares may range from 50% to 250% of the target award amount. The total amount of compensation expense recognized reflects management’s assessment of the probability that performance goals will be achieved. A cumulative adjustment is recognized to compensation expense in the current period to reflect any changes in the probability of achievement of performance goals.

Restricted stock units, deferred stock units and performance-based award units receive dividend equivalents equal to the cash dividends earned during the vesting period that are only paid out upon vesting. Share-based award units are generally forfeited if a holder terminates employment or service with the Company prior to the vesting date, except in cases where employees are eligible for accelerated vesting based on having satisfied retirement requirements relating to age and years of service. The Company estimates that 15% of its share-based awards will be forfeited based on an analysis of historical trends. The Company evaluates the estimated forfeiture rate on an annual basis and makes adjustments as appropriate. Stock options have exercise prices equal to the market price of the underlying Common Shares on the date of grant and a term of 10 years. If available, Scotts Miracle-Gro typically uses treasury shares, or if not available, newly-issued Common Shares, to settle vested share-based awards. The Company classifies share-based compensation expense within selling, general and administrative expenses to correspond with the same line item as cash compensation paid to employees. Cash flows resulting from tax deductions in excess of the cumulative compensation cost recognized for share-based awards (excess tax benefits) are classified as operating cash inflows.

Cash and Cash Equivalents

Cash and cash equivalents were held in cash depository accounts with major financial institutions around the world or invested in high quality, short-term liquid investments. The Company considers all highly liquid financial instruments with original maturities of three months or less to be cash equivalents. The Company maintains cash deposits in banks which from time to time exceed the amount of deposit insurance available. Management periodically assesses the financial condition of the Company’s banks and believes that the risk of any potential credit loss is minimal.

Accounts Receivable and Allowances

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Allowances for doubtful accounts reflect the Company’s estimate of amounts in its existing accounts receivable that may not be collected due to customer claims or customer inability or unwillingness to pay. The allowance is determined based on a combination of factors, including the Company’s ongoing risk assessment regarding the credit worthiness of its customers, historical collection experience and length of time the receivables are past due. Account balances are charged off against the allowance when the Company believes it is probable the receivable will not be recovered.

Inventories

Inventories are stated at the lower of cost or net realizable value and include the cost of raw materials, labor, manufacturing overhead and freight and inbound handling costs incurred to pre-position goods in the Company’s warehouse network. The Company makes provisions for obsolete or slow-moving inventories as necessary to properly reflect inventory at

the lower of cost or net realizable value. Inventories are valued using the first in, first out method. Adjustments to reflect inventories at net realizable values were $118.8 and $22.5 at September 30, 2022 and 2021, respectively. Refer to “NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER” for more information.

Loans Receivable

Loans receivable are carried at outstanding principal amount, and are recognized in the “Other assets” line in the Consolidated Balance Sheets. Loans receivable are impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement. If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the asset exceeds the present value of expected future cash flows. Interest income on loans receivable was $2.7, $3.8 and $7.6 for fiscal 2022, fiscal 2021 and fiscal 2020, respectively. Interest income is recorded on an accrual basis and is classified in the “Other non-operating income, net” line in the Consolidated Statements of Operations.

Investment in Unconsolidated Affiliates

Non-marketable equity investments in which the Company has the ability to exercise significant influence, but does not control, are accounted for using the equity method of accounting, with the Company’s proportionate share of the earnings and losses of these entities reflected in the Consolidated Statements of Operations. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, an impairment loss is recognized in earnings for the amount by which the carrying amount of the investment exceeds its estimated fair value.

Long-Lived Assets

Property, plant and equipment are stated at cost. Interest capitalized in property, plant and equipment amounted to $2.2, $0.8 and $0.4 during fiscal 2022, fiscal 2021 and fiscal 2020, respectively. Expenditures for maintenance and repairs are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost of the asset and the related accumulated depreciation are removed from the accounts with the resulting gain or loss being reflected in income from operations.

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows:


Land improvements			10 – 25 years
Buildings			10 – 40 years
Machinery and equipment			3 – 15 years
Furniture and fixtures			6 – 10 years
Software			3 – 8 years

Intangible assets subject to amortization include technology, patents, customer relationships, non-compete agreements and certain trade names. These intangible assets are amortized over their estimated useful economic lives, which typically range from 3 to 25 years. The Company’s fixed assets and intangible assets subject to amortization are required to be tested for recoverability whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. If an evaluation of recoverability is required, the estimated undiscounted future cash flows associated with the asset group would be compared to the asset group carrying amount to determine if a write-down is required. If the undiscounted cash flows are less than the carrying amount, an impairment loss is recorded to the extent that the carrying amount exceeds fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

The Company had non-cash investing activities of $33.3, $41.6 and $26.4 during fiscal 2022, fiscal 2021 and fiscal 2020, respectively, representing unpaid liabilities to acquire property, plant and equipment.

Internal Use Software

The Company capitalizes certain qualifying costs incurred in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest and payroll and payroll-related costs for employees during the application development stage. Internal and external costs incurred during the preliminary project stage and post implementation-operation stage, mainly training and maintenance costs, are expensed as incurred. Once the application is substantially complete and ready for its intended use, qualifying costs are amortized on a straight-line basis over the software’s estimated useful life. Capitalized internal use software is included in the “Property, plant and equipment, net” line in the

Consolidated Balance Sheets. Capitalized software as a service is included in the “Prepaid and other current assets” line in the Consolidated Balance Sheets and is amortized using the straight-line method over the term of the hosting arrangement which typically ranges from 3 to 7 years.

Goodwill and Indefinite-lived Intangible Assets

Goodwill and indefinite-lived intangible assets are not subject to amortization. Goodwill and indefinite-lived intangible assets are reviewed for impairment by applying a fair-value based test on an annual basis as of the first day of the Company’s fiscal fourth quarter or more frequently if circumstances indicate impairment may have occurred. With respect to goodwill, the Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative test include reporting unit specific operating results as well as new events and circumstances impacting the operations or cash flows of the reporting units. For the quantitative test, the Company assesses goodwill for impairment by comparing the carrying value of its reporting units to their respective fair values. A reporting unit is defined as an operating segment or one level below an operating segment. The Company determines the fair value of its reporting units using a combination of income-based and market-based approaches and incorporates assumptions it believes market participants would utilize. The income-based approach utilizes discounted cash flows while the market-based approach utilizes market multiples. These approaches depend upon internally-developed forecasts based on annual budgets and longer-range strategic plans. The Company uses discount rates that are commensurate with the risks and uncertainties inherent in the respective reporting units and in the internally-developed forecasts. To further substantiate fair value, the Company compares the aggregate fair value of the reporting units to the Company’s total market capitalization.

With respect to indefinite-lived intangible assets, the Company performs either a qualitative or quantitative evaluation for each asset. Factors considered in the qualitative test include asset specific operating results as well as new events and circumstances impacting the cash flows of the assets. For the quantitative test, the fair value of the Company’s indefinite-lived intangible assets is determined under the income-based approach utilizing discounted cash flows and incorporating assumptions the Company believes market participants would utilize. For trade names, fair value is determined using a relief-from-royalty methodology similar to that employed when the associated businesses were acquired but using updated estimates of sales, cash flow and profitability.

If it is determined that an impairment has occurred, an impairment loss is recognized for the amount by which the carrying value of the reporting unit or intangible asset exceeds its estimated fair value and classified as “Impairment, restructuring and other” within “Operating expenses” in the Consolidated Statements of Operations.

Investments in Securities

Convertible debt investments are classified as “available for sale,” are reported at fair value and are presented in the “Other assets” line in the Consolidated Balance Sheets. Unrealized gains and losses on these investments are included in accumulated other comprehensive loss (“AOCL”) in the Consolidated Balance Sheets. When a decline in fair value is considered to be other-than-temporary at the balance sheet date, an allowance for credit losses (impairment), including any write-off of accrued interest receivable, is charged to earnings. If management can assert that it does not intend to sell the security and it is not more likely than not that it will have to sell the security before recovering its amortized cost basis (net of allowance), then the impairment allowance is separated into two components: (i) the amount related to credit losses (recorded in earnings) and (ii) the amount related to all other factors (recorded in other comprehensive income). Interest income is recorded on an accrual basis and is classified in the “Other non-operating income, net” line in the Consolidated Statements of Operations.

Insurance and Self-Insurance

The Company maintains insurance for certain risks, including workers’ compensation, general liability and vehicle liability, and is self-insured for employee-related health care benefits up to a specified level for individual claims. The Company accrues for the expected costs associated with these risks by considering historical claims experience, demographic factors, severity factors and other relevant information. Costs are recognized in the period the claim is incurred, and accruals include an actuarially determined estimate of claims incurred but not yet reported.

Income Taxes

The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax bases. Management reviews the Company’s deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company’s tax provision in the period of change.

The Company establishes a liability for tax return positions in which there is uncertainty as to whether or not the position will ultimately be sustained. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled. The Company recognizes interest expense and penalties related to these unrecognized tax benefits within income tax expense. GAAP provides that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits of the position. The amount recognized is measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.

U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.

Translation of Foreign Currencies

The functional currency for each Scotts Miracle-Gro subsidiary is generally its local currency. Assets and liabilities of these subsidiaries are translated at the exchange rate in effect at each fiscal year-end. Income and expense accounts are translated at the average rate of exchange prevailing during the year. Translation gains and losses arising from the use of differing exchange rates from period to period are included in AOCL within shareholders’ equity. Foreign exchange transaction gains and losses are included in the determination of net income and classified as “Other (income) expense, net” in the Consolidated Statements of Operations. The Company recognized foreign exchange transaction (gains) losses of $1.3, $(1.8) and $0.9 during fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

Derivative Instruments

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. A variety of financial instruments, including forwards, futures and swap contracts, are used to manage these exposures. These financial instruments are recognized at fair value in the Consolidated Balance Sheets, and all changes in fair value are recognized in net income or shareholders’ equity through AOCL. The Company’s objective in managing these exposures is to better control these elements of cost and mitigate the earnings and cash flow volatility associated with changes in the applicable rates and prices.

The Company has established policies and procedures that encompass risk-management philosophy and objectives, guidelines for derivative instrument usage, counterparty credit approval, and the monitoring and reporting of derivative activity. The Company does not enter into derivative instruments for the purpose of speculation.

The Company formally designates and documents instruments at inception that qualify for hedge accounting of underlying exposures in accordance with GAAP. The Company formally assesses, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the expected cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. The Company designates certain commodity hedges as cash flow hedges of forecasted purchases of commodities and interest rate swap agreements as cash flow hedges of interest payments on variable rate borrowings. Changes in the fair value of derivative contracts that qualify for hedge accounting are recorded in AOCL. For commodity hedges, realized gains or losses remain as a component of AOCL until the related inventory is sold.

During the second quarter of fiscal 2016, the Company entered into definitive agreements with Bonnie Plants, Inc. and its sole shareholder, Alabama Farmers Cooperative, Inc. (“AFC”), that included options beginning in fiscal 2020 providing for either (i) the Company to increase its economic interest in Bonnie’s business of planting, growing, developing, manufacturing, distributing, marketing, and selling live plants, plant food, fertilizer and potting soil (the “Bonnie Business”) or (ii) AFC and Bonnie to repurchase the Company’s economic interest in the Bonnie Business (collectively, the “Bonnie Option”). The Bonnie Option was surrendered at the time of the formation of the Bonnie Plants, LLC joint venture on December 31, 2020. Prior to this, the Bonnie Option was required to be accounted for as a derivative instrument and was recorded at fair value in the “Other assets” line in the Consolidated Balance Sheets, with changes in fair value recognized in the “Other non-operating income, net” line in the Consolidated Statements of Operations.

Leases

The Company determines whether an arrangement contains a lease at inception by determining if the contract conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consideration and other facts and circumstances. Right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease

term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets are calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date and initial direct costs incurred by the Company and exclude any lease incentives received from the lessor. Lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. The lease term may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date based on the lease term. The Company considers its credit rating and the current economic environment in determining this collateralized rate. Variable lease payments are the portion of lease payments that are not fixed over the lease term. Variable lease payments are expensed as incurred and include certain non-lease components, such as maintenance and other services provided by the lessor, and other charges included in the lease, as applicable. The Company elected to exclude short-term leases, defined as leases with initial terms of 12 months or less, from its Consolidated Balance Sheets.

Statements of Cash Flows

Supplemental cash flow information was as follows:


	Year Ended September 30,
	2022		2021		2020

Interest paid	$	112.5	$	61.6	$	75.9


Income taxes paid	27.2		179.7		124.2

Cash flow from operating activities in fiscal 2022 and fiscal 2021 was favorably impacted by extended payment terms with vendors across the U.S. Consumer and Hawthorne segments, as well as Monsanto Company, a subsidiary of Bayer AG (“Monsanto”), for payments originally due in the final weeks of fiscal 2022 and fiscal 2021 that were paid in the first quarter of fiscal 2023 and 2022, respectively.

The Company received (paid) cash of $29.3, $(8.7) and $(2.9) during fiscal 2022, fiscal 2021 and fiscal 2020, respectively, associated with currency forward contracts, which was classified as an investing activity in the “Other investing, net” line in the Consolidated Statements of Cash Flows.

The Company uses the “cumulative earnings” approach for determining cash flow presentation of distributions from unconsolidated affiliates. Distributions received are included in the Consolidated Statements of Cash Flows as operating activities, unless the cumulative distributions exceed the portion of the cumulative equity in the net earnings of the unconsolidated affiliate, in which case the excess distributions are deemed to be returns of the investment and are classified as investing activities in the Consolidated Statements of Cash Flows.

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and also clarifies and amends existing guidance to improve consistent application. The company adopted this guidance on October 1, 2021. The adoption of this guidance did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

REVENUE RECOGNITION	12 Months Ended
REVENUE RECOGNITION	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
REVENUE RECOGNITION	REVENUE RECOGNITION Nature of Goods and Services The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. Prior to December 31, 2020, the Company also provided marketing, research and development and certain ancillary services to Bonnie. Refer to “NOTE 21. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 7. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements. Identification and Satisfaction of Performance Obligations The Company recognizes product sales at a point in time when it transfers control of products to customers and has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction and, therefore, primarily records revenue on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer. Under the terms of the Third Amended and Restated Exclusive Agency and Marketing Agreement (the “Third Restated Agreement”), pursuant to which the Company serves as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The Third Restated Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Third Restated Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income. Prior to December 31, 2020, in exchange for services performed pursuant to the terms of the Marketing, R&D and Ancillary Services Agreement (the “Services Agreement”) between the Company and AFC, Bonnie reimbursed the Company for certain costs and provided a commission fee earned based on a percentage of the growth in earnings before interest, income taxes and amortization of the Bonnie Business. The commission earned under the Services Agreement was included in the “Net sales” line in the Consolidated Statements of Operations. Additionally, the Company recorded costs incurred under the Services Agreement for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income. Transactional Price and Promotional Allowances Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto agreements is recognized over the program year as the services are performed based upon the commission income formula in the agreements. The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotional costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

DISCONTINUED OPERATIONS

12 Months Ended

Sep. 30, 2022

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS

International Business

Prior to August 31, 2017, the Company operated consumer lawn and garden businesses located in Australia, Austria, Belgium, Luxembourg, Czech Republic, France, Germany, Poland and the United Kingdom (the “International Business”). On August 31, 2017, the Company completed the sale of the International Business. As a result, effective in its fourth quarter of fiscal 2017, the Company classified its results of operations for all periods presented to reflect the International Business as a discontinued operation. The sale proceeds were net of seller financing provided by the Company in the form of a $29.7 loan for seven years bearing interest at 5% for the first three years, with annual 2.5% increases thereafter. The seller financing loan receivable is recorded in the “Other assets” line in the Consolidated Balance Sheets as of September 30, 2022. The transaction also included contingent consideration with a maximum payout of $23.8 and an initial fair value of $18.2, the payment of which depended on the achievement of certain performance criteria by the International Business following the closing of the transaction through fiscal 2020. During fiscal 2021, the Company agreed to accept a contingent consideration payout of $6.0 and recorded a pre-tax charge of $12.2 in the “Income (loss) from discontinued operations, net of tax” line in the Consolidated Statements of Operations during fiscal 2021 to write-down the contingent consideration receivable to the agreed upon payout amount. This contingent consideration payment was received during fiscal 2022 and this amount was classified as a financing activity in the “Other financing, net” line in the Consolidated Statements of Cash Flows.

The following table summarizes the results of discontinued operations described above and reflected within discontinued operations in the Company’s consolidated financial statements for each of the periods presented:


	Year Ended September 30,
	2022		2021		2020


Operating and exit costs	$	—	$	—	$	1.3
Impairment, restructuring and other charges (recoveries)	—		—		(3.1)

Write-down of contingent consideration receivable	—		12.2		—

Income (loss) from discontinued operations before income taxes	—		(12.2)		1.8
Income tax expense (benefit) from discontinued operations	—		(8.3)		0.1
Income (loss) from discontinued operations, net of tax	$	—	$	(3.9)	$	1.7

The Consolidated Statements of Cash Flows do not present the cash flows from discontinued operations separately from cash flows from continuing operations. Cash provided by (used in) operating activities related to discontinued operations was zero for fiscal 2022 and fiscal 2021, and was $3.6 for fiscal 2020. Cash (used in) provided by investing activities related to discontinued operations was zero for fiscal 2022, fiscal 2021 and fiscal 2020.

IMPAIRMENT, RESTRUCTURING AND OTHER

12 Months Ended

Sep. 30, 2022

Restructuring and Related Activities [Abstract]

IMPAIRMENT, RESTRUCTURING AND OTHER

Activity described herein is classified within the “Cost of sales—impairment, restructuring and other,” “Impairment, restructuring and other” and “Income (loss) from discontinued operations, net of tax” lines in the Consolidated Statements of Operations. The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:


	Year Ended September 30,
	2022		2021		2020

Cost of sales—impairment, restructuring and other:
COVID-19 related costs	$	—	$	25.0	$	15.5
Restructuring and other charges (recoveries), net	143.6		(0.3)		(0.1)
Property, plant and equipment impairments	16.6		—		0.6

Operating expenses—impairment, restructuring and other:
COVID-19 related costs	—		4.2		3.9
Restructuring and other charges (recoveries), net	40.9		0.1		(3.1)
Gains on sale of property, plant and equipment	(16.2)		—		—
Goodwill and intangible asset impairments	668.3		—		—
Impairment, restructuring and other charges from continuing operations	853.2		29.0		16.8
Restructuring and other charges (recoveries), net, from discontinued operations	—		—		(3.1)
Total impairment, restructuring and other charges	$	853.2	$	29.0	$	13.7

The following table summarizes the activity related to liabilities associated with restructuring activities for each of the periods presented:


	Year Ended September 30,
	2022		2021		2020

Amounts accrued for restructuring activities at beginning of year	$	1.9	$	3.9	$	11.6
Restructuring and other charges from continuing operations	47.1		29.0		20.0

Payments and other	(17.5)		(31.0)		(27.7)
Amounts accrued for restructuring activities at end of year	$	31.5	$	1.9	$	3.9

Included in restructuring accruals, as of September 30, 2022, is $4.6 that is classified as long-term. The remaining amounts accrued will continue to be paid out over the course of the next twelve months.

During fiscal 2022, the Company recognized non-cash, pre-tax goodwill and intangible asset impairment charges of $632.4 as a result of interim impairment testing of its Hawthorne segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, comprised of $522.4 of goodwill impairment charges and $110.0 of finite-lived intangible asset impairment charges.

During fiscal 2022, the Company incurred inventory write-down charges of $120.9 in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations and finite-lived intangible asset impairment charges of $35.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with its decision to discontinue and exit the market for certain Hawthorne lighting products and brands.

During fiscal 2022, the Company began implementing a series of organizational changes and initiatives intended to create operational and management-level efficiencies. As part of this restructuring program, the Company is reducing the size of its supply chain network, reducing staffing levels and implementing other cost-reduction initiatives. During fiscal 2022, the Company incurred costs of $65.2 associated with this restructuring initiative primarily related to employee termination benefits and impairment of property, plant and equipment. The Company incurred costs of $9.7 in its U.S. Consumer segment and $27.1 in its Hawthorne segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022. The Company incurred costs of $11.9 in its U.S. Consumer segment, $8.1 in its Hawthorne segment, $0.7 in its Other segment and $7.7 at Corporate in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2022.

During fiscal 2022, the Company recognized gains of $16.2 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with the sale of property, plant and equipment.

Costs incurred during fiscal 2022 related to COVID-19 were immaterial. During 2021, the Company incurred costs of $29.2 associated with the COVID-19 pandemic primarily related to premium pay. The Company incurred costs of $21.2 in its U.S. Consumer segment, $3.2 in its Hawthorne segment and $0.6 in its Other segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2021. The Company incurred costs of $4.0 in its U.S. Consumer segment and $0.2 in its Other segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2021. During fiscal 2020, the Company incurred costs of $19.4 associated with the COVID-19 pandemic primarily related to premium pay. The Company incurred costs of $12.4 in its U.S. Consumer segment, $2.6 in its Hawthorne segment and $0.5 in its Other segment in the “Cost of sales—impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2020. The Company incurred costs of $3.8 in its U.S. Consumer segment and $0.1 in its Other segment in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations during fiscal 2020.

GOODWILL AND INTANGIBLE ASSETS, NET

12 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS, NET

GOODWILL AND INTANGIBLE ASSETS, NETThe following table displays a rollforward of the carrying amount of goodwill by reportable segment:


	U.S. Consumer		Hawthorne		Other		Total
Goodwill	$	229.9	$	400.1	$	10.5	$	640.5
Accumulated impairment losses	(1.8)		(94.6)		—		(96.4)
Balance at September 30, 2020	228.1		305.5		10.5		544.1
Acquisitions and measurement-period adjustments	—		60.5		—		60.5
Foreign currency translation	—		—		0.6		0.6
Reallocation	15.8		(15.8)		—		—


Goodwill	$	245.7	$	444.8	$	11.1	$	701.6
Accumulated impairment losses	(1.8)		(94.6)		—		(96.4)
Balance at September 30, 2021	243.9		350.2		11.1		605.2
Acquisitions and measurement-period adjustments	—		180.8		—		180.8
Foreign currency translation	—		(8.6)		(1.0)		(9.6)
Impairment	—		(522.4)		—		(522.4)


Goodwill	$	245.7	$	617.0	$	10.1	$	872.8
Accumulated impairment losses	(1.8)		(617.0)		—		(618.8)
Balance at September 30, 2022	$	243.9	$	—	$	10.1	$	254.0

The following table presents intangible assets, net of accumulated amortization and impairment charges:


	September 30, 2022						September 30, 2021
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount

Finite-lived intangible assets:
Trade names	$	318.4	$	(174.3)	$	144.1	$	293.4	$	(73.3)	$	220.1
Customer relationships	251.1		(158.4)		92.7		228.3		(91.7)		136.6
Technology	49.1		(43.3)		5.8		49.2		(41.3)		7.9
Other	34.7		(21.0)		13.7		35.3		(14.2)		21.1
Total finite-lived intangible assets, net					256.3						385.7
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7

Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	580.2					$	709.6

During fiscal 2022, the Company’s Hawthorne reporting unit experienced adverse financial results due to decreased sales volume and higher transportation and warehousing costs. Sales volume decreased due to an oversupply of cannabis, which significantly decreased cannabis wholesale prices and indoor and outdoor cannabis cultivation. As a result, the Company revised its internal forecasts relating to its Hawthorne reporting unit. The Company concluded that the changes in circumstances in this reporting unit and the decline in the Company’s market capitalization triggered the need for an interim impairment review of its goodwill during the third quarter of fiscal 2022. These changes in circumstances also indicated that the carrying amounts of Hawthorne’s long-lived assets, including trade names and customer relationships, may not be recoverable. Accordingly, the Company performed a recoverability test for long-lived assets during the third quarter of fiscal 2022. The Company concluded that the carrying value of long-lived assets exceeded their estimated fair value and recorded pre-tax impairment charges of $69.0 related to trade names and $41.0 related to customer relationships, which were recognized during the third quarter of fiscal 2022 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The fair values of long-lived assets were determined using income-based approaches, including the relief-from-royalty method for trade names, that include market participant expectations of cash flows that the assets will generate over the remaining useful life discounted to present value using an appropriate discount rate. These fair value estimates utilize significant unobservable inputs and, therefore, represent Level 3 fair value measurements.

After adjusting the carrying values of the finite-lived intangible assets, the Company completed an interim quantitative impairment test for goodwill during the third quarter of fiscal 2022. This quantitative test resulted in a non-cash, pre-tax goodwill impairment charge of $522.4 related to the Hawthorne reporting unit, which was recognized during the third quarter of fiscal 2022 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The carrying value of goodwill of the Hawthorne reporting unit, after recognizing the impairment, is zero. The estimated fair value of the Hawthorne reporting unit was based upon an equal weighting of the income-based and market-based approaches, utilizing estimated cash flows and a terminal value, discounted at a rate of return that reflects the relative risk of the cash flows, as well as valuation multiples derived from comparable publicly traded companies that are applied to operating performance of the reporting unit. The fair value estimate utilizes significant unobservable inputs and thus represents a Level 3 fair value measurement.

During fiscal 2022, the Company also incurred additional finite-lived intangible asset impairment charges of $35.3, comprised of $22.5 related to trade names and $12.8 related to customer relationships, which were recognized during the fourth quarter of fiscal 2022 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations, associated with its decision to discontinue and exit the market for certain Hawthorne lighting products and brands.

During fiscal 2021, the Company changed its internal organization structure such that AeroGrow is now managed by and reported within the U.S. Consumer segment. Within the U.S. Consumer segment, AeroGrow is integrated into the Company’s overall direct to consumer focus and strategy. AeroGrow was previously managed by and reported within the Hawthorne segment. This change in organization structure resulted in a change in the Company’s reporting units. As a result, goodwill included in impacted reporting units was reallocated using a relative fair value approach, resulting in $15.8 of goodwill

reallocated from the Hawthorne segment to the U.S. Consumer segment during fiscal 2021. In addition, the Company completed an assessment of potential goodwill impairment immediately before and after the reallocation and determined that no impairment existed.

Total amortization expense was $37.1, $30.9 and $32.5 for fiscal 2022, fiscal 2021 and fiscal 2020, respectively. Amortization expense is estimated to be as follows for the years ending September 30:


2023	$	27.0
2024	22.8
2025	20.0
2026	18.6
2027	17.4

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS

12 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS

The following presents detail regarding certain financial statement accounts:


	September 30,
	2022		2021

INVENTORIES:
Finished goods	$	926.2	$	793.7
Raw materials	293.2		242.8
Work-in-progress	124.1		90.1
	$	1,343.5	$	1,126.6
PROPERTY, PLANT AND EQUIPMENT, NET:
Land and improvements	$	145.0	$	144.2
Buildings	262.2		268.5
Machinery and equipment	644.0		585.9
Furniture and fixtures	65.4		53.0
Software	127.9		116.2
Finance leases	43.9		42.4
Aircraft	—		16.6
Construction in progress	95.5		132.8
	1,383.9		1,359.6
Less: accumulated depreciation	(777.9)		(737.4)
	$	606.0	$	622.2
OTHER ASSETS:
Operating lease right-of-use assets	$	288.9	$	293.0
Deferred tax assets	143.5		—
Convertible debt investments	117.0		190.3
Accrued pension, postretirement and executive retirement assets	69.6		89.9
Loans receivable	32.8		35.8

Other	29.1		23.0
	$	680.9	$	632.0

During fiscal 2022, the Company sold certain property, plant and equipment, including building, land and aircraft, for proceeds of $63.3, and recognized gains of $16.2 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations associated with these sales.


	September 30,
	2022		2021

OTHER CURRENT LIABILITIES:
Current operating lease liabilities	$	76.2	$	66.4
Advertising and promotional accruals	74.8		132.7
Payroll and other compensation accruals	44.2		91.5

Accrued taxes	29.4		31.7
Accrued interest	30.1		28.0



Other	142.3		122.9
	$	397.0	$	473.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	$	223.2	$	234.4
Accrued pension, postretirement and executive retirement liabilities	82.1		98.2
Deferred tax liabilities	8.5		47.8

Other	45.2		29.2
	$	359.0	$	409.6

MARKETING AGREEMENT

12 Months Ended

Sep. 30, 2022

Marketing Agreement [Abstract]

MARKETING AGREEMENT

The Scotts Company LLC (“Scotts LLC”) is the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries. The annual commission payable under the Third Restated Agreement is equal to 50% of the actual earnings before interest and income taxes of Monsanto’s consumer Roundup® business for each program year in the markets covered by the Third Restated Agreement (“Program EBIT”). The Third Restated Agreement also requires the Company to make annual payments of $18.0 to Monsanto as a contribution against the overall expenses of its consumer Roundup® business, subject to reduction pursuant to the Third Restated Agreement for any program year in which the Program EBIT does not equal or exceed $36.0.

Unless Monsanto terminates the Third Restated Agreement due to an event of default by the Company, termination rights under the Third Restated Agreement include the following:

•The Company may terminate the Third Restated Agreement upon the insolvency or bankruptcy of Monsanto;

•Monsanto may terminate the Third Restated Agreement in the event that Monsanto decides to decommission the permits, licenses and registrations needed for, and the trademarks, trade names, packages, copyrights and designs used in, the sale of the Roundup® products in the lawn and garden market (a “Brand Decommissioning Termination”); and

•Each party may terminate the Third Restated Agreement if Program EBIT falls below $50.0 and, in such case, no termination fee would be payable to either party.

The termination fee structure requires Monsanto to pay a termination fee to the Company in an amount equal to (i) $375.0 upon a Brand Decommissioning Termination, and (ii) the greater of $175.0 or four times an amount equal to the average of the Program EBIT for the three program years before the year of termination, minus $186.4, if Monsanto or its successor terminates the Third Restated Agreement as a result of a Roundup Sale or Change of Control of Monsanto (each, as defined in the Third Restated Agreement).

The Company entered into the Brand Extension Agreement Asset Purchase Agreement (the “BEA Purchase Agreement”) on August 1, 2019 in connection with signing of the Third Restated Agreement. The BEA Purchase Agreement provides for the sale by the Company to Monsanto of specified assets related to, among other things, the development, manufacture, production, advertising, marketing, promotion, distribution, importation, exportation, offer for sale and sale of specified Roundup® branded products sold outside the non-selective weedkiller category within the residential lawn and garden market. The consideration paid by Monsanto was $112.0 plus the value of finished goods inventory of $3.5. This consideration receivable was recorded in the “Prepaid and other current assets” line in the Consolidated Balance Sheets until it was received by the Company on January 13, 2020. The carrying value of the assets sold, which included the brand extension agreement intangible asset with a carrying value of $111.7, approximated the consideration received, resulting in an insignificant gain on the sale.

The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Consolidated Statements of Operations are as follows:


	Year Ended September 30
	2022		2021		2020

Gross commission	$	83.4	$	94.0	$	90.4
Contribution expenses	(18.0)		(18.0)		(18.0)

Net commission	65.4		76.0		72.4
Reimbursements associated with Roundup® marketing agreement	67.9		70.8		61.6
Total net sales associated with Roundup® marketing agreement	$	133.3	$	146.8	$	134.0

ACQUISITIONS AND INVESTMENTS	12 Months Ended
ACQUISITIONS AND INVESTMENTS	Sep. 30, 2022
Business Combinations [Abstract]
ACQUISITIONS AND INVESTMENTS	ACQUISITIONS AND INVESTMENTS Cyco On April 28, 2022, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of S.J. Enterprises PTY LTD, d.b.a. Cyco (“Cyco”), an Australia-based provider of premium nutrients, additives and growing media products for indoor growing sold mostly in the United States, for an estimated purchase price of $37.3. The purchase price includes contingent consideration, a non-cash investing activity, with an initial fair value of $3.1 and a maximum payout of $10.0, which will be paid by the Company based on the achievement of certain performance metrics through December 31, 2024. Prior to the transaction, the Company served as the exclusive distributor of Cyco’s products in the United States. The valuation of the acquired assets included (i) $1.3 of inventory, (ii) $10.5 of finite-lived identifiable intangible assets and (iii) $25.6 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Luxx Lighting On December 30, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of Luxx Lighting, Inc., a provider of lighting products for indoor growing. The purchase price was $213.2, a portion of which was paid by the issuance of 0.1 million Common Shares, a non-cash investing and financing activity, with a fair value of $21.0 based on the share price at the time of payment. The valuation of the acquired assets included (i) $32.8 of inventory and accounts receivable, (ii) $5.7 of other current assets, (iii) $24.2 of current liabilities, (iv) $47.3 of finite-lived identifiable intangible assets and (v) $151.6 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. During the fourth quarter of fiscal 2022, the Company decided it would discontinue and exit the market for certain Hawthorne lighting products and brands, including Luxx Lighting. Refer to “NOTE 4. IMPAIRMENT, RESTRUCTURING AND OTHER” for more information. True Liberty Bags On December 23, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of True Liberty Bags, a leading provider of liners and storage solutions to dry and cure plant products, for $10.1. The valuation of the acquired assets included (i) $1.1 of inventory, (ii) $5.8 of finite-lived identifiable intangible assets and (iii) $3.2 of tax-deductible goodwill. Identifiable intangible assets included trade names and customer relationships with useful lives of 15 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. Hydro-Logic On August 27, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of Hydro-Logic Purification Systems, Inc., a leading provider of products, accessories and systems for water filtration and purification, for $65.3. The valuation of the acquired assets included (i) $4.5 of inventory and accounts receivable, (ii) $1.6 of non-current assets, (iii) $2.6 of other liabilities, (iv) $23.1 of finite-lived identifiable intangible assets and (v) $38.7 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with useful lives ranging between 5 and 15 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. The Hawthorne Collective On August 24, 2021, the Company’s wholly-owned subsidiary, The Hawthorne Collective, Inc. (“THC”), made its initial investment under the Company’s strategic minority non-equity investment initiative in the form of a $150.0 six-year convertible note issued to the Company by Toronto-based RIV Capital Inc. (“RIV Capital”) (CSE: RIV) (OTC: CNPOF), a cannabis investment and acquisition firm listed on the Canadian Securities Exchange. The note bears interest on the principal amount at a rate of approximately 2% for the first two years of the term. No interest will accrue on the note for the remainder of the term. The note is convertible into RIV Capital common shares at a conversion price of CAD $1.90 per share which is based upon the RIV Capital closing stock price on August 9, 2021. On April 22, 2022, pursuant to its follow-on investment rights, the Company made an additional investment in RIV Capital in the form of a $25.0 convertible note which matures on August 24, 2027. The note bears interest on the principal amount at a rate of approximately 2% for the first two years of the term. No interest will accrue on the note for the remainder of the term. The note is convertible into RIV Capital common shares at a conversion price of CAD $1.65 per share which is based upon the RIV Capital closing stock price on March 29, 2022. Accrued interest on the initial $150.0 convertible note and the follow-on $25.0 convertible note (collectively, the “RIV Convertible Notes”) will be payable to THC at maturity or will be included in the conversion value of the notes at the time of conversion. Assuming full conversion of the RIV Convertible Notes, including the full amount of the anticipated accrued interest over the life of the notes, THC would be entitled to receive approximately 123.0 million common shares of RIV Capital, representing approximately 42% of RIV Capital’s outstanding shares as of September 30, 2022. The RIV Convertible Notes are convertible into common shares of RIV Capital either (i) at the election of THC or (ii) at the election of RIV Capital after the date on which federal laws in the United States are amended to allow for the general cultivation, distribution, and possession of cannabis. In connection with issuance of the RIV Convertible Notes, the Company entered into an investor rights agreement with RIV Capital providing for, among other things, customary registration rights, participation rights, as well as certain standstill and transfer restrictions. In addition, THC is entitled to designate three nominees to the RIV Capital board of directors for so long as the board is comprised of seven directors, and shall be entitled to designate four nominees to the RIV Capital board of directors if the size of the board is increased to nine directors. During the fourth quarter of fiscal 2021, THC made minority non-equity investments of $43.1 in other entities focused on branded cannabis and high quality genetics. These additional investments also include conversion features that would provide the Company with minority ownership interests if it exercises the conversion features. The Company or THC will not have control of or an active day-to-day role in any entity in which THC has a convertible debt investment. The convertible notes include restrictions that the funds received from the Company will be used for general corporate and other lawful purposes, which could include acquisitions, and that the funds will not be used in connection with or for any cannabis or cannabis-related operations in the U.S. unless and until such operations comply with all applicable U.S. federal laws. Rhizoflora On August 13, 2021, the Company’s Hawthorne segment completed the acquisition of substantially all of the assets of Rhizoflora, Inc., the manufacturer of terpene enhancing nutrient products Terpinator® and Purpinator®, for $33.7. The valuation of the acquired assets included (i) $0.6 of inventory, (ii) $10.9 of finite-lived identifiable intangible assets and (iii) $22.2 of tax-deductible goodwill. Identifiable intangible assets included trade names, customer relationships and non-compete agreements with useful lives ranging between 5 and 25 years. The estimated fair values of the identifiable intangible assets were determined using an income-based approach, which includes market participant expectations of cash flows that an asset will generate over the remaining useful life discounted to present value using an appropriate discount rate. AeroGrow On November 11, 2020, the Company entered into an agreement and plan of merger to acquire the remaining outstanding shares of AeroGrow for cash consideration of $3.00 per share, or approximately $20.1. The merger closed on February 26, 2021. SMG Growing Media, Inc., a wholly-owned subsidiary of Scotts Miracle-Gro, was the holder of 80.5% of the outstanding shares of AeroGrow prior to the closing and now holds 100% of the outstanding shares of AeroGrow. The closing date carrying value of the noncontrolling interest was $6.7 and the $13.4 difference between the purchase price and carrying value was recognized in the “Common shares and capital in excess of $0.01 stated value per share” line within “Total equity” in the Consolidated Balance Sheets.

INVESTMENT IN UNCONSOLIDATED AFFILIATES	12 Months Ended
INVESTMENT IN UNCONSOLIDATED AFFILIATES	Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENT IN UNCONSOLIDATED AFFILIATES	INVESTMENT IN UNCONSOLIDATED AFFILIATES On December 31, 2020, pursuant to the terms of the Contribution and Unit Purchase Agreement between the Company and AFC, the Company acquired a 50% equity interest in the Bonnie Plants business of planting, growing, developing, distributing, marketing and selling live plants through a joint venture with AFC (“Bonnie Plants, LLC”) in exchange for cash payments of $102.3, as well as non-cash investing activities that included forgiveness of the Company’s outstanding loan receivable with AFC and surrender of the Company’s options to increase its economic interest in the Bonnie Plants business. The Company’s loan receivable with AFC, which was previously recognized in the “Other assets” line in the Consolidated Balance Sheets, had a carrying value of $66.4 on December 31, 2020 and the Company recognized a gain of $12.5 during the first quarter of fiscal 2021 to write-up the value of the loan to its closing date fair value of $78.9 in the “Other non-operating income, net” line in the Consolidated Statements of Operations. The Company’s options to increase its economic interest in the Bonnie Plants business were previously recognized in the “Other assets” line in the Consolidated Balance Sheets and had an estimated fair value of $23.3 on December 31, 2020. The Company’s interest in Bonnie Plants, LLC had an initial fair value of $202.9 and is recorded in the “Investment in unconsolidated affiliates” line in the Consolidated Balance Sheets. The estimated fair value of the loan receivable with AFC was determined using an income-based approach, which includes market participant expectations of cash flows over the remaining useful life discounted to present value using an appropriate discount rate. The fair value estimate utilized significant unobservable inputs and thus represents a Level 3 nonrecurring fair value measurement.The Company’s interest is accounted for using the equity method of accounting, with the Company’s proportionate share of Bonnie Plants, LLC earnings subsequent to December 31, 2020 reflected in the Consolidated Statements of Operations. The Company recorded equity in (income) loss of unconsolidated affiliates associated with Bonnie Plants, LLC of $12.9 and $(14.4) during fiscal 2022 and fiscal 2021, respectively. The Company also received a distribution of $12.0 from Bonnie Plants, LLC during fiscal 2021, which was classified as an operating activity in the Consolidated Statements of Cash Flows.

RETIREMENT PLANS

12 Months Ended

Sep. 30, 2022

Retirement Benefits [Abstract]

RETIREMENT PLANS

The Company sponsors a defined contribution 401(k) plan for substantially all U.S. associates. The Company matches 200% of associates’ initial 3% contribution and 50% of their remaining contribution up to 6%. The Company may make additional discretionary profit sharing matching contributions to eligible employees on their initial 4% contribution. The Company recorded charges of $28.3, $30.1 and $27.7 under the plan in fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

The Company sponsors two defined benefit pension plans for certain U.S. associates and three defined benefit pension plans associated with the former businesses in the United Kingdom and Germany. Benefits under these plans have been frozen and closed to new associates since 1997 for the U.S. plans, 2010 for the United Kingdom plans and 2017 for the Germany plan. The benefits under the plans are based on years of service and compensation levels. The Company’s funding policy for the defined benefit pension plans, consistent with statutory requirements and tax considerations, is based on actuarial computations using the Projected Unit Credit method.

During fiscal 2021, a defined benefit pension plan associated with the former business in the United Kingdom entered into a buy-in insurance policy in exchange for a premium payment of $67.7, which is subject to adjustment as a result of subsequent data cleansing activities. Under the terms of this buy-in insurance policy, the insurer is liable to pay the benefits to the plan but the plan still retains full legal responsibility to pay the benefits to plan participants using the insurance payments. The buy-in policy will be treated as an asset of the plan going forward until such time as the buy-in policy is converted to a buy-out policy, which is when individual insurance policies will be assigned to each plan participant and the plan will no longer have legal responsibility to pay the benefits to the plan participants.

The following tables present information about benefit obligations, plan assets, annual expense, assumptions and other information about the Company’s defined benefit pension plans. The defined benefit pension plans are valued using a September 30 measurement date.


	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2022		2021		2022		2021

Change in projected benefit obligation:
Benefit obligation at beginning of year	$	100.2	$	109.8	$	193.6	$	193.7

Interest cost	1.7		1.5		3.0		2.6
Actuarial gain	(17.2)		(4.1)		(55.1)		(2.9)
Benefits paid	(7.0)		(7.0)		(7.5)		(7.6)





Foreign currency translation	—		—		(24.8)		7.8
Projected benefit obligation (“PBO”) at end of year	$	77.7	$	100.2	$	109.2	$	193.6
Accumulated benefit obligation (“ABO”) at end of year	$	77.7	$	100.2	$	109.2	$	193.6
Change in plan assets:
Fair value of plan assets at beginning of year	$	81.7	$	81.5	$	221.6	$	209.9
Actual return on plan assets	(15.8)		5.9		(61.2)		2.1
Employer contribution	0.2		1.3		5.3		7.9

Benefits paid	(7.0)		(7.0)		(7.5)		(7.6)

Foreign currency translation	—		—		(29.3)		9.3

Fair value of plan assets at end of year	$	59.1	$	81.7	$	128.9	$	221.6
Overfunded (underfunded) status at end of year	$	(18.6)	$	(18.5)	$	19.7	$	28.0

The decrease in the PBO during fiscal 2022 was primarily driven by the increase in discount rates. These gains were partially offset by demographic experience losses, an update to the terminated vested retirement assumption, and the adoption of the updated mortality projection scale.


	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2022		2021		2022		2021

Information for pension plans with an ABO in excess of plan assets:

Accumulated benefit obligation	$	77.7	$	100.2	$	11.6	$	16.9
Fair value of plan assets	59.1		81.7		—		—
Information for pension plans with a PBO in excess of plan assets:
Projected benefit obligation	$	77.7	$	100.2	$	11.6	$	16.9
Fair value of plan assets	59.1		81.7		—		—
Amounts recognized in the Consolidated Balance Sheets consist of:

Non-current assets	$	—	$	—	$	31.3	$	44.9
Current liabilities	(0.2)		(0.2)		(0.8)		(0.9)
Non-current liabilities	(18.4)		(18.3)		(10.8)		(16.0)
Total amount accrued	$	(18.6)	$	(18.5)	$	19.7	$	28.0
Amounts recognized in AOCL consist of:
Actuarial loss	$	38.8	$	39.2	$	51.2	$	51.4
Prior service cost	—		—		2.1		2.7
Total amount recognized	$	38.8	$	39.2	$	53.3	$	54.1


	U.S. Defined Benefit Pension Plans						International Defined Benefit Pension Plans
	2022			2021			2022			2021

Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	$	(1.3)		$	6.6		$	(11.1)		$	(0.6)
Reclassification to net income	1.7			2.1			1.3			1.3



Foreign currency translation	—			—			10.6			(2.0)
Total change in other comprehensive loss	$	0.4		$	8.7		$	0.8		$	(1.3)




Weighted average assumptions used in development of projected benefit obligation:
Discount rate	5.06		%	2.37		%	4.96		%	1.90		%


	U.S. Defined Benefit Pension Plans									International Defined Benefit Pension Plans
	2022			2021			2020			2022			2021			2020

Components of net periodic benefit cost (income):

Interest cost	$	1.7		$	1.5		$	2.6		$	3.0		$	2.6		$	2.7
Expected return on plan assets	(2.8)			(3.4)			(3.9)			(5.1)			(5.5)			(6.9)
Net amortization	1.7			2.1			1.8			1.3			1.3			1.0
Net periodic benefit cost (income)	$	0.6		$	0.2		$	0.5		$	(0.8)		$	(1.6)		$	(3.2)




Weighted average assumptions used in development of net periodic benefit cost (income):


Weighted average discount rate - interest cost	1.74		%	1.43		%	2.44		%	1.64		%	1.26		%	1.42		%
Expected return on plan assets	3.50		%	4.25		%	5.00		%	2.37		%	2.45		%	3.39		%

Investment Strategy

Target allocation percentages among various asset classes are maintained based on an individual investment policy established for each of the various pension plans. Asset allocations are designed to achieve long-term objectives of return while mitigating against downside risk considering expected cash requirements necessary to fund benefit payments. However, the Company cannot predict future investment returns and therefore cannot determine whether future pension plan funding requirements could materially and adversely affect its financial condition, results of operations or cash flows.

Basis for Long-Term Rate of Return on Asset Assumptions

The Company’s expected long-term rate of return on asset assumptions are derived from studies conducted by third parties. The studies include a review of anticipated future long-term performance of individual asset classes and consideration of the appropriate asset allocation strategy given the anticipated requirements of the plans to determine the average rate of earnings expected. While the studies give appropriate consideration to recent fund performance and historical returns, the assumptions primarily represent expectations about future rates of return over the long term.


	U.S. Defined Benefit Pension Plans			International Defined Benefit Pension Plans

Other information:
Plan asset allocations:
Target for September 30, 2023:
Equity securities	22		%	25		%
Debt securities	74		%	44		%
Real estate securities	4		%	—		%
Cash and cash equivalents	—		%	1		%
Insurance contracts	—		%	30		%
September 30, 2022
Equity securities	17		%	25		%
Debt securities	75		%	44		%
Real estate securities	5		%	—		%
Cash and cash equivalents	3		%	1		%
Insurance contracts	—		%	30		%
September 30, 2021
Equity securities	20		%	22		%
Debt securities	73		%	48		%
Real estate securities	4		%	—		%
Cash and cash equivalents	3		%	—		%
Insurance contracts	—		%	30		%

Expected company contributions in fiscal 2023	$	0.2		$	1.1
Expected future benefit payments:
2023	$	7.4		$	5.6
2024	7.2			5.8
2025	7.0			6.1
2026	6.9			6.2
2027	6.8			6.2
2028 – 2032	30.5			33.8

The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value hierarchy:


		U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	Fair Value Hierarchy Level	2022		2021		2022		2021
Cash and cash equivalents	Level 1	$	2.1	$	2.9	$	1.7	$	0.2
Insurance contracts	Level 3	—		—		38.1		66.7
Total assets in the fair value hierarchy		$	2.1	$	2.9	$	39.8	$	66.9
Common collective trusts measured at net asset value
Real estate		$	2.8	$	3.4	$	—	$	—
Equities		10.0		16.0		32.6		48.3
Fixed income		44.2		59.4		56.5		106.4

Total common collective trusts measured at net asset value		57.0		78.8		89.1		154.7
Total assets at fair value		$	59.1	$	81.7	$	128.9	$	221.6

The carrying value of cash equivalents approximated their aggregate fair value as of September 30, 2022 and 2021. The valuation of the buy-in insurance policy was calculated on an insurer pricing basis updated for changes in market implied insurance pricing, market rates, and inflation during the year, and was estimated using unobservable inputs. Common collective trusts are not publicly traded and were valued at a net asset value unit price determined by the portfolio’s sponsor based on the fair value of underlying assets held by the common collective trust on September 30, 2022 and 2021. The common collective trusts hold underlying investments that have prices derived from quoted prices in active markets. The underlying assets are principally marketable equity and fixed income securities.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI https://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

ASSOCIATE MEDICAL BENEFITS

12 Months Ended

Sep. 30, 2022

Defined Benefit Plan, Postretirement Medical Plan with Prescription Drug Benefits [Abstract]

ASSOCIATE MEDICAL BENEFITS

The Company provides comprehensive major medical benefits to its associates. The Company is self-insured for certain health benefits up to $1.0 per occurrence per individual. The cost of such benefits is recognized as expense in the period the claim is incurred. This cost was $46.6, $43.7 and $34.2 in fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

The Company also provides comprehensive major medical benefits to certain retired associates and their dependents. Substantially all of the Company’s domestic associates who were hired before January 1, 1998 become eligible for these benefits if they retire at age 55 or older with more than ten years of service. The retiree medical plan requires certain minimum contributions from retired associates and includes provisions to limit the overall cost increases the Company is required to cover. The Company funds its portion of retiree medical benefits as claims are paid.

The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.


	2022		2021

Change in Accumulated Plan Benefit Obligation (APBO):
Benefit obligation at beginning of year	$	20.1	$	22.4
Service cost	0.2		0.2
Interest cost	0.5		0.4
Plan participants’ contributions	0.4		0.4
Actuarial gain	(4.0)		(0.8)
Curtailment loss	0.6		—

Benefits paid	(2.1)		(2.4)

Benefit obligation at end of year	$	15.7	$	20.1
Change in plan assets:
Fair value of plan assets at beginning of year	$	—	$	—
Employer contribution	1.7		2.0
Plan participants’ contributions	0.4		0.4
Gross benefits paid	(2.1)		(2.4)
Fair value of plan assets at end of year	$	—	$	—
Unfunded status at end of year	$	(15.7)	$	(20.1)

The decrease in the benefit obligation during fiscal 2022 was primarily driven by the increase in the discount rate. These gains were partially offset by demographic experience losses.


	2022			2021

Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	$	(1.6)		$	(1.5)
Non-current liabilities	(14.1)			(18.6)
Total amount accrued	$	(15.7)		$	(20.1)
Amounts recognized in AOCL consist of:
Actuarial (gain) loss	$	(1.2)		$	2.5
Prior service credit	(0.2)			(1.4)
Total accumulated other comprehensive (income) loss	$	(1.4)		$	1.1
Total change in other comprehensive loss attributable to:
Gain during the period	$	3.4		$	0.8

Reclassification to net income	(0.9)			(0.8)
Total change in other comprehensive loss	$	2.5		$	—

Discount rate used in development of APBO	5.60		%	2.66		%

Net periodic benefit cost (income) was $(0.2), $(0.2), and $(0.1) during fiscal 2022, fiscal 2021 and fiscal 2020, respectively. For measurement as of September 30, 2022, management has assumed that health care costs will increase at an annual rate of 7.50%, and thereafter decreasing to an ultimate trend rate of 5.00% in 2028.

The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:


	Gross Benefit Payments		Retiree Contributions		Net Company Payments

2023	$	2.2	$	(0.6)	$	1.6
2024	2.2		(0.6)		1.6
2025	2.1		(0.5)		1.6
2026	2.1		(0.6)		1.5
2027	2.2		(0.7)		1.5
2028 – 2032	10.5		(3.9)		6.6

DEBT

12 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

DEBT

The components of debt are as follows:


	September 30,
	2022		2021

Credit Facilities:
Revolving loans	$	300.5	$	—
Term loans	975.0		670.0
Senior Notes due 2031 – 4.000%	500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0

Receivables facility	75.0		—
Finance lease obligations	28.9		33.4
Other	12.7		11.9
Total debt	2,992.1		2,315.3
Less current portions	144.3		57.8
Less unamortized debt issuance costs	21.6		20.8
Long-term debt	$	2,826.2	$	2,236.7

The Company’s aggregate scheduled maturities of debt, excluding finance lease obligations, are as follows:


2023	$	137.7
2024	50.0
2025	50.0
2026	50.0
2027	1,325.5
Thereafter	1,350.0
	$	2,963.2

Credit Facilities

On July 5, 2018, the Company entered into a fifth amended and restated credit agreement (the “Fifth A&R Credit Agreement”), which provided the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,300.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $800.0 (the “Fifth A&R Credit Facilities”). Under the Fifth A&R Credit Facilities, the Company had the ability to obtain letters of credit up to $75.0.

On April 8, 2022, the Company entered into a sixth amended and restated credit agreement (the “Sixth A&R Credit Agreement”), providing the Company and certain of its subsidiaries with five-year senior secured loan facilities in the aggregate principal amount of $2,500.0, comprised of a revolving credit facility of $1,500.0 and a term loan in the original principal amount of $1,000.0 (the “Sixth A&R Credit Facilities”). The Sixth A&R Credit Agreement also provides the Company with

the right to seek additional committed credit under the agreement in an aggregate amount of up to $500.0 plus an unlimited additional amount, subject to certain specified financial and other conditions. The Sixth A&R Credit Agreement replaced the Fifth A&R Credit Agreement and will terminate on April 8, 2027. The Sixth A&R Credit Facilities are available for the issuance of letters of credit up to $100.0. The terms of the Sixth A&R Credit Agreement include customary representations and warranties, affirmative and negative covenants, financial covenants, and events of default.

Under the terms of the Sixth A&R Credit Agreement, loans bear interest, at the Company’s election, at a rate per annum equal to either (i) the Alternate Base Rate plus the Applicable Spread (each, as defined in the Sixth A&R Credit Agreement) or (ii) the Adjusted Term SOFR Rate for the Interest Period in effect for such borrowing plus the Applicable Spread (all as defined in the Sixth A&R Credit Agreement). Swingline Loans bear interest at the applicable Swingline Rate set forth in the Sixth A&R Credit Agreement. Interest rates for other select non-U.S. dollar borrowings, including borrowings denominated in euro, Pounds Sterling and Canadian dollars, are based on separate interest rate indices, as set forth in the Sixth A&R Credit Agreement. The Sixth A&R Credit Agreement is secured by (i) a perfected first priority security interest in all of the accounts receivable, inventory and equipment of Scotts Miracle-Gro and certain of its domestic subsidiaries and (ii) the pledge of all of the capital stock of certain of Scotts Miracle-Gro’s domestic subsidiaries and a portion of the capital stock of certain of its foreign subsidiaries. The collateral does not include any of the Company’s intellectual property.

On June 8, 2022, the Company entered into Amendment No. 1 (the “Amendment”) to the Sixth A&R Credit Agreement. The Amendment increases the maximum permitted leverage ratio for the quarterly leverage covenant effective for the third quarter of fiscal 2022 until the earlier of (i) April 1, 2024 and (ii) subject to certain conditions specified in the Amendment, the termination by the Company of such increase (such period, the “Leverage Adjustment Period”). The Amendment also increases the interest rate applicable to borrowings under the revolving credit facility by 35 bps and the term loan facility by 50 bps, and increases the annual facility fee rate on the revolving credit facility by 15 bps, in each case, when the Company’s quarterly-tested leverage ratio exceeds 4.75. Additionally, the Amendment limits the Company’s ability to declare or pay any discretionary dividends, distributions or other restricted payments during the Leverage Adjustment Period to only the payment of (i) regularly scheduled cash dividends to holders of its Common Shares in an aggregate amount not to exceed $225.0 per fiscal year and (ii) other dividends, distributions or other restricted payments in an aggregate amount not to exceed $25.0. The Amendment also requires pro forma compliance with certain leverage levels specified in the Amendment with respect to the Company’s ability to consummate certain acquisitions and incur debt.

At September 30, 2022, the Company had letters of credit outstanding in the aggregate principal amount of $14.1, and had $1,185.5 of borrowing availability under the Sixth A&R Credit Agreement. The weighted average interest rates on average borrowings under the Fifth A&R Credit Agreement and Sixth A&R Credit Agreement were 2.8%, 1.9% and 3.3% for fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

The Sixth A&R Credit Agreement contains, among other obligations, an affirmative covenant regarding the Company’s leverage ratio determined as of the end of each of its fiscal quarters calculated as average total indebtedness, divided by the Company’s earnings before interest, taxes, depreciation and amortization, as adjusted pursuant to the terms of the Sixth A&R Credit Agreement (“Adjusted EBITDA”). Pursuant to the Amendment, the maximum permitted leverage ratio is (i) 6.25 for the third quarter of fiscal 2022 through the first quarter of fiscal 2023, (ii) 6.50 for the second and third quarters of fiscal 2023, (iii) 6.25 for the fourth quarter of fiscal 2023 and the first quarter of fiscal 2024, (iv) 5.50 for the second quarter of fiscal 2024, and (v) 4.50 for the third quarter of fiscal 2024 and thereafter. The Company’s leverage ratio was 6.01 at September 30, 2022. The Sixth A&R Credit Agreement also contains an affirmative covenant regarding the Company’s interest coverage ratio determined as of the end of each of its fiscal quarters. The interest coverage ratio is calculated as Adjusted EBITDA divided by interest expense, as described in the Sixth A&R Credit Agreement, and excludes costs related to refinancings. The minimum required interest coverage ratio is 3.00, which is unchanged from the Fifth A&R Credit Agreement. The Company’s interest coverage ratio was 4.83 for the twelve months ended September 30, 2022.

As of September 30, 2022, the Company was in compliance with all applicable covenants in the agreements governing its debt. Based on the Company’s projections of its financial performance for the twelve-month period subsequent to the date of the filing of the financial statements on Form 10-K, the Company expects to remain in compliance with the financial covenants under the Company’s Sixth A&R Credit Agreement. However, the Company’s assessment of its ability to meet its future obligations is inherently subjective, judgment-based, and susceptible to change based on future events. A covenant violation may result in an event of default. Such a default would allow the lender under the Sixth A&R Credit Agreement to accelerate the maturity of the debt and would also implicate cross-default provisions under the Senior Notes, as defined below, making them due and payable at that time. As of September 30, 2022, the Company’s indebtedness under the Sixth A&R Credit Agreement and Senior Notes was $2,875.5. The Company does not have sufficient cash on hand or available liquidity that can be utilized to repay these outstanding amounts in the event of default.

As part of its contingency planning to address potential future circumstances that could result in noncompliance, the Company has contemplated alternative plans including additional restructuring activities to reduce operating expenses and certain cash management strategies that are within the Company’s control. Additionally, the Company has contemplated alternative plans that are subject to market conditions and not in the Company’s control, including, among others, discussions with its lender to amend the terms of its financial covenant under the debt instrument and generating cash by completing other financing transactions, which may include issuing equity. There is no assurance that the Company will be successful in implementing these alternative plans.

Senior Notes

On December 15, 2016, Scotts Miracle-Gro issued $250.0 aggregate principal amount of 5.250% Senior Notes due 2026 (the “5.250% Senior Notes”). The 5.250% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 5.250% Senior Notes have interest payment dates of June 15 and December 15 of each year.

On October 22, 2019, Scotts Miracle-Gro issued $450.0 aggregate principal amount of 4.500% Senior Notes due 2029 (the “4.500% Senior Notes”). The 4.500% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.500% Senior Notes have interest payment dates of April 15 and October 15 of each year.

On October 23, 2019, Scotts Miracle-Gro redeemed all of its outstanding 6.000% Senior Notes due 2023 (the “6.000% Senior Notes”) for a redemption price of $412.5, comprised of $0.5 of accrued and unpaid interest, $12.0 of redemption premium, and $400.0 for outstanding principal amount. The $12.0 redemption premium was recognized in the “Costs related to refinancing” line on the Consolidated Statements of Operations during the first quarter of fiscal 2020. Additionally, the Company had $3.1 in unamortized bond issuance costs associated with the 6.000% Senior Notes, which were written-off during the first quarter of fiscal 2020 and were recognized in the “Costs related to refinancing” line in the Consolidated Statements of Operations.

On March 17, 2021, Scotts Miracle-Gro issued $500.0 aggregate principal amount of 4.000% Senior Notes due 2031 (the “4.000% Senior Notes”). The 4.000% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.000% Senior Notes have interest payment dates of April 1 and October 1 of each year.

On August 13, 2021, Scotts Miracle-Gro issued $400.0 aggregate principal amount of 4.375% Senior Notes due 2032 (the “4.375% Senior Notes”). The 4.375% Senior Notes represent general unsecured senior obligations and rank equal in right of payment with the Company’s existing and future unsecured senior debt. The 4.375% Senior Notes have interest payment dates of February 1 and August 1 of each year.

Substantially all of Scotts Miracle-Gro’s directly and indirectly owned domestic subsidiaries serve as guarantors of the 5.250% Senior Notes, the 4.500% Senior Notes, the 4.000% Senior Notes and the 4.375% Senior Notes.

Receivables Facility

On April 7, 2017, the Company entered into a Master Repurchase Agreement (including the annexes thereto, the “Repurchase Agreement”) and a Master Framework Agreement, as amended (the “Framework Agreement” and, together with the Repurchase Agreement, the “Receivables Facility”). Under the Receivables Facility, the Company may sell a portfolio of available and eligible outstanding customer accounts receivable to the purchasers and simultaneously agree to repurchase the receivables on a weekly basis. The eligible accounts receivable consist of accounts receivable generated by sales to three specified customers. The eligible amount of customer accounts receivables which may be sold under the Receivables Facility is $400.0 and the commitment amount during the seasonal commitment period beginning on February 24, 2023 and ending on June 16, 2023 is $160.0. The Receivables Facility expires on August 18, 2023.

The Company accounts for the sale of receivables under the Receivables Facility as short-term debt and continues to carry the receivables on its Consolidated Balance Sheets, primarily as a result of the Company’s requirement to repurchase receivables sold. As of September 30, 2022 and 2021, there were $75.0 and zero, respectively, in borrowings on receivables pledged as collateral under the Receivables Facility, and the carrying value of the receivables pledged as collateral was $79.8 and zero, respectively.

Interest Rate Swap Agreements

The Company enters into interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest payments made between the effective date and expiration date are hedged by the swap agreements. Swap agreements that were hedging interest payments as of September 30, 2022 and 2021 had a maximum total U.S. dollar equivalent notional amount of $800.0 and $600.0, respectively. The notional amount, effective date, expiration date and rate of each of the swap agreements outstanding at September 30, 2022 are shown in the table below:


Notional Amount		Effective Date (a)	Expiration Date	Fixed Rate
100		12/21/2020	6/20/2023	1.36	%
300	(b)	1/7/2021	6/7/2023	1.34	%
200		10/7/2021	6/7/2023	1.37	%
200	(b)	1/20/2022	6/20/2024	0.58	%
200		6/7/2023	6/8/2026	0.85	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

Weighted Average Interest Rate

The weighted average interest rates on the Company’s debt were 3.6%, 3.7% and 4.3% for fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

EQUITY

12 Months Ended

Sep. 30, 2022

Equity [Abstract]

EQUITY

Authorized and issued shares consisted of the following (in millions):


	September 30,
	2022	2021

Preferred shares, no par value:
Authorized	0.2 shares	0.2 shares
Issued	0.0 shares	0.0 shares
Common shares, no par value, $0.01 stated value per share:
Authorized	100.0 shares	100.0 shares
Issued	68.1 shares	68.1 shares

In fiscal 1995, The Scotts Company merged with Stern’s Miracle-Gro Products, Inc. (“Miracle-Gro”). At September 30, 2022, the former shareholders of Miracle-Gro, including the Hagedorn Partnership, L.P., owned approximately 26% of Scotts Miracle-Gro’s outstanding Common Shares on a fully diluted basis and, therefore, have the ability to significantly influence the election of directors and other actions requiring the approval of Scotts Miracle-Gro’s shareholders.

Under the terms of the merger agreement with Miracle-Gro, the former shareholders of Miracle-Gro may not collectively acquire, directly or indirectly, beneficial ownership of Voting Stock (as that term is defined in the Miracle-Gro merger agreement) representing more than 49% of the total voting power of the outstanding Voting Stock, except pursuant to a tender offer for 100% of that total voting power, which tender offer is made at a price per share which is not less than the market price per share on the last trading day before the announcement of the tender offer and is conditioned upon the receipt of at least 50% of the Voting Stock beneficially owned by shareholders of Scotts Miracle-Gro other than the former shareholders of Miracle-Gro and their affiliates and associates.

Accumulated Other Comprehensive Loss

Changes in AOCL by component were as follows for the fiscal years ended September 30:


	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Loss On Securities		Net Unrealized Gain (Loss) in Pension and Other Post- Retirement Benefits		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2019	$	(17.4)	$	(8.1)	$	—	$	(68.4)	$	(93.9)
Other comprehensive income (loss) before reclassifications	10.5		(19.7)		—		(12.9)		(22.1)
Amounts reclassified from accumulated other comprehensive net income (loss)	0.8		10.1		—		0.3		11.2
Income tax benefit (expense)	—		2.5		—		3.2		5.7
Net current period other comprehensive income (loss)	11.3		(7.1)		—		(9.4)		(5.2)
Balance at September 30, 2020	(6.2)		(15.1)		—		(77.8)		(99.1)
Other comprehensive income (loss) before reclassifications	4.5		26.8		(3.1)		6.9		35.1
Amounts reclassified from accumulated other comprehensive net income (loss)	—		7.3		—		0.4		7.7
Income tax benefit (expense)	—		(8.9)		0.8		(1.9)		(10.0)
Net current period other comprehensive income (loss)	4.5		25.2		(2.3)		5.4		32.8
Balance at September 30, 2021	(1.7)		10.2		(2.3)		(72.5)		(66.4)
Other comprehensive income (loss) before reclassifications	(27.2)		40.1		(102.0)		(7.3)		(96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.1)		—		11.7		2.6
Income tax benefit (expense)	—		(7.9)		24.6		(1.1)		15.6
Net current period other comprehensive income (loss)	(27.2)		23.1		(77.4)		3.3		(78.2)
Balance at September 30, 2022	$	(28.9)	$	33.3	$	(79.7)	$	(69.3)	$	(144.6)

The sum of the components may not equal due to rounding.

Dividends

On July 27, 2020, the Scotts Miracle-Gro Board of Directors approved an increase in Scotts Miracle-Gro’s quarterly cash dividend from $0.58 to $0.62 per Common Share, which was first paid in the fourth quarter of fiscal 2020. In addition, on July 27, 2020, the Scotts Miracle-Gro Board of Directors approved a special cash dividend of $5.00 per Common Share, which was paid on September 10, 2020 to all shareholders of record at the close of business on August 27, 2020. On July 30, 2021, the Scotts Miracle-Gro Board of Directors approved an increase in the Scotts Miracle-Gro’s quarterly cash dividend from $0.62 to $0.66 per Common Share, which was first paid in the fourth quarter of fiscal 2021.

Share Repurchases

On August 11, 2014, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $500.0 of Common Shares over a five-year period (effective November 1, 2014 through September 30, 2019). On August 3, 2016, Scotts Miracle-Gro announced that its Board of Directors authorized a $500.0 increase to the share repurchase authorization ending on September 30, 2019. On August 2, 2019, the Scotts Miracle-Gro Board of Directors authorized an extension of the share repurchase authorization through March 28, 2020. The amended authorization allowed for repurchases of Common Shares of up to an aggregate amount of $1,000.0 through March 28, 2020. During fiscal 2020 through March 28, 2020, Scotts Miracle-Gro repurchased 0.4 million Common Shares under this share repurchase authorization for $48.2. From the effective date of this share repurchase authorization in the fourth quarter of fiscal 2014 through March 28, 2020, Scotts Miracle-Gro repurchased approximately 8.7 million Common Shares for $762.8.

On February 6, 2020, Scotts Miracle-Gro announced that its Board of Directors authorized the repurchase of up to $750.0 of Common Shares from April 30, 2020 through March 25, 2023. The authorization permits the Company to purchase

Common Shares from time to time in open market purchases or through privately negotiated transactions. All or part of the repurchases may be made under Rule 10b5-1 plans, which the Company may enter into from time to time and which enable the repurchases to occur on a more regular basis, or pursuant to accelerated share repurchases. The share repurchase authorization may be suspended or discontinued by the Board of Directors at any time, and there can be no guarantee as to the timing or amount of any repurchases. During fiscal 2022 and fiscal 2021, Scotts Miracle-Gro repurchased 1.1 million and 0.6 million Common Shares under this share repurchase authorization for $175.0 and $113.1, respectively. There were no share repurchases under this share repurchase authorization during fiscal 2020. Treasury share purchases also include cash paid to tax authorities to satisfy statutory income tax withholding obligations related to share-based compensation of $82.9, $16.3 and $4.9 for fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

Share-Based Awards

A maximum of 5.0 million Common Shares are available for issuance under share-based award plans. At September 30, 2022, approximately 3.4 million Common Shares were not subject to outstanding awards and were available to underlie the grant of new share-based awards. Common Shares held in treasury totaling 0.9 million, 0.4 million and 0.4 million were reissued in support of share-based compensation awards and employee purchases under the employee stock purchase plan during fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

Subsequent to September 30, 2022, the Company awarded restricted stock units, performance-based award units and stock options representing 1.6 million Common Shares to employees with an estimated fair value of $51.8 on the date of grant.

The following is a summary of the share-based awards granted during each of the periods indicated:


	Year Ended September 30,
	2022		2021		2020
Employees
Options	—		183,553		37,255
Restricted stock units	228,558		70,936		119,726

Performance units	105,756		1,903		37,570
Non-Employee Directors
Restricted and deferred stock units	20,015		9,173		18,948

Total share-based awards	354,329		265,565		213,499

Aggregate fair value at grant dates	$	41.2	$	30.2	$	21.5

Total share-based compensation was as follows for each of the periods indicated:


	Year Ended September 30,
	2022		2021		2020

Share-based compensation	$	30.3	$	40.6	$	57.9
Related tax benefit recognized	4.9		7.4		14.6

Excess tax benefits related to share-based compensation were $14.8, $18.3 and $5.8 for fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

Stock Options

Stock option activity was as follows:


	No. of Options	Wtd. Avg. Exercise Price
Awards outstanding at September 30, 2021	568,191	$	118.38


Forfeited	(39,720)	236.53
Awards outstanding at September 30, 2022	528,471	110.86
Exercisable	388,002	65.36

At September 30, 2022, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested stock options not yet recognized was $1.4, which is expected to be recognized over a weighted-average period of 1.3 years. The total intrinsic value of stock options exercised was $41.8 and $21.9 during fiscal 2021 and fiscal 2020, respectively. Cash received from the exercise of stock options, including amounts received from employee purchases under the employee stock purchase plan, was $3.3, $15.2, and $17.6 for fiscal 2022, fiscal 2021 and fiscal 2020, respectively. The following summarizes certain information pertaining to stock option awards outstanding and exercisable at September 30, 2022:


	Awards Outstanding			Awards Exercisable
Range of Exercise Price	No. of Options	Wtd. Avg. Remaining Life	Wtd. Avg. Exercise Price	No. of Options	Wtd. Avg. Remaining Life	Wtd. Avg. Exercise Price
$59.62 - $64.55	380,932	2.85	62.18	380,932	2.85	62.18
$236.53 - $236.53	147,539	8.35	236.53	7,070	8.35	236.53

	528,471	4.39	110.86	388,002	2.95	65.36

The intrinsic values of the stock option awards outstanding and exercisable at September 30, 2022 were zero.

Restricted share-based awards

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:


	No. of Shares	Wtd. Avg. Grant Date Fair Value per Share








Awards outstanding at September 30, 2021	375,825	124.50
Granted	248,573	109.10
Vested	(246,846)	75.38
Forfeited	(56,977)	165.01
Awards outstanding at September 30, 2022	320,575	143.19

At September 30, 2022, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested restricted share units not yet recognized was $10.0, which is expected to be recognized over a weighted-average period of 1.7 years. The total fair value of restricted stock units and deferred stock units vested was $28.2, $41.8 and $15.2 during fiscal 2022, fiscal 2021 and fiscal 2020, respectively.

Performance-based awards

Performance-based award activity was as follows (based on target award amounts):


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit








Awards outstanding at September 30, 2021	572,557	95.09
Granted	105,756	132.74
Vested (a)	(533,441)	93.22
Forfeited	(31,616)	124.15
Awards outstanding at September 30, 2022	113,256	130.94

(a)Vested at a weighted average of 228% of the target performance share units granted.

At September 30, 2022, the total pre-tax compensation cost, net of estimated forfeitures, related to nonvested performance-based units not yet recognized was $3.6, which is expected to be recognized over a weighted-average period of 2.1 years. The total fair value of performance-based units vested was $182.5, $11.9, and $3.9 during fiscal 2022, fiscal 2021, and fiscal 2020, respectively.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

EARNINGS PER COMMON SHARE

12 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

EARNINGS PER COMMON SHARE

The following table presents information necessary to calculate basic and diluted income per Common Share.


	Year Ended September 30,
	2022		2021		2020

Income (loss) from continuing operations	$	(437.5)	$	517.3	$	386.9
Net income attributable to noncontrolling interest	—		(0.9)		(1.2)
Income (loss) attributable to controlling interest from continuing operations	(437.5)		516.4		385.7
Income (loss) from discontinued operations, net of tax	—		(3.9)		1.7
Net income (loss) attributable to controlling interest	$	(437.5)	$	512.5	$	387.4
Basic income (loss) per common share:
Weighted-average common shares outstanding during the period	55.5		55.7		55.7
Income (loss) from continuing operations	$	(7.88)	$	9.27	$	6.92
Income (loss) from discontinued operations	—		(0.07)		0.04
Basic net income (loss) per common share	$	(7.88)	$	9.20	$	6.96
Diluted income (loss) per common share:
Weighted-average common shares outstanding during the period	55.5		55.7		55.7
Dilutive potential common shares	—		1.5		1.2
Weighted-average number of common shares outstanding and dilutive potential common shares	55.5		57.2		56.9
Income (loss) from continuing operations	$	(7.88)	$	9.03	$	6.78
Income (loss) from discontinued operations	—		(0.07)		0.03
Diluted net income (loss) per common share	$	(7.88)	$	8.96	$	6.81

Diluted average common shares used in the diluted loss per common share calculation for fiscal 2022 were 55.5 million, which excluded potential Common Shares of 0.6 million because the effect of their inclusion would be anti-dilutive as the Company incurred a net loss for fiscal 2022. Diluted average common shares used in the diluted income per common share calculation were 57.2 million and 56.9 million for fiscal 2021 and fiscal 2020, respectively, which included dilutive potential Common Shares of 1.5 million and 1.2 million, respectively.

Stock options with exercise prices greater than the average market price of the underlying Common Shares are excluded from the computation of diluted income per common share because they are out-of-the-money and the effect of their inclusion would be anti-dilutive. For fiscal 2022 and fiscal 2021, the average number of out-of-the money options was 0.2 million and 0.1 million, respectively. There were no out-of-the-money options for fiscal 2020.

INCOME TAXES

12 Months Ended

Sep. 30, 2022

Income Tax Disclosure [Abstract]

INCOME TAXES

The provision (benefit) for income taxes allocated to continuing operations consisted of the following:


	Year Ended September 30,
	2022		2021		2020

Current:
Federal	$	22.8	$	113.7	$	104.3
State	9.3		31.6		25.3
Foreign	8.7		2.7		0.3
Total Current	40.8		148.0		129.9
Deferred:
Federal	(125.5)		9.1		(1.6)
State	(23.3)		1.5		(2.0)
Foreign	(12.6)		1.2		(2.6)
Total Deferred	(161.4)		11.8		(6.2)
Income tax expense (benefit) from continuing operations	$	(120.6)	$	159.8	$	123.7

The domestic and foreign components of income (loss) from continuing operations before income taxes were as follows:


	Year Ended September 30,
	2022		2021		2020

Domestic	$	(427.3)	$	670.2	$	483.7
Foreign	(130.8)		6.9		26.9
Income (loss) from continuing operations before income taxes	$	(558.1)	$	677.1	$	510.6

A reconciliation of the federal corporate income tax rate and the effective tax rate on income (loss) from continuing operations before income taxes is summarized below:


	Year Ended September 30,
	2022		2021		2020
Statutory income tax rate	21.0	%	21.0	%	21.0	%
Effect of foreign operations	(2.5)		(0.1)		(0.7)
State taxes, net of federal benefit	2.6		3.9		3.5
Effect of other permanent differences	2.8		(1.1)		—
Research and Experimentation and other federal tax credits	0.2		(0.2)		(0.3)
Effect of tax contingencies	(1.8)		—		0.1
Other	(0.7)		0.1		0.6
Effective income tax rate	21.6	%	23.6	%	24.2	%

During fiscal 2022, the Company recognized non-cash, pre-tax goodwill and intangible asset impairment charges of $668.3 in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The tax impact of the impairment charges was a benefit of $148.3, which is net of the impact of non-deductible goodwill of $18.8, for fiscal 2022 and was recorded in the “Income tax expense (benefit) from continuing operations” line in the Consolidated Statements of Operations. The tax impact of non-deductible goodwill was considered a discrete item because the Company has no remaining non-deductible goodwill. This discrete item, which is included in the “Effect of foreign operations” line in the table above, decreased the fiscal 2022 effective tax rate by approximately 340 bps because the Company incurred a net loss during this period. Additionally, excess tax benefits related to share-based compensation, which are included in the “Effect of other permanent differences” line in the table above, increased the fiscal 2022 effective tax rate by approximately 260 bps.

Deferred income taxes arise from temporary differences between financial reporting and tax reporting bases of assets and liabilities, and operating loss and tax credit carryforwards for tax purposes. The components of the deferred income tax assets and liabilities were as follows:


	September 30,
	2022		2021

DEFERRED TAX ASSETS
Accrued liabilities	$	80.8	$	65.6
Lease liabilities	70.7		71.0
Intangible assets	60.8		—
Inventories	43.2		16.8
Convertible debt investments	25.3		—
Net operating loss carryovers	21.7		14.2
Foreign tax credit carryovers	15.0		14.9
Accounts receivable	8.7		8.5
Other	12.5		5.0
Gross deferred tax assets	338.7		196.0
Valuation allowance	(40.7)		(32.3)
Total deferred tax assets	298.0		163.7
DEFERRED TAX LIABILITIES
Intangible assets	—		(73.3)
Lease right-of-use assets	(68.6)		(69.6)
Property, plant and equipment	(65.8)		(55.8)
Outside basis difference in equity investments	(14.8)		(7.2)
Derivative contracts	(10.5)		—
Other	(3.3)		(5.6)
Total deferred tax liabilities	(163.0)		(211.5)
Net deferred tax asset (liability)	$	135.0	$	(47.8)

At September 30, 2022, after netting by taxing jurisdiction, net deferred tax assets of $143.5 were recorded in the “Other assets” line in the Consolidated Balance Sheets, and net deferred tax liabilities of $8.5 were recorded in the “Other liabilities” line in the Consolidated Balance Sheets. At September 30, 2021, net deferred tax liabilities were $47.8 and were recorded in the “Other liabilities” line in the Consolidated Balance Sheets. The change in the net deferred tax balance was primarily driven by deferred tax assets recorded during fiscal 2022 associated with goodwill and intangible asset impairment charges and unrealized losses on convertible debt investments.

GAAP requires that a valuation allowance be recorded against a deferred tax asset if it is more likely than not that the tax benefit associated with the asset will not be realized in the future. As shown in the table above, valuation allowances were recorded against $40.7 and $32.3 of deferred tax assets as of September 30, 2022 and 2021, respectively. Most of these valuation allowances relate to certain credits and net operating losses (“NOLs”), as explained further below.

Deferred tax assets related to foreign tax credits were $15.0 and $14.9 at September 30, 2022 and 2021, respectively. A full valuation allowance has been established against these foreign tax credits at September 30, 2022 as the Company does not expect to utilize them prior to their expiration. Tax benefits associated with state tax credits will also expire if not utilized and amounted to $1.4 at September 30, 2022 and 2021. A valuation allowance in the amount of $1.2 has been established at September 30, 2022 related to state credits the Company does not expect to utilize.

Deferred tax assets related to certain federal NOLs subject to limitation under IRC §382 from current and prior ownership changes were $10.7 and $10.8 at September 30, 2022 and 2021, respectively. These NOLs will be subject to expiration gradually from fiscal year end 2023 through fiscal year end 2032. The Company determined that $10.5 of these deferred tax assets will expire unutilized due to the closing of statutes of limitation and has established a valuation allowance accordingly at September 30, 2022.

Deferred tax assets related to foreign NOLs of certain controlled foreign corporations were $3.7 and $1.8 as of September 30, 2022 and 2021, respectively. Due to a history of losses in some of these entities, a valuation allowance has been

established against $2.9 of these deferred tax assets at September 30, 2022. A valuation allowance has also been established against deferred tax assets related to other foreign items of $6.3 at September 30, 2022.

Deferred tax assets related to state NOLs were $7.3 and $1.7 as of September 30, 2022 and 2021, respectively, with carryforward periods ranging from 5 to 20 years. Any losses not utilized within a specific state’s carryforward period will expire. A valuation allowance was recorded against $4.8 of these deferred tax assets as of September 30, 2022 for state NOLs that the Company does not expect to realize within their respective carryforward periods.

As of September 30, 2022, the Company maintains its assertions of indefinite reinvestment of the earnings of all material foreign subsidiaries.

The Company had $35.8, $24.1 and $30.2 of gross unrecognized tax benefits related to uncertain tax positions at September 30, 2022, 2021 and 2020, respectively. Of these amounts, $0.2, $0.2 and $6.4 of gross unrecognized tax benefits are related to discontinued operations at September 30, 2022, 2021 and 2020, respectively. Included in the September 30, 2022, 2021 and 2020 balances were $31.5, $19.9 and $25.9, respectively, of unrecognized tax benefits that, if recognized, would have an impact on the effective tax rate.

A reconciliation of the unrecognized tax benefits is as follows:


	Year Ended September 30,
	2022		2021		2020

Balance at beginning of year	$	24.1	$	30.2	$	29.5
Additions for tax positions of the current year	11.3		0.3		0.3
Additions for tax positions of prior years	2.2		6.1		4.5
Reductions for tax positions of prior years	(2.5)		(5.9)		(2.4)
Settlements with tax authorities	1.3		0.2		0.3
Expiration of statutes of limitation	(0.6)		(6.8)		(2.0)
Balance at end of year	$	35.8	$	24.1	$	30.2

The Company continues to recognize accrued interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes. As of September 30, 2022, 2021 and 2020, the Company had $3.2, $2.7 and $2.8, respectively, accrued for the payment of interest that, if recognized, would impact the effective tax rate. The Company had $1.6 accrued for the payment of penalties as of September 30, 2022, 2021 and 2020.

Scotts Miracle-Gro or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state, local and foreign jurisdictions. Subject to the following exceptions, the Company is no longer subject to examination by these tax authorities for fiscal years prior to 2019. There are currently no ongoing audits with respect to the U.S. federal jurisdiction. With respect to the foreign jurisdictions, a German audit covering fiscal years 2014 through 2017 is in process. The Company is currently under examination by certain U.S. state and local tax authorities covering various periods from fiscal years 2017 through 2020. In addition to the aforementioned audits, certain other tax deficiency notices and refund claims for previous years remain unresolved.

The Company currently anticipates that few of its open and active audits will be resolved within the next twelve months. The Company is unable to make a reasonably reliable estimate as to when or if cash settlements with taxing authorities may occur. Although the outcomes of such examinations and the timing of any payments required upon the conclusion of such examinations are subject to significant uncertainty, the Company does not anticipate that the resolution of these tax matters or any events related thereto will result in a material change to its consolidated financial position, results of operations or cash flows.

The Inflation Reduction Act (the “Act”) was signed into law on August 16, 2022. The Act introduces a new 15% corporate minimum tax for certain large corporations that becomes effective for the Company’s fiscal year 2024 and it imposes a 1% excise tax on the value of share repurchases, net of new share issuances, after December 31, 2022. These provisions, as well as the other corporate tax changes included in the Act, are not expected to have a material impact on the Company’s financial statements.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

12 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

The Company is exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. To manage a portion of the volatility related to these exposures, the Company enters into various financial transactions. The utilization of these financial transactions is governed by policies covering acceptable counterparty exposure, instrument types and other hedging practices. The Company does not hold or issue derivative financial instruments for speculative trading purposes.

Exchange Rate Risk Management

The Company uses currency forward contracts to manage the exchange rate risk associated with intercompany loans and certain other balances denominated in foreign currencies. Currency forward contracts are valued using observable forward rates in commonly quoted intervals for the full term of the contracts. The notional amount of outstanding currency forward contracts was $178.6 and $180.3 at September 30, 2022 and 2021, respectively. Contracts outstanding at September 30, 2022 will mature over the next fiscal quarter.

Interest Rate Risk Management

The Company enters into interest rate swap agreements as a means to hedge its variable interest rate risk on debt instruments. Net amounts to be received or paid under the swap agreements are reflected as adjustments to interest expense. The Company has outstanding interest rate swap agreements with major financial institutions that effectively convert a portion of the Company’s variable-rate debt to a fixed rate. Interest rate swap agreements are valued based on the present value of the estimated future net cash flows using implied rates in the applicable yield curve as of the valuation date. Swap agreements that were hedging interest payments as of September 30, 2022 and 2021 had a maximum total U.S. dollar equivalent notional amount of $800.0 and $600.0, respectively. Refer to “NOTE 12. DEBT” for the terms of the swap agreements outstanding at September 30, 2022. Included in the AOCL balance at September 30, 2022 was a gain of $9.7 related to interest rate swap agreements that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.

Commodity Price Risk Management

The Company enters into hedging arrangements designed to fix the price of a portion of its projected future urea and diesel requirements. Commodity contracts are valued using observable commodity exchange prices in active markets. Included in the AOCL balance at September 30, 2022 was a gain of $9.5 related to commodity hedges that is expected to be reclassified to earnings during the next twelve months, consistent with the timing of the underlying hedged transactions.

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:


	September 30,
	2022	2021
Commodity
Urea	54,000 tons	94,500 tons

Diesel	3,150,000 gallons	5,880,000 gallons

Heating Oil	1,218,000 gallons	2,268,000 gallons

Fair Values of Derivative Instruments

The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows:


		Assets / (Liabilities)
		2022		2021
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value
Interest rate swap agreements	Prepaid and other current assets	$	12.8	$	—
	Other assets	18.2		3.3
	Other current liabilities	—		(5.7)
	Other liabilities	—		(2.5)
Commodity hedging instruments	Prepaid and other current assets	2.4		13.9

Total derivatives designated as hedging instruments		$	33.4	$	9.0

Derivatives Not Designated as Hedging Instruments	Balance Sheet Location
Currency forward contracts	Prepaid and other current assets	$	3.4	$	3.4
	Other current liabilities	—		(0.2)
Commodity hedging instruments	Prepaid and other current assets	0.4		1.3

Total derivatives not designated as hedging instruments		3.8		4.5
Total derivatives		$	37.2	$	13.5

The effect of derivative instruments on AOCL, net of tax, and the Consolidated Statements of Operations for the years ended September 30 was as follows:


	Amount of Gain / (Loss) Recognized in AOCL
Derivatives in Cash Flow Hedging Relationships	2022		2021

Interest rate swap agreements	$	24.1	$	3.4
Commodity hedging instruments	5.8		16.4
Total	$	29.9	$	19.8


	Reclassified from AOCL into	Amount of Gain / (Loss)
Derivatives in Cash Flow Hedging Relationships	Statement of Operations	2022		2021

Interest rate swap agreements	Interest expense	$	(2.1)	$	(7.7)
Commodity hedging instruments	Cost of sales	8.9		2.3
Total		$	6.8	$	(5.4)


	Recognized in	Amount of Gain / (Loss)
Derivatives Not Designated as Hedging Instruments	Statement of Operations	2022		2021

Currency forward contracts	Other income / expense, net	$	17.9	$	(4.2)
Commodity hedging instruments	Cost of sales	10.5		4.5
Total		$	28.4	$	0.3

FAIR VALUE MEASUREMENTS

12 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or the most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following describes the valuation methodologies used for financial assets and liabilities measured or disclosed at fair value on a recurring basis, as well as the general classification within the valuation hierarchy.

Cash Equivalents

Cash equivalents consist of highly liquid financial instruments with original maturities of three months or less. The carrying value of these cash equivalents approximates fair value due to their short-term maturities.

Other

Investment securities in non-qualified retirement plan assets are valued using observable market prices in active markets. Loans receivable are carried at outstanding principal amount. The estimated fair value is determined using an income-based approach, which includes market participant expectations of cash flows over the remaining useful life discounted to present value using an appropriate discount rate. The estimate requires subjective assumptions to be made, including those related to credit risk and discount rates.

The fair values of convertible debt investments are determined using scenario-based internally developed valuation models that consider a probability-weighted assessment of possible future cash flows related to the debt component and the conversion component of the instruments, discounted to present value using an appropriate discount rate. The probability of amendments to federal laws in the United States to allow for the general cultivation, distribution, and possession of cannabis, and the impact of such amendments on the value of the underlying investments are important assumptions in the fair value estimates. The valuation models and related assumptions require significant judgment. These and other assumptions are impacted by economic conditions and expectations of management and may change in the future based on period specific facts and circumstances.

Debt Instruments

Debt instruments are recorded at cost. The interest rate on borrowings under the Sixth A&R Credit Agreement fluctuates in accordance with the terms of the Sixth A&R Credit Agreement and thus the carrying value is a reasonable estimate of fair value. The fair values of the 4.000% Senior Notes, 4.375% Senior Notes, 4.500% Senior Notes and 5.250% Senior Notes are determined based on quoted market prices. The interest rate on the short-term debt associated with accounts receivable pledged under the Receivables Facility fluctuates in accordance with the terms of the Receivables Facility and thus the carrying value is a reasonable estimate of fair value.

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:


		2022				2021
	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	64.3	$	64.3	$	222.5	$	222.5




Other
Investment securities in non-qualified retirement plan assets	Level 1	38.4		38.4		45.0		45.0
Loans receivable	Level 3	32.8		32.8		35.8		35.8
Convertible debt investments	Level 3	117.0		117.0		190.3		190.3

Liabilities




Debt instruments
Credit facilities – revolving loans	Level 2	300.5		300.5		—		—
Credit facilities – term loans	Level 2	975.0		975.0		670.0		670.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		350.6		500.0		498.8
Senior Notes due 2032 – 4.375%	Level 2	400.0		284.0		400.0		402.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		325.7		450.0		466.9
Senior Notes due 2026 – 5.250%	Level 2	250.0		230.0		250.0		258.1

Receivables facility	Level 2	75.0		75.0		—		—

Other debt	Level 2	12.7		12.7		11.9		11.9

Changes in balances of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.


	Year Ended September 30,
	2022		2021
Fair value at beginning of year	$	190.3	$	—
Purchases	25.0		193.1
Total realized / unrealized gains included in net earnings	3.7		0.3
Total realized / unrealized losses included in OCI	(102.0)		$	(3.1)
Fair value at end of year	$	117.0	$	190.3

The amortized cost basis of convertible debt investments was $222.1 and $193.4 at September 30, 2022 and 2021, respectively. At September 30, 2022 and 2021, gross unrealized losses on convertible debt investments were $105.1 and $3.1, respectively, and there were no gross unrealized gains. These investments have been in a continuous unrealized loss position for greater than 12 months as of September 30, 2022. The decline in fair value of the convertible debt investments is related to a decline in the value of the underlying conversion options and is not reflective of a credit risk associated with the notes. The Company believes it will recover its cost basis in the convertible debt securities and that the Company has the ability to hold the securities until they recover in value and had no intent to sell or convert them at September 30, 2022.

LEASES

12 Months Ended

Sep. 30, 2022

Leases [Abstract]

LEASES

The Company leases certain property and equipment from third parties under various non-cancelable lease agreements, including industrial, commercial and office properties and equipment that support the management, manufacturing, distribution and research and development of products marketed and sold by the Company. The lease agreements generally require that the Company pay taxes, insurance and maintenance expenses related to the leased assets. At September 30, 2022, the Company had entered into operating leases that were yet to commence with a combined total expected lease liability of $49.8. From time to time, the Company will sublease portions of its facilities, resulting in sublease income. Sublease income and the related cash flows were not material to the consolidated financial statements for fiscal 2022.

The Company leases certain vehicles (primarily cars and light trucks) under agreements that are cancellable after the first year, but typically continue on a month-to-month basis until canceled by the Company. The vehicle leases and certain other non-cancelable operating leases contain residual value guarantees that create a contingent obligation on the part of the Company to compensate the lessor if the leased asset cannot be sold for an amount in excess of a specified minimum value at the conclusion of the lease term. If all such vehicle leases had been canceled as of September 30, 2022, the Company’s residual value guarantee would have approximated $3.9.

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	September 30, 2022		September 30, 2021

Operating leases:
Right-of-use assets	Other assets	$	288.9	$	293.0

Current lease liabilities	Other current liabilities	76.2		66.4
Non-current lease liabilities	Other liabilities	223.2		234.4
Total operating lease liabilities		$	299.4	$	300.8

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	26.4	$	31.3

Current lease liabilities	Current portion of debt	6.4		5.9
Non-current lease liabilities	Long-term debt	22.5		27.5
Total finance lease liabilities		$	28.9	$	33.4

Components of lease cost were as follows:


	Year Ended September 30,
	2022		2021

Operating lease cost (a)	$	86.7	$	70.3
Variable lease cost	35.9		29.4


Finance lease cost
Amortization of right-of-use assets	6.4		6.0
Interest on lease liabilities	1.2		1.4
Total finance lease cost	$	7.6	$	7.4

(a)Operating lease cost includes amortization of ROU assets of $75.3 and $62.3 for fiscal 2022 and fiscal 2021, respectively. Short-term lease expense is excluded from operating lease cost and was $19.1 and $22.8 for fiscal 2022 and fiscal 2021, respectively.

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Year Ended September 30,
	2022		2021

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	83.9	$	66.9
Operating cash flows from finance leases	1.2		1.4
Financing cash flows from finance leases	5.9		5.3

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	71.9	$	200.0
Finance leases	1.5		2.6

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	September 30, 2022
Weighted-average remaining lease term (in years):
Operating leases	4.9
Finance leases	7.3

Weighted-average discount rate:
Operating leases	3.5	%
Finance leases	4.3	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2022 were as follows:


Year	Operating Leases		Finance Leases
2023	$	85.2	$	7.5
2024	78.0		7.5
2025	61.2		3.3
2026	42.2		2.2
2027	18.9		1.9
Thereafter	40.5		11.8
Total lease payments	326.0		34.2
Less: Imputed interest	(26.6)		(5.3)
Total lease liabilities	$	299.4	$	28.9

On September 21, 2022, the Company completed an asset sale-leaseback transaction relating to a facility in Vancouver, Washington. The Company received proceeds of $44.7, net of selling costs, and the asset had a carrying value of $36.7, resulting in a $8.0 gain on the transaction which was recorded in the “Impairment, restructuring and other” line in the Consolidated Statements of Operations. The leaseback has a term of 3 years and is accounted for as an operating lease.

LEASES

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	September 30, 2022		September 30, 2021

Operating leases:
Right-of-use assets	Other assets	$	288.9	$	293.0

Current lease liabilities	Other current liabilities	76.2		66.4
Non-current lease liabilities	Other liabilities	223.2		234.4
Total operating lease liabilities		$	299.4	$	300.8

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	26.4	$	31.3

Current lease liabilities	Current portion of debt	6.4		5.9
Non-current lease liabilities	Long-term debt	22.5		27.5
Total finance lease liabilities		$	28.9	$	33.4

Components of lease cost were as follows:


	Year Ended September 30,
	2022		2021

Operating lease cost (a)	$	86.7	$	70.3
Variable lease cost	35.9		29.4


Finance lease cost
Amortization of right-of-use assets	6.4		6.0
Interest on lease liabilities	1.2		1.4
Total finance lease cost	$	7.6	$	7.4

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Year Ended September 30,
	2022		2021

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	83.9	$	66.9
Operating cash flows from finance leases	1.2		1.4
Financing cash flows from finance leases	5.9		5.3

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	71.9	$	200.0
Finance leases	1.5		2.6

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	September 30, 2022
Weighted-average remaining lease term (in years):
Operating leases	4.9
Finance leases	7.3

Weighted-average discount rate:
Operating leases	3.5	%
Finance leases	4.3	%

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2022 were as follows:


Year	Operating Leases		Finance Leases
2023	$	85.2	$	7.5
2024	78.0		7.5
2025	61.2		3.3
2026	42.2		2.2
2027	18.9		1.9
Thereafter	40.5		11.8
Total lease payments	326.0		34.2
Less: Imputed interest	(26.6)		(5.3)
Total lease liabilities	$	299.4	$	28.9

COMMITMENTS

12 Months Ended

Sep. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS

The Company has the following unconditional purchase obligations due during each of the next five fiscal years that have not been recognized in the Consolidated Balance Sheet at September 30, 2022:


2023	$	547.2
2024	358.6
2025	201.1
2026	147.7
2027	128.8
Thereafter	84.8
	$	1,468.2

Purchase obligations primarily represent commitments for materials used in the Company’s manufacturing processes, including urea and packaging, as well as commitments for warehouse services, grass seed, marketing services and information technology services.

CONTINGENCIES	12 Months Ended
CONTINGENCIES	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Management regularly evaluates the Company’s contingencies, including various judicial and administrative proceedings and claims arising in the ordinary course of business, including product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. Regulatory Matters At September 30, 2022, $2.4 was accrued in the “Other liabilities” line in the Consolidated Balance Sheets for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material. Other The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor does it expect the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows. The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.

- Definition

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

+ References + Details

SEGMENT INFORMATION

12 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

SEGMENT INFORMATION

The Company divides its operations into three reportable segments: U.S. Consumer, Hawthorne and Other. U.S. Consumer consists of the Company’s consumer lawn and garden business in the United States. Hawthorne consists of the Company’s indoor and hydroponic gardening business. Other primarily consists of the Company’s consumer lawn and garden business outside the United States. This identification of reportable segments is consistent with how the segments report to and are managed by the chief operating decision maker of the Company. In addition, Corporate consists of general and administrative expenses and certain other income and expense items not allocated to the business segments.

The performance of each reportable segment is evaluated based on several factors, including income (loss) from continuing operations before income taxes, amortization, impairment, restructuring and other charges (“Segment Profit (Loss)”). Senior management uses Segment Profit (Loss) to evaluate segment performance because the Company believes this measure is indicative of performance trends and the overall earnings potential of each segment.

The following tables present financial information for the Company’s reportable segments for the periods indicated:


	Year Ended September 30,
	2022		2021		2020

Net Sales:
U.S. Consumer	$	2,928.8	$	3,197.7	$	2,883.5
Hawthorne	716.2		1,424.2		1,023.1
Other	279.1		303.1		225.0
Consolidated	$	3,924.1	$	4,925.0	$	4,131.6
Segment Profit (Loss):
U.S. Consumer	$	568.6	$	726.7	$	694.3
Hawthorne	(21.1)		163.8		111.9
Other	20.2		42.1		11.7
Total Segment Profit	567.7		932.6		817.9
Corporate	(112.4)		(149.7)		(183.4)
Intangible asset amortization	(37.1)		(30.9)		(32.5)

Impairment, restructuring and other	(852.2)		(29.0)		(16.8)
Equity in income (loss) of unconsolidated affiliates	(12.9)		14.4		—
Costs related to refinancing	—		—		(15.1)
Interest expense	(118.1)		(78.9)		(79.6)
Other non-operating income, net	6.9		18.6		20.1
Income (loss) from continuing operations before income taxes	$	(558.1)	$	677.1	$	510.6
Depreciation and amortization:
U.S. Consumer	$	55.8	$	48.6	$	48.0
Hawthorne	34.8		30.3		31.7
Other	7.0		7.0		7.5
Corporate	7.6		7.9		7.5
	$	105.2	$	93.8	$	94.7
Capital expenditures:
U.S. Consumer	$	97.4	$	78.3	$	52.3
Hawthorne	12.4		25.0		7.8
Other	3.7		3.6		2.6
	$	113.5	$	106.9	$	62.7


	September 30,
	2022		2021

Total assets:
U.S. Consumer	$	2,454.4	$	2,333.1
Hawthorne	1,061.5		1,442.8
Other	197.1		209.6
Corporate	583.8		814.5

Consolidated	$	4,296.8	$	4,800.0

The following table presents net sales by product category for the periods indicated:


	Year Ended September 30,
	2022		2021		2020

U.S. Consumer:
Growing media and mulch	$	1,192.6	$	1,286.7	$	1,164.0
Lawn care	973.6		1,060.6		943.3
Controls	382.2		402.4		383.7
Roundup® marketing agreement	132.3		145.2		132.7
Other, primarily gardening	248.1		302.8		259.8
Hawthorne:
Lighting	200.0		452.4		328.7
Nutrients	148.0		324.7		250.1
Growing environment	143.7		264.0		154.2
Growing media	119.0		192.6		148.9
Other, primarily hardware	105.5		190.5		141.2
Other:
Growing media	96.6		116.7		90.6
Lawn care	92.9		99.2		73.7
Other, primarily gardening and controls	89.6		87.2		60.7
Total net sales	$	3,924.1	$	4,925.0	$	4,131.6

The Company’s two largest customers accounted for the following percentages of net sales for the fiscal years ended September 30:


	Percentage of Net Sales
	2022		2021		2020
Home Depot	28	%	24	%	26	%
Lowe’s	15	%	15	%	18	%

Accounts receivable for these two largest customers as a percentage of consolidated accounts receivable were 46% and 42% as of September 30, 2022 and 2021, respectively.

The following table presents net sales by geographic area for the periods indicated:


	Year Ended September 30,
	2022		2021		2020

Net sales:
United States	$	3,554.6	$	4,507.0	$	3,773.4
International	369.5		418.0		358.2
	$	3,924.1	$	4,925.0	$	4,131.6

Other than the United States, no other country accounted for more than 10% of the Company’s net sales for any period presented above.

The following table presents long-lived assets (property, plant and equipment and finite-lived intangibles) by geographic area:


	September 30,
	2022		2021

Long-lived assets:
United States	$	753.3	$	868.8
International	109.0		139.1
	$	862.3	$	1,007.9

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Sep. 30, 2022

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Schedule II - Valuation and Qualifying Accounts

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2022


Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Reserves Acquired		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for doubtful accounts	$	16.8	$	—	$	5.8	$	(8.2)	$	14.4
Income tax valuation allowance	32.3		—		9.0		(0.6)		40.7

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2021


Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Reserves Acquired		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for doubtful accounts	$	7.5	$	—	$	11.1	$	(1.8)	$	16.8
Income tax valuation allowance	33.8		—		3.0		(4.5)		32.3

Schedule II—Valuation and Qualifying Accounts

for the fiscal year ended September 30, 2020


Column A	Column B		Column C		Column D		Column E		Column F
Classification	Balance at Beginning of Period		Reserves Acquired		Additions Charged to Expense		Deductions Credited and Write-Offs		Balance at End of Period
	(In millions)
Valuation and qualifying accounts deducted from the assets to which they apply:
Allowance for doubtful accounts	$	4.2	$	—	$	7.2	$	(3.9)	$	7.5
Income tax valuation allowance	35.8		—		0.5		(2.5)		33.8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Nature of Operations

Organization and Basis of Presentation

Organization and Basis of PresentationThe Company’s consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Scotts Miracle-Gro and its subsidiaries. All intercompany transactions and accounts have been eliminated in consolidation. The Company’s consolidation criteria are based on majority ownership (as evidenced by a majority voting interest in the entity) and an objective evaluation and determination of effective management control. On February 26, 2021, the Company acquired the remaining outstanding shares of AeroGrow International, Inc. (“AeroGrow”). Prior to this date, the equity owned by other shareholders was shown as noncontrolling interest in the Consolidated Balance Sheets, and the other shareholders’ portion of net earnings and other comprehensive income was shown as net (income) loss or comprehensive (income) loss attributable to noncontrolling interest in the Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income (Loss), respectively. The results of businesses acquired or disposed of are included in the consolidated financial statements from the date of each acquisition or up to the date of disposal, respectively.

Use of Estimates

Advertising

Research and Development

Environmental Costs

Earnings per Common Share

Share-Based Compensation Awards

Cash and Cash Equivalents

Accounts Receivable and Allowances

Inventories

Loans Receivable

Investment in Unconsolidated Affiliates

Investment in Unconsolidated AffiliatesNon-marketable equity investments in which the Company has the ability to exercise significant influence, but does not control, are accounted for using the equity method of accounting, with the Company’s proportionate share of the earnings and losses of these entities reflected in the Consolidated Statements of Operations. The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, an impairment loss is recognized in earnings for the amount by which the carrying amount of the investment exceeds its estimated fair value.

Long-lived Assets

Long-Lived Assets

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows:


Land improvements			10 – 25 years
Buildings			10 – 40 years
Machinery and equipment			3 – 15 years
Furniture and fixtures			6 – 10 years
Software			3 – 8 years

Internal Use Software

Goodwill and Indefinite-lived Intangible Assets

Investments in Securities

Insurance and Self-Insurance

Income Taxes

Translation of Foreign Currencies

Translation of Foreign CurrenciesThe functional currency for each Scotts Miracle-Gro subsidiary is generally its local currency. Assets and liabilities of these subsidiaries are translated at the exchange rate in effect at each fiscal year-end. Income and expense accounts are translated at the average rate of exchange prevailing during the year. Translation gains and losses arising from the use of differing exchange rates from period to period are included in AOCL within shareholders’ equity. Foreign exchange transaction gains and losses are included in the determination of net income and classified as “Other (income) expense, net” in the Consolidated Statements of Operations.

Derivative Instruments

Leases

Recently Adopted and Recently Issued Accounting Pronouncements

RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS

Revenue Recognition

Nature of Goods and Services

The Company’s revenue is primarily generated from sales of branded and private label lawn and garden care and indoor and hydroponic gardening finished products to home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, indoor gardening and hydroponic product distributors, retailers and growers. In addition to product sales, the Company acts as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, and performs certain other services under ancillary agreements with Monsanto. Prior to December 31, 2020, the Company also provided marketing, research and development and certain ancillary services to Bonnie. Refer to “NOTE 21. SEGMENT INFORMATION” for disaggregated revenue information and “NOTE 7. MARKETING AGREEMENT” for revenue information related to the Monsanto agreements.

Identification and Satisfaction of Performance Obligations

The Company recognizes product sales at a point in time when it transfers control of products to customers and has no further obligation to provide services related to such products. Control is the ability of customers to direct the “use of” and “obtain” the benefit from the Company’s products. In evaluating the timing of the transfer of control of products to customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are typically recognized when products are delivered to or picked up by the customer. The Company is generally the principal in a transaction and, therefore, primarily records revenue on a gross basis. When the Company is a principal in a transaction, it has determined that it controls the ability to direct the use of the product prior to transfer to a customer, is primarily responsible for fulfilling the promise to provide the product or service to the customer, has discretion in establishing prices, and ultimately controls the transfer of the product or services provided to the customer.

Under the terms of the Third Amended and Restated Exclusive Agency and Marketing Agreement (the “Third Restated Agreement”), pursuant to which the Company serves as the exclusive agent of Monsanto for the marketing and distribution of certain of Monsanto’s consumer Roundup® branded products in the United States and certain other specified countries, the Company is entitled to receive an annual commission from Monsanto as consideration for the performance of the Company’s duties as agent. The Third Restated Agreement also requires the Company to make annual payments to Monsanto as a contribution against the overall expenses of its consumer Roundup® business. The gross commission earned under the Third Restated Agreement and the contribution payments to Monsanto are included in the “Net sales” line in the Consolidated Statements of Operations. The Company performs other services, including conversion services, pursuant to ancillary agreements with Monsanto. The actual costs incurred for these activities are charged to and reimbursed by Monsanto. The Company records costs incurred for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income.

Prior to December 31, 2020, in exchange for services performed pursuant to the terms of the Marketing, R&D and Ancillary Services Agreement (the “Services Agreement”) between the Company and AFC, Bonnie reimbursed the Company for certain costs and provided a commission fee earned based on a percentage of the growth in earnings before interest, income taxes and amortization of the Bonnie Business. The commission earned under the Services Agreement was included in the “Net sales” line in the Consolidated Statements of Operations. Additionally, the Company recorded costs incurred under the Services Agreement for which the Company is the primary obligor on a gross basis, recognizing such costs in the “Cost of sales” line and the reimbursement of these costs in the “Net sales” line in the Consolidated Statements of Operations, with no effect on gross margin dollars or net income.

Transactional Price and Promotional Allowances

Revenue for product sales is recorded net of sales returns and allowances. Revenues are measured based on the amount of consideration that the Company expects to receive as derived from a list price, reduced by estimates for variable consideration. Variable consideration includes the cost of current and continuing promotional programs and expected sales returns. Commission income related to the Monsanto agreements is recognized over the program year as the services are performed based upon the commission income formula in the agreements.

The Company’s promotional programs primarily include rebates based on sales volumes, in-store promotional allowances, cooperative advertising programs, direct consumer rebate programs and special purchasing incentives. The cost of promotional programs is estimated considering all reasonably available information, including current expectations and historical experience. Promotional costs (including allowances and rebates) incurred during the year are expensed to interim periods in relation to revenues and are recorded as a reduction of net sales. Accruals for expected payouts under these programs are included in the “Other current liabilities” line in the Consolidated Balance Sheets. Provisions for estimated returns and allowances are recorded at the time revenue is recognized based on historical rates and are periodically adjusted for known changes in return levels. Shipping and handling costs are accounted for as contract fulfillment costs and included in the “Cost of sales” line in the Consolidated Statements of Operations. The Company excludes from revenue any amounts collected from customers for sales or other taxes.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Schedule of Estimated Useful Economic Lives of Property, Plant and Equipment

Depreciation of property, plant and equipment is provided on the straight-line method and is based on the estimated useful economic lives of the assets as follows:


Land improvements			10 – 25 years
Buildings			10 – 40 years
Machinery and equipment			3 – 15 years
Furniture and fixtures			6 – 10 years
Software			3 – 8 years

Schedule of Supplemental Cash Flow Information

Supplemental cash flow information was as follows:


	Year Ended September 30,
	2022		2021		2020

Interest paid	$	112.5	$	61.6	$	75.9


Income taxes paid	27.2		179.7		124.2

DISCONTINUED OPERATIONS (Tables)

12 Months Ended

Sep. 30, 2022

Discontinued Operations and Disposal Groups [Abstract]

Results of Discontinued Operations and Schedule of the Major Classes of Assets and Liabilities


	Year Ended September 30,
	2022		2021		2020


Operating and exit costs	$	—	$	—	$	1.3
Impairment, restructuring and other charges (recoveries)	—		—		(3.1)

Write-down of contingent consideration receivable	—		12.2		—

Income (loss) from discontinued operations before income taxes	—		(12.2)		1.8
Income tax expense (benefit) from discontinued operations	—		(8.3)		0.1
Income (loss) from discontinued operations, net of tax	$	—	$	(3.9)	$	1.7

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760

+ Details

IMPAIRMENT, RESTRUCTURING AND OTHER (Tables)

12 Months Ended

Sep. 30, 2022

Restructuring and Related Activities [Abstract]

Schedule of Impairment, Restructuring, and Other Charges

The following table details impairment, restructuring and other charges (recoveries) for each of the periods presented:


	Year Ended September 30,
	2022		2021		2020

Cost of sales—impairment, restructuring and other:
COVID-19 related costs	$	—	$	25.0	$	15.5
Restructuring and other charges (recoveries), net	143.6		(0.3)		(0.1)
Property, plant and equipment impairments	16.6		—		0.6

Operating expenses—impairment, restructuring and other:
COVID-19 related costs	—		4.2		3.9
Restructuring and other charges (recoveries), net	40.9		0.1		(3.1)
Gains on sale of property, plant and equipment	(16.2)		—		—
Goodwill and intangible asset impairments	668.3		—		—
Impairment, restructuring and other charges from continuing operations	853.2		29.0		16.8
Restructuring and other charges (recoveries), net, from discontinued operations	—		—		(3.1)
Total impairment, restructuring and other charges	$	853.2	$	29.0	$	13.7

Schedule of Reserve

The following table summarizes the activity related to liabilities associated with restructuring activities for each of the periods presented:


	Year Ended September 30,
	2022		2021		2020

Amounts accrued for restructuring activities at beginning of year	$	1.9	$	3.9	$	11.6
Restructuring and other charges from continuing operations	47.1		29.0		20.0

Payments and other	(17.5)		(31.0)		(27.7)
Amounts accrued for restructuring activities at end of year	$	31.5	$	1.9	$	3.9

GOODWILL AND INTANGIBLE ASSETS, NET (Tables)

12 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Rollforward of Carrying Amount of Goodwill by Reportable Segment

The following table displays a rollforward of the carrying amount of goodwill by reportable segment:


	U.S. Consumer		Hawthorne		Other		Total
Goodwill	$	229.9	$	400.1	$	10.5	$	640.5
Accumulated impairment losses	(1.8)		(94.6)		—		(96.4)
Balance at September 30, 2020	228.1		305.5		10.5		544.1
Acquisitions and measurement-period adjustments	—		60.5		—		60.5
Foreign currency translation	—		—		0.6		0.6
Reallocation	15.8		(15.8)		—		—


Goodwill	$	245.7	$	444.8	$	11.1	$	701.6
Accumulated impairment losses	(1.8)		(94.6)		—		(96.4)
Balance at September 30, 2021	243.9		350.2		11.1		605.2
Acquisitions and measurement-period adjustments	—		180.8		—		180.8
Foreign currency translation	—		(8.6)		(1.0)		(9.6)
Impairment	—		(522.4)		—		(522.4)


Goodwill	$	245.7	$	617.0	$	10.1	$	872.8
Accumulated impairment losses	(1.8)		(617.0)		—		(618.8)
Balance at September 30, 2022	$	243.9	$	—	$	10.1	$	254.0

Schedule of Finite-lived Intangible Assets

The following table presents intangible assets, net of accumulated amortization and impairment charges:


	September 30, 2022						September 30, 2021
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount

Finite-lived intangible assets:
Trade names	$	318.4	$	(174.3)	$	144.1	$	293.4	$	(73.3)	$	220.1
Customer relationships	251.1		(158.4)		92.7		228.3		(91.7)		136.6
Technology	49.1		(43.3)		5.8		49.2		(41.3)		7.9
Other	34.7		(21.0)		13.7		35.3		(14.2)		21.1
Total finite-lived intangible assets, net					256.3						385.7
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7

Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	580.2					$	709.6

Schedule of Indefinite-lived Intangible Assets

The following table presents intangible assets, net of accumulated amortization and impairment charges:


	September 30, 2022						September 30, 2021
	Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization/ Impairment Charges		Net Carrying Amount

Finite-lived intangible assets:
Trade names	$	318.4	$	(174.3)	$	144.1	$	293.4	$	(73.3)	$	220.1
Customer relationships	251.1		(158.4)		92.7		228.3		(91.7)		136.6
Technology	49.1		(43.3)		5.8		49.2		(41.3)		7.9
Other	34.7		(21.0)		13.7		35.3		(14.2)		21.1
Total finite-lived intangible assets, net					256.3						385.7
Indefinite-lived intangible assets:
Indefinite-lived trade names					168.2						168.2
Roundup® marketing agreement amendment					155.7						155.7

Total indefinite-lived intangible assets					323.9						323.9
Total intangible assets, net					$	580.2					$	709.6

Schedule of Future Estimates of Amortization Expense

Amortization expense is estimated to be as follows for the years ending September 30:


2023	$	27.0
2024	22.8
2025	20.0
2026	18.6
2027	17.4

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

+ Details

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS (Tables)

12 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Detail of Certain Financial Statement Accounts

The following presents detail regarding certain financial statement accounts:


	September 30,
	2022		2021

INVENTORIES:
Finished goods	$	926.2	$	793.7
Raw materials	293.2		242.8
Work-in-progress	124.1		90.1
	$	1,343.5	$	1,126.6
PROPERTY, PLANT AND EQUIPMENT, NET:
Land and improvements	$	145.0	$	144.2
Buildings	262.2		268.5
Machinery and equipment	644.0		585.9
Furniture and fixtures	65.4		53.0
Software	127.9		116.2
Finance leases	43.9		42.4
Aircraft	—		16.6
Construction in progress	95.5		132.8
	1,383.9		1,359.6
Less: accumulated depreciation	(777.9)		(737.4)
	$	606.0	$	622.2
OTHER ASSETS:
Operating lease right-of-use assets	$	288.9	$	293.0
Deferred tax assets	143.5		—
Convertible debt investments	117.0		190.3
Accrued pension, postretirement and executive retirement assets	69.6		89.9
Loans receivable	32.8		35.8

Other	29.1		23.0
	$	680.9	$	632.0


	September 30,
	2022		2021

OTHER CURRENT LIABILITIES:
Current operating lease liabilities	$	76.2	$	66.4
Advertising and promotional accruals	74.8		132.7
Payroll and other compensation accruals	44.2		91.5

Accrued taxes	29.4		31.7
Accrued interest	30.1		28.0



Other	142.3		122.9
	$	397.0	$	473.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	$	223.2	$	234.4
Accrued pension, postretirement and executive retirement liabilities	82.1		98.2
Deferred tax liabilities	8.5		47.8

Other	45.2		29.2
	$	359.0	$	409.6

MARKETING AGREEMENT (Tables)

12 Months Ended

Sep. 30, 2022

Marketing Agreement [Abstract]

Marketing Agreement

The elements of the net commission and reimbursements earned under the Third Restated Agreement and included in the “Net sales” line in the Consolidated Statements of Operations are as follows:


	Year Ended September 30
	2022		2021		2020

Gross commission	$	83.4	$	94.0	$	90.4
Contribution expenses	(18.0)		(18.0)		(18.0)

Net commission	65.4		76.0		72.4
Reimbursements associated with Roundup® marketing agreement	67.9		70.8		61.6
Total net sales associated with Roundup® marketing agreement	$	133.3	$	146.8	$	134.0

RETIREMENT PLANS (Tables)

12 Months Ended

Sep. 30, 2022

Retirement Benefits [Abstract]

Schedule of Defined Benefit Pension Plans

The defined benefit pension plans are valued using a September 30 measurement date.


	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2022		2021		2022		2021

Change in projected benefit obligation:
Benefit obligation at beginning of year	$	100.2	$	109.8	$	193.6	$	193.7

Interest cost	1.7		1.5		3.0		2.6
Actuarial gain	(17.2)		(4.1)		(55.1)		(2.9)
Benefits paid	(7.0)		(7.0)		(7.5)		(7.6)





Foreign currency translation	—		—		(24.8)		7.8
Projected benefit obligation (“PBO”) at end of year	$	77.7	$	100.2	$	109.2	$	193.6
Accumulated benefit obligation (“ABO”) at end of year	$	77.7	$	100.2	$	109.2	$	193.6
Change in plan assets:
Fair value of plan assets at beginning of year	$	81.7	$	81.5	$	221.6	$	209.9
Actual return on plan assets	(15.8)		5.9		(61.2)		2.1
Employer contribution	0.2		1.3		5.3		7.9

Benefits paid	(7.0)		(7.0)		(7.5)		(7.6)

Foreign currency translation	—		—		(29.3)		9.3

Fair value of plan assets at end of year	$	59.1	$	81.7	$	128.9	$	221.6
Overfunded (underfunded) status at end of year	$	(18.6)	$	(18.5)	$	19.7	$	28.0


	U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	2022		2021		2022		2021

Information for pension plans with an ABO in excess of plan assets:

Accumulated benefit obligation	$	77.7	$	100.2	$	11.6	$	16.9
Fair value of plan assets	59.1		81.7		—		—
Information for pension plans with a PBO in excess of plan assets:
Projected benefit obligation	$	77.7	$	100.2	$	11.6	$	16.9
Fair value of plan assets	59.1		81.7		—		—
Amounts recognized in the Consolidated Balance Sheets consist of:

Non-current assets	$	—	$	—	$	31.3	$	44.9
Current liabilities	(0.2)		(0.2)		(0.8)		(0.9)
Non-current liabilities	(18.4)		(18.3)		(10.8)		(16.0)
Total amount accrued	$	(18.6)	$	(18.5)	$	19.7	$	28.0
Amounts recognized in AOCL consist of:
Actuarial loss	$	38.8	$	39.2	$	51.2	$	51.4
Prior service cost	—		—		2.1		2.7
Total amount recognized	$	38.8	$	39.2	$	53.3	$	54.1


	U.S. Defined Benefit Pension Plans						International Defined Benefit Pension Plans
	2022			2021			2022			2021

Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	$	(1.3)		$	6.6		$	(11.1)		$	(0.6)
Reclassification to net income	1.7			2.1			1.3			1.3



Foreign currency translation	—			—			10.6			(2.0)
Total change in other comprehensive loss	$	0.4		$	8.7		$	0.8		$	(1.3)




Weighted average assumptions used in development of projected benefit obligation:
Discount rate	5.06		%	2.37		%	4.96		%	1.90		%

Components of Net Periodic Benefit Cost


	U.S. Defined Benefit Pension Plans									International Defined Benefit Pension Plans
	2022			2021			2020			2022			2021			2020

Components of net periodic benefit cost (income):

Interest cost	$	1.7		$	1.5		$	2.6		$	3.0		$	2.6		$	2.7
Expected return on plan assets	(2.8)			(3.4)			(3.9)			(5.1)			(5.5)			(6.9)
Net amortization	1.7			2.1			1.8			1.3			1.3			1.0
Net periodic benefit cost (income)	$	0.6		$	0.2		$	0.5		$	(0.8)		$	(1.6)		$	(3.2)




Weighted average assumptions used in development of net periodic benefit cost (income):


Weighted average discount rate - interest cost	1.74		%	1.43		%	2.44		%	1.64		%	1.26		%	1.42		%
Expected return on plan assets	3.50		%	4.25		%	5.00		%	2.37		%	2.45		%	3.39		%

Schedule of Other Information


	U.S. Defined Benefit Pension Plans			International Defined Benefit Pension Plans

Other information:
Plan asset allocations:
Target for September 30, 2023:
Equity securities	22		%	25		%
Debt securities	74		%	44		%
Real estate securities	4		%	—		%
Cash and cash equivalents	—		%	1		%
Insurance contracts	—		%	30		%
September 30, 2022
Equity securities	17		%	25		%
Debt securities	75		%	44		%
Real estate securities	5		%	—		%
Cash and cash equivalents	3		%	1		%
Insurance contracts	—		%	30		%
September 30, 2021
Equity securities	20		%	22		%
Debt securities	73		%	48		%
Real estate securities	4		%	—		%
Cash and cash equivalents	3		%	—		%
Insurance contracts	—		%	30		%

Expected company contributions in fiscal 2023	$	0.2		$	1.1
Expected future benefit payments:
2023	$	7.4		$	5.6
2024	7.2			5.8
2025	7.0			6.1
2026	6.9			6.2
2027	6.8			6.2
2028 – 2032	30.5			33.8

Fair Value of The Company's Pension Plan Asset

The following tables set forth the fair value of the Company’s pension plan assets, segregated by level within the fair value hierarchy:


		U.S. Defined Benefit Pension Plans				International Defined Benefit Pension Plans
	Fair Value Hierarchy Level	2022		2021		2022		2021
Cash and cash equivalents	Level 1	$	2.1	$	2.9	$	1.7	$	0.2
Insurance contracts	Level 3	—		—		38.1		66.7
Total assets in the fair value hierarchy		$	2.1	$	2.9	$	39.8	$	66.9
Common collective trusts measured at net asset value
Real estate		$	2.8	$	3.4	$	—	$	—
Equities		10.0		16.0		32.6		48.3
Fixed income		44.2		59.4		56.5		106.4

Total common collective trusts measured at net asset value		57.0		78.8		89.1		154.7
Total assets at fair value		$	59.1	$	81.7	$	128.9	$	221.6

ASSOCIATE MEDICAL BENEFITS (Tables)

12 Months Ended

Sep. 30, 2022

Defined Benefit Plan, Postretirement Medical Plan with Prescription Drug Benefits [Abstract]

Schedule of Changes in Accumulated Postemployment Benefit Obligations

The following tables set forth information about the retiree medical plan for domestic associates. The retiree medical plan is valued using a September 30 measurement date.


	2022		2021

Change in Accumulated Plan Benefit Obligation (APBO):
Benefit obligation at beginning of year	$	20.1	$	22.4
Service cost	0.2		0.2
Interest cost	0.5		0.4
Plan participants’ contributions	0.4		0.4
Actuarial gain	(4.0)		(0.8)
Curtailment loss	0.6		—

Benefits paid	(2.1)		(2.4)

Benefit obligation at end of year	$	15.7	$	20.1
Change in plan assets:
Fair value of plan assets at beginning of year	$	—	$	—
Employer contribution	1.7		2.0
Plan participants’ contributions	0.4		0.4
Gross benefits paid	(2.1)		(2.4)
Fair value of plan assets at end of year	$	—	$	—
Unfunded status at end of year	$	(15.7)	$	(20.1)

The decrease in the benefit obligation during fiscal 2022 was primarily driven by the increase in the discount rate. These gains were partially offset by demographic experience losses.


	2022			2021

Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	$	(1.6)		$	(1.5)
Non-current liabilities	(14.1)			(18.6)
Total amount accrued	$	(15.7)		$	(20.1)
Amounts recognized in AOCL consist of:
Actuarial (gain) loss	$	(1.2)		$	2.5
Prior service credit	(0.2)			(1.4)
Total accumulated other comprehensive (income) loss	$	(1.4)		$	1.1
Total change in other comprehensive loss attributable to:
Gain during the period	$	3.4		$	0.8

Reclassification to net income	(0.9)			(0.8)
Total change in other comprehensive loss	$	2.5		$	—

Discount rate used in development of APBO	5.60		%	2.66		%

Schedule of Expected Benefit Payments

The following benefit payments under the plan are expected to be paid by the Company and the retirees for the fiscal years indicated:


	Gross Benefit Payments		Retiree Contributions		Net Company Payments

2023	$	2.2	$	(0.6)	$	1.6
2024	2.2		(0.6)		1.6
2025	2.1		(0.5)		1.6
2026	2.1		(0.6)		1.5
2027	2.2		(0.7)		1.5
2028 – 2032	10.5		(3.9)		6.6

DEBT (Tables)

12 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Schedule of Components of Long-Term Debt

The components of debt are as follows:


	September 30,
	2022		2021

Credit Facilities:
Revolving loans	$	300.5	$	—
Term loans	975.0		670.0
Senior Notes due 2031 – 4.000%	500.0		500.0
Senior Notes due 2032 – 4.375%	400.0		400.0
Senior Notes due 2029 – 4.500%	450.0		450.0
Senior Notes due 2026 – 5.250%	250.0		250.0

Receivables facility	75.0		—
Finance lease obligations	28.9		33.4
Other	12.7		11.9
Total debt	2,992.1		2,315.3
Less current portions	144.3		57.8
Less unamortized debt issuance costs	21.6		20.8
Long-term debt	$	2,826.2	$	2,236.7

Schedule of Company's Debt Maturities

The Company’s aggregate scheduled maturities of debt, excluding finance lease obligations, are as follows:


2023	$	137.7
2024	50.0
2025	50.0
2026	50.0
2027	1,325.5
Thereafter	1,350.0
	$	2,963.2

Schedule of Derivative Instruments


Notional Amount		Effective Date (a)	Expiration Date	Fixed Rate
100		12/21/2020	6/20/2023	1.36	%
300	(b)	1/7/2021	6/7/2023	1.34	%
200		10/7/2021	6/7/2023	1.37	%
200	(b)	1/20/2022	6/20/2024	0.58	%
200		6/7/2023	6/8/2026	0.85	%

(a)The effective date refers to the date on which interest payments are first hedged by the applicable swap agreement.

(b)Notional amount adjusts in accordance with a specified seasonal schedule. This represents the maximum notional amount at any point in time.

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959

+ Details

EQUITY (Tables)

12 Months Ended

Sep. 30, 2022

Equity [Abstract]

Schedule of Authorized and Issued Shares

Authorized and issued shares consisted of the following (in millions):


	September 30,
	2022	2021

Preferred shares, no par value:
Authorized	0.2 shares	0.2 shares
Issued	0.0 shares	0.0 shares
Common shares, no par value, $0.01 stated value per share:
Authorized	100.0 shares	100.0 shares
Issued	68.1 shares	68.1 shares

Schedule of Accumulated Other Comprehensive Loss

Changes in AOCL by component were as follows for the fiscal years ended September 30:


	Foreign Currency Translation Adjustments		Net Unrealized Gain (Loss) On Derivative Instruments		Net Unrealized Loss On Securities		Net Unrealized Gain (Loss) in Pension and Other Post- Retirement Benefits		Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2019	$	(17.4)	$	(8.1)	$	—	$	(68.4)	$	(93.9)
Other comprehensive income (loss) before reclassifications	10.5		(19.7)		—		(12.9)		(22.1)
Amounts reclassified from accumulated other comprehensive net income (loss)	0.8		10.1		—		0.3		11.2
Income tax benefit (expense)	—		2.5		—		3.2		5.7
Net current period other comprehensive income (loss)	11.3		(7.1)		—		(9.4)		(5.2)
Balance at September 30, 2020	(6.2)		(15.1)		—		(77.8)		(99.1)
Other comprehensive income (loss) before reclassifications	4.5		26.8		(3.1)		6.9		35.1
Amounts reclassified from accumulated other comprehensive net income (loss)	—		7.3		—		0.4		7.7
Income tax benefit (expense)	—		(8.9)		0.8		(1.9)		(10.0)
Net current period other comprehensive income (loss)	4.5		25.2		(2.3)		5.4		32.8
Balance at September 30, 2021	(1.7)		10.2		(2.3)		(72.5)		(66.4)
Other comprehensive income (loss) before reclassifications	(27.2)		40.1		(102.0)		(7.3)		(96.4)
Amounts reclassified from accumulated other comprehensive net income (loss)	—		(9.1)		—		11.7		2.6
Income tax benefit (expense)	—		(7.9)		24.6		(1.1)		15.6
Net current period other comprehensive income (loss)	(27.2)		23.1		(77.4)		3.3		(78.2)
Balance at September 30, 2022	$	(28.9)	$	33.3	$	(79.7)	$	(69.3)	$	(144.6)

The sum of the components may not equal due to rounding.

Schedule of Share-Based Awards Granted

The following is a summary of the share-based awards granted during each of the periods indicated:


	Year Ended September 30,
	2022		2021		2020
Employees
Options	—		183,553		37,255
Restricted stock units	228,558		70,936		119,726

Performance units	105,756		1,903		37,570
Non-Employee Directors
Restricted and deferred stock units	20,015		9,173		18,948

Total share-based awards	354,329		265,565		213,499

Aggregate fair value at grant dates	$	41.2	$	30.2	$	21.5

Schedule of Share-Based Compensation

Total share-based compensation was as follows for each of the periods indicated:


	Year Ended September 30,
	2022		2021		2020

Share-based compensation	$	30.3	$	40.6	$	57.9
Related tax benefit recognized	4.9		7.4		14.6

Schedule of Aggregate Stock Option Activity

Stock option activity was as follows:


	No. of Options	Wtd. Avg. Exercise Price
Awards outstanding at September 30, 2021	568,191	$	118.38


Forfeited	(39,720)	236.53
Awards outstanding at September 30, 2022	528,471	110.86
Exercisable	388,002	65.36

Summary of Certain Information Pertaining to Stock Option Awards Outstanding and Exercisable

The following summarizes certain information pertaining to stock option awards outstanding and exercisable at September 30, 2022:


	Awards Outstanding			Awards Exercisable
Range of Exercise Price	No. of Options	Wtd. Avg. Remaining Life	Wtd. Avg. Exercise Price	No. of Options	Wtd. Avg. Remaining Life	Wtd. Avg. Exercise Price
$59.62 - $64.55	380,932	2.85	62.18	380,932	2.85	62.18
$236.53 - $236.53	147,539	8.35	236.53	7,070	8.35	236.53

	528,471	4.39	110.86	388,002	2.95	65.36

Schedule of Intrinsic Value of Stock Option Awards Outstanding and Exercisable

The intrinsic values of the stock option awards outstanding and exercisable at September 30, 2022 were zero.

Schedule of Restricted Share-Based Award Activity

Restricted share-based award activity (including restricted stock units and deferred stock units) was as follows:


	No. of Shares	Wtd. Avg. Grant Date Fair Value per Share








Awards outstanding at September 30, 2021	375,825	124.50
Granted	248,573	109.10
Vested	(246,846)	75.38
Forfeited	(56,977)	165.01
Awards outstanding at September 30, 2022	320,575	143.19

Schedule of Performance-Based Award Activity

Performance-based award activity was as follows (based on target award amounts):


	No. of Units	Wtd. Avg. Grant Date Fair Value per Unit








Awards outstanding at September 30, 2021	572,557	95.09
Granted	105,756	132.74
Vested (a)	(533,441)	93.22
Forfeited	(31,616)	124.15
Awards outstanding at September 30, 2022	113,256	130.94

(a)Vested at a weighted average of 228% of the target performance share units granted.

EARNINGS PER COMMON SHARE (Tables)

12 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Information to Calculate Basic and Diluted Earnings (Loss) Per Common Share

The following table presents information necessary to calculate basic and diluted income per Common Share.


	Year Ended September 30,
	2022		2021		2020

Income (loss) from continuing operations	$	(437.5)	$	517.3	$	386.9
Net income attributable to noncontrolling interest	—		(0.9)		(1.2)
Income (loss) attributable to controlling interest from continuing operations	(437.5)		516.4		385.7
Income (loss) from discontinued operations, net of tax	—		(3.9)		1.7
Net income (loss) attributable to controlling interest	$	(437.5)	$	512.5	$	387.4
Basic income (loss) per common share:
Weighted-average common shares outstanding during the period	55.5		55.7		55.7
Income (loss) from continuing operations	$	(7.88)	$	9.27	$	6.92
Income (loss) from discontinued operations	—		(0.07)		0.04
Basic net income (loss) per common share	$	(7.88)	$	9.20	$	6.96
Diluted income (loss) per common share:
Weighted-average common shares outstanding during the period	55.5		55.7		55.7
Dilutive potential common shares	—		1.5		1.2
Weighted-average number of common shares outstanding and dilutive potential common shares	55.5		57.2		56.9
Income (loss) from continuing operations	$	(7.88)	$	9.03	$	6.78
Income (loss) from discontinued operations	—		(0.07)		0.03
Diluted net income (loss) per common share	$	(7.88)	$	8.96	$	6.81

INCOME TAXES (Tables)

12 Months Ended

Sep. 30, 2022

Income Tax Disclosure [Abstract]

Provision (Benefit) For Income Taxes Allocated to Continuing Operations

The provision (benefit) for income taxes allocated to continuing operations consisted of the following:


	Year Ended September 30,
	2022		2021		2020

Current:
Federal	$	22.8	$	113.7	$	104.3
State	9.3		31.6		25.3
Foreign	8.7		2.7		0.3
Total Current	40.8		148.0		129.9
Deferred:
Federal	(125.5)		9.1		(1.6)
State	(23.3)		1.5		(2.0)
Foreign	(12.6)		1.2		(2.6)
Total Deferred	(161.4)		11.8		(6.2)
Income tax expense (benefit) from continuing operations	$	(120.6)	$	159.8	$	123.7

The Domestic and Foreign Components of Income From Continuing Operations Before Income Taxes

The domestic and foreign components of income (loss) from continuing operations before income taxes were as follows:


	Year Ended September 30,
	2022		2021		2020

Domestic	$	(427.3)	$	670.2	$	483.7
Foreign	(130.8)		6.9		26.9
Income (loss) from continuing operations before income taxes	$	(558.1)	$	677.1	$	510.6

Reconciliation of the Federal Corporate Income Tax Rate and the Effective Tax Rate

A reconciliation of the federal corporate income tax rate and the effective tax rate on income (loss) from continuing operations before income taxes is summarized below:


	Year Ended September 30,
	2022		2021		2020
Statutory income tax rate	21.0	%	21.0	%	21.0	%
Effect of foreign operations	(2.5)		(0.1)		(0.7)
State taxes, net of federal benefit	2.6		3.9		3.5
Effect of other permanent differences	2.8		(1.1)		—
Research and Experimentation and other federal tax credits	0.2		(0.2)		(0.3)
Effect of tax contingencies	(1.8)		—		0.1
Other	(0.7)		0.1		0.6
Effective income tax rate	21.6	%	23.6	%	24.2	%

Components of Deferred Income Tax Assets and Liabilities


	September 30,
	2022		2021

DEFERRED TAX ASSETS
Accrued liabilities	$	80.8	$	65.6
Lease liabilities	70.7		71.0
Intangible assets	60.8		—
Inventories	43.2		16.8
Convertible debt investments	25.3		—
Net operating loss carryovers	21.7		14.2
Foreign tax credit carryovers	15.0		14.9
Accounts receivable	8.7		8.5
Other	12.5		5.0
Gross deferred tax assets	338.7		196.0
Valuation allowance	(40.7)		(32.3)
Total deferred tax assets	298.0		163.7
DEFERRED TAX LIABILITIES
Intangible assets	—		(73.3)
Lease right-of-use assets	(68.6)		(69.6)
Property, plant and equipment	(65.8)		(55.8)
Outside basis difference in equity investments	(14.8)		(7.2)
Derivative contracts	(10.5)		—
Other	(3.3)		(5.6)
Total deferred tax liabilities	(163.0)		(211.5)
Net deferred tax asset (liability)	$	135.0	$	(47.8)

Reconciliation of the Unrecognized Tax Benefits

A reconciliation of the unrecognized tax benefits is as follows:


	Year Ended September 30,
	2022		2021		2020

Balance at beginning of year	$	24.1	$	30.2	$	29.5
Additions for tax positions of the current year	11.3		0.3		0.3
Additions for tax positions of prior years	2.2		6.1		4.5
Reductions for tax positions of prior years	(2.5)		(5.9)		(2.4)
Settlements with tax authorities	1.3		0.2		0.3
Expiration of statutes of limitation	(0.6)		(6.8)		(2.0)
Balance at end of year	$	35.8	$	24.1	$	30.2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)

12 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Outstanding Commodity Contracts that Hedge Forecasted Purchases

The Company had the following outstanding commodity contracts that were entered into to hedge forecasted purchases:


	September 30,
	2022	2021
Commodity
Urea	54,000 tons	94,500 tons

Diesel	3,150,000 gallons	5,880,000 gallons

Heating Oil	1,218,000 gallons	2,268,000 gallons

Summary of Fair Values of the Company's Derivative Instruments

The fair values of the Company’s derivative instruments, which represent Level 2 fair value measurements, were as follows:


		Assets / (Liabilities)
		2022		2021
Derivatives Designated as Hedging Instruments	Balance Sheet Location	Fair Value
Interest rate swap agreements	Prepaid and other current assets	$	12.8	$	—
	Other assets	18.2		3.3
	Other current liabilities	—		(5.7)
	Other liabilities	—		(2.5)
Commodity hedging instruments	Prepaid and other current assets	2.4		13.9

Total derivatives designated as hedging instruments		$	33.4	$	9.0

Derivatives Not Designated as Hedging Instruments	Balance Sheet Location
Currency forward contracts	Prepaid and other current assets	$	3.4	$	3.4
	Other current liabilities	—		(0.2)
Commodity hedging instruments	Prepaid and other current assets	0.4		1.3

Total derivatives not designated as hedging instruments		3.8		4.5
Total derivatives		$	37.2	$	13.5

Schedule of the Effect of Derivative Instruments on AOCI and Operations

The effect of derivative instruments on AOCL, net of tax, and the Consolidated Statements of Operations for the years ended September 30 was as follows:


	Amount of Gain / (Loss) Recognized in AOCL
Derivatives in Cash Flow Hedging Relationships	2022		2021

Interest rate swap agreements	$	24.1	$	3.4
Commodity hedging instruments	5.8		16.4
Total	$	29.9	$	19.8


	Reclassified from AOCL into	Amount of Gain / (Loss)
Derivatives in Cash Flow Hedging Relationships	Statement of Operations	2022		2021

Interest rate swap agreements	Interest expense	$	(2.1)	$	(7.7)
Commodity hedging instruments	Cost of sales	8.9		2.3
Total		$	6.8	$	(5.4)


	Recognized in	Amount of Gain / (Loss)
Derivatives Not Designated as Hedging Instruments	Statement of Operations	2022		2021

Currency forward contracts	Other income / expense, net	$	17.9	$	(4.2)
Commodity hedging instruments	Cost of sales	10.5		4.5
Total		$	28.4	$	0.3

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements, Recurring Basis

The following table summarizes the fair value of the Company’s assets and liabilities for which disclosure of fair value is required:


		2022				2021
	Fair Value Hierarchy Level	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Assets
Cash equivalents	Level 1	$	64.3	$	64.3	$	222.5	$	222.5




Other
Investment securities in non-qualified retirement plan assets	Level 1	38.4		38.4		45.0		45.0
Loans receivable	Level 3	32.8		32.8		35.8		35.8
Convertible debt investments	Level 3	117.0		117.0		190.3		190.3

Liabilities




Debt instruments
Credit facilities – revolving loans	Level 2	300.5		300.5		—		—
Credit facilities – term loans	Level 2	975.0		975.0		670.0		670.0
Senior Notes due 2031 – 4.000%	Level 2	500.0		350.6		500.0		498.8
Senior Notes due 2032 – 4.375%	Level 2	400.0		284.0		400.0		402.0
Senior Notes due 2029 – 4.500%	Level 2	450.0		325.7		450.0		466.9
Senior Notes due 2026 – 5.250%	Level 2	250.0		230.0		250.0		258.1

Receivables facility	Level 2	75.0		75.0		—		—

Other debt	Level 2	12.7		12.7		11.9		11.9

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation

Changes in balances of Level 3 convertible debt investments carried at fair value are presented below. There were no transfers into or out of Level 3.


	Year Ended September 30,
	2022		2021
Fair value at beginning of year	$	190.3	$	—
Purchases	25.0		193.1
Total realized / unrealized gains included in net earnings	3.7		0.3
Total realized / unrealized losses included in OCI	(102.0)		$	(3.1)
Fair value at end of year	$	117.0	$	190.3

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

LEASES (Tables)

12 Months Ended

Sep. 30, 2022

Leases [Abstract]

Supplemental Balance Sheet Information Schedule and Weighted-average remaining lease term

Supplemental balance sheet information related to the Company’s leases was as follows:


	Balance Sheet Location	September 30, 2022		September 30, 2021

Operating leases:
Right-of-use assets	Other assets	$	288.9	$	293.0

Current lease liabilities	Other current liabilities	76.2		66.4
Non-current lease liabilities	Other liabilities	223.2		234.4
Total operating lease liabilities		$	299.4	$	300.8

Finance leases:
Right-of-use assets	Property, plant and equipment, net	$	26.4	$	31.3

Current lease liabilities	Current portion of debt	6.4		5.9
Non-current lease liabilities	Long-term debt	22.5		27.5
Total finance lease liabilities		$	28.9	$	33.4

Weighted-average remaining lease term and discount rate for the Company’s leases were as follows:


	September 30, 2022
Weighted-average remaining lease term (in years):
Operating leases	4.9
Finance leases	7.3

Weighted-average discount rate:
Operating leases	3.5	%
Finance leases	4.3	%

Components of lease cost

Components of lease cost were as follows:


	Year Ended September 30,
	2022		2021

Operating lease cost (a)	$	86.7	$	70.3
Variable lease cost	35.9		29.4


Finance lease cost
Amortization of right-of-use assets	6.4		6.0
Interest on lease liabilities	1.2		1.4
Total finance lease cost	$	7.6	$	7.4

Supplemental cash flow information and non-cash activity related to the Company’s leases were as follows:


	Year Ended September 30,
	2022		2021

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases, net	$	83.9	$	66.9
Operating cash flows from finance leases	1.2		1.4
Financing cash flows from finance leases	5.9		5.3

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	71.9	$	200.0
Finance leases	1.5		2.6

Maturities of Operating Lease Liabilities by Fiscal Year Schedule

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2022 were as follows:


Year	Operating Leases		Finance Leases
2023	$	85.2	$	7.5
2024	78.0		7.5
2025	61.2		3.3
2026	42.2		2.2
2027	18.9		1.9
Thereafter	40.5		11.8
Total lease payments	326.0		34.2
Less: Imputed interest	(26.6)		(5.3)
Total lease liabilities	$	299.4	$	28.9

Maturities of Finance Lease Liabilities by Fiscal Year Schedule

Maturities of lease liabilities by fiscal year for the Company’s leases as of September 30, 2022 were as follows:


Year	Operating Leases		Finance Leases
2023	$	85.2	$	7.5
2024	78.0		7.5
2025	61.2		3.3
2026	42.2		2.2
2027	18.9		1.9
Thereafter	40.5		11.8
Total lease payments	326.0		34.2
Less: Imputed interest	(26.6)		(5.3)
Total lease liabilities	$	299.4	$	28.9

COMMITMENTS (Tables)

12 Months Ended

Sep. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Unconditional Purchase Obligations That Have Not Been Recognized

The Company has the following unconditional purchase obligations due during each of the next five fiscal years that have not been recognized in the Consolidated Balance Sheet at September 30, 2022:


2023	$	547.2
2024	358.6
2025	201.1
2026	147.7
2027	128.8
Thereafter	84.8
	$	1,468.2

SEGMENT INFORMATION (Tables)

12 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Segment Financial Information

The following tables present financial information for the Company’s reportable segments for the periods indicated:


	Year Ended September 30,
	2022		2021		2020

Net Sales:
U.S. Consumer	$	2,928.8	$	3,197.7	$	2,883.5
Hawthorne	716.2		1,424.2		1,023.1
Other	279.1		303.1		225.0
Consolidated	$	3,924.1	$	4,925.0	$	4,131.6
Segment Profit (Loss):
U.S. Consumer	$	568.6	$	726.7	$	694.3
Hawthorne	(21.1)		163.8		111.9
Other	20.2		42.1		11.7
Total Segment Profit	567.7		932.6		817.9
Corporate	(112.4)		(149.7)		(183.4)
Intangible asset amortization	(37.1)		(30.9)		(32.5)

Impairment, restructuring and other	(852.2)		(29.0)		(16.8)
Equity in income (loss) of unconsolidated affiliates	(12.9)		14.4		—
Costs related to refinancing	—		—		(15.1)
Interest expense	(118.1)		(78.9)		(79.6)
Other non-operating income, net	6.9		18.6		20.1
Income (loss) from continuing operations before income taxes	$	(558.1)	$	677.1	$	510.6
Depreciation and amortization:
U.S. Consumer	$	55.8	$	48.6	$	48.0
Hawthorne	34.8		30.3		31.7
Other	7.0		7.0		7.5
Corporate	7.6		7.9		7.5
	$	105.2	$	93.8	$	94.7
Capital expenditures:
U.S. Consumer	$	97.4	$	78.3	$	52.3
Hawthorne	12.4		25.0		7.8
Other	3.7		3.6		2.6
	$	113.5	$	106.9	$	62.7


	September 30,
	2022		2021

Total assets:
U.S. Consumer	$	2,454.4	$	2,333.1
Hawthorne	1,061.5		1,442.8
Other	197.1		209.6
Corporate	583.8		814.5

Consolidated	$	4,296.8	$	4,800.0

Net sales by product category

The following table presents net sales by product category for the periods indicated:


	Year Ended September 30,
	2022		2021		2020

U.S. Consumer:
Growing media and mulch	$	1,192.6	$	1,286.7	$	1,164.0
Lawn care	973.6		1,060.6		943.3
Controls	382.2		402.4		383.7
Roundup® marketing agreement	132.3		145.2		132.7
Other, primarily gardening	248.1		302.8		259.8
Hawthorne:
Lighting	200.0		452.4		328.7
Nutrients	148.0		324.7		250.1
Growing environment	143.7		264.0		154.2
Growing media	119.0		192.6		148.9
Other, primarily hardware	105.5		190.5		141.2
Other:
Growing media	96.6		116.7		90.6
Lawn care	92.9		99.2		73.7
Other, primarily gardening and controls	89.6		87.2		60.7
Total net sales	$	3,924.1	$	4,925.0	$	4,131.6

Percentages of Largest Customers Consolidated Net Sales

The Company’s two largest customers accounted for the following percentages of net sales for the fiscal years ended September 30:


	Percentage of Net Sales
	2022		2021		2020
Home Depot	28	%	24	%	26	%
Lowe’s	15	%	15	%	18	%

Net Sales and Long-lived Assets by Geographic Area

The following table presents net sales by geographic area for the periods indicated:


	Year Ended September 30,
	2022		2021		2020

Net sales:
United States	$	3,554.6	$	4,507.0	$	3,773.4
International	369.5		418.0		358.2
	$	3,924.1	$	4,925.0	$	4,131.6

The following table presents long-lived assets (property, plant and equipment and finite-lived intangibles) by geographic area:


	September 30,
	2022		2021

Long-lived assets:
United States	$	753.3	$	868.8
International	109.0		139.1
	$	862.3	$	1,007.9

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Jul. 02, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Significant Accounting Policies [Line Items]
Percentage of annual net sales from combined second and third quarter sales	75.00%
Advertising expenses		$ 120.3	$ 165.7	$ 147.4
Research and development charge		45.3	45.4	39.7
Product registration costs		13.0	12.3	11.0
Adjustment to reflect inventories at net realizable values		118.8	22.5
Interest capitalized on capital projects		2.2	0.8	0.4
Noncash investing activities for unpaid liabilities incurred		33.3	41.6	26.4
Recognition of accumulated foreign currency translation loss		1.3	(1.8)	0.9
Operating lease right-of-use assets		288.9	293.0
Current lease liabilities		76.2	66.4
Non-current operating lease liabilities		$ 223.2	$ 234.4
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]		Other Liabilities, Current	Other Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]		Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Other investing, net		$ 29.3	$ (8.7)	(2.9)
Officer \| Options \| Project Focus
Significant Accounting Policies [Line Items]
Expiration period (in years)		10 years
Director
Significant Accounting Policies [Line Items]
Award vesting period (in years)		1 year
Minimum
Significant Accounting Policies [Line Items]
Award vesting period (in years)		3 years
Expected forfeiture rate		15.00%
Intangible assets amortization period		3 years
Minimum \| Software
Significant Accounting Policies [Line Items]
Intangible assets amortization period		3 years
Minimum \| Officer \| Performance units \| Project Focus
Significant Accounting Policies [Line Items]
Vesting percent of target award		50.00%
Maximum
Significant Accounting Policies [Line Items]
Award vesting period (in years)		5 years
Intangible assets amortization period		25 years
Maximum \| Software
Significant Accounting Policies [Line Items]
Intangible assets amortization period		7 years
Maximum \| Officer \| Performance units \| Project Focus
Significant Accounting Policies [Line Items]
Vesting percent of target award		250.00%
Other Nonoperating Income (Expense)
Significant Accounting Policies [Line Items]
Interest income on loans receivable		$ 2.7	$ 3.8	$ 7.6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Economic Lives of Assets (Details)	12 Months Ended
	Sep. 30, 2022
Land improvements \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Land improvements \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	25 years
Buildings \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Buildings \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	40 years
Machinery and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	3 years
Machinery and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	15 years
Furniture and fixtures \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	6 years
Furniture and fixtures \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	10 years
Software \| Minimum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	3 years
Software \| Maximum
Property, Plant and Equipment [Line Items]
Estimated useful economic lives (in years)	8 years

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Accounting Policies [Abstract]
Interest paid	$ 112.5	$ 61.6	$ 75.9
Income taxes paid	$ 27.2	$ 179.7	$ 124.2

DISCONTINUED OPERATIONS - Additional Information (Details) - USD ($) $ in Millions		12 Months Ended
	Aug. 31, 2017	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Financing receivables, initial term (in years)		3 years
Cash provided by (used in) operating activities from discontinued operations		$ 0.0	$ 0.0	$ 3.6
Cash provided by (used in) investing activities from discontinued operations		0.0	0.0	$ 0.0
International Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Vendor financing loan	$ 29.7
Financing loan term (in years)	7 years
Annual interest rate	5.00%
Annual interest rate increases	2.50%
Contingent consideration maximum payout	$ 23.8
Fair value of contingent consideration	$ 18.2
International Business \| Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contingent consideration payout		$ 6.0
Pre-tax charge			$ 12.2

DISCONTINUED OPERATIONS - Results of Discontinued Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Discontinued Operations and Disposal Groups [Abstract]
Operating and exit costs	$ 0.0	$ 0.0	$ 1.3
Impairment, restructuring and other charges (recoveries)	0.0	0.0	(3.1)
Write-down of contingent consideration receivable	0.0	12.2	0.0
Income (loss) from discontinued operations before income taxes	0.0	(12.2)	1.8
Income tax expense (benefit) from discontinued operations	0.0	(8.3)	0.1
Income (loss) from discontinued operations, net of tax	$ 0.0	$ (3.9)	$ 1.7

- Definition

Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References + Details

- Definition

Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319

+ Details

- Definition

Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(12))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 45
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337

+ Details

IMPAIRMENT, RESTRUCTURING AND OTHER - Schedule of Impairment, Restructuring, and Other Charges (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries)	$ 693.1	$ 4.3	$ 0.8
Impairment, restructuring and other charges from continuing operations	853.2	29.0	16.8
Restructuring and other charges (recoveries), net, from discontinued operations	0.0	0.0	(3.1)
Total impairment, restructuring and other charges	853.2	29.0	13.7
Restructuring Reserve
Amounts accrued for restructuring activities at beginning of year	1.9	3.9	11.6
Restructuring and other charges from continuing operations	47.1	29.0	20.0
Payments and other	(17.5)	(31.0)	(27.7)
Amounts accrued for restructuring activities at end of year	31.5	1.9	3.9
Operating expenses
Restructuring Cost and Reserve [Line Items]
Gains on sale of property, plant and equipment	(16.2)	0.0	0.0
COVID-19 related costs \| Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring costs	0.0	25.0	15.5
COVID-19 related costs \| Operating expenses
Restructuring Cost and Reserve [Line Items]
Restructuring costs	0.0	4.2	3.9
Restructuring and other charges (recoveries), net \| Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries)	143.6	(0.3)	(0.1)
Restructuring and other charges (recoveries), net \| Operating expenses
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries)	40.9	0.1	(3.1)
Property, plant and equipment impairments \| Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries)	16.6	0.0	0.6
Goodwill and intangible asset impairments \| Operating expenses
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges (recoveries)	$ 668.3	$ 0.0	$ 0.0

IMPAIRMENT, RESTRUCTURING AND OTHER - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Jul. 02, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring reserves classified as long-term		$ 4.6
Impairment, restructuring and other charges		853.2	$ 29.0	$ 16.8
Noncash impairment charge		$ 35.3
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]		Impairment, restructuring and other
Employee Severance and Impairment Of Property, Plant, And Equipment
Restructuring Cost and Reserve [Line Items]
Restructuring costs		$ 65.2
Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Inventory Write-down		120.9
Operating expenses
Restructuring Cost and Reserve [Line Items]
Gains on sale of property, plant and equipment		(16.2)	0.0	0.0
COVID-19 related costs
Restructuring Cost and Reserve [Line Items]
Restructuring costs			29.2	19.4
U.S. Consumer \| Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs		9.7
U.S. Consumer \| Impairment, Restructuring, And Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs		11.9
U.S. Consumer \| COVID-19 related costs \| Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs			21.2	12.4
U.S. Consumer \| COVID-19 related costs \| Restructuring, Settlement and Impairment Provisions
Restructuring Cost and Reserve [Line Items]
Restructuring costs			4.0	3.8
Hawthorne \| Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs		27.1
Hawthorne \| Impairment, Restructuring, And Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs		8.1
Goodwill and intangible asset impairment		632.4
Hawthorne \| Goodwill Impairment
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 522.4	522.4
Hawthorne \| Finite-Lived Intangible Asset Impairment
Restructuring Cost and Reserve [Line Items]
Restructuring costs		110.0
Hawthorne \| COVID-19 related costs \| Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs			3.2	2.6
Other \| Impairment, Restructuring, And Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs		0.7
Other \| COVID-19 related costs \| Cost of Sales, Impairment, Restructuring and Other Charges
Restructuring Cost and Reserve [Line Items]
Restructuring costs			0.6	0.5
Other \| COVID-19 related costs \| Restructuring, Settlement and Impairment Provisions
Restructuring Cost and Reserve [Line Items]
Restructuring costs			$ 0.2	$ 0.1
Corporate Segment \| Impairment, Restructuring, And Other
Restructuring Cost and Reserve [Line Items]
Restructuring costs		$ 7.7

GOODWILL AND INTANGIBLE ASSETS, NET - Rollforward of Carrying Amount of Goodwill by Reportable Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Goodwill [Roll Forward]
Goodwill, gross (beginning of period)	$ 701.6	$ 640.5
Accumulated impairment losses	(96.4)	(96.4)
Goodwill, net (beginning of period)	605.2	544.1
Acquisitions and measurement-period adjustments	180.8	60.5
Foreign currency translation	(9.6)	0.6
Reallocation		0.0
Impairment	(522.4)
Goodwill, gross (end of period)	872.8	701.6
Accumulated impairment losses	(618.8)	(96.4)
Goodwill, net (end of period)	254.0	605.2
U.S. Consumer
Goodwill [Roll Forward]
Goodwill, gross (beginning of period)	245.7	229.9
Accumulated impairment losses	(1.8)	(1.8)
Goodwill, net (beginning of period)	243.9	228.1
Acquisitions and measurement-period adjustments	0.0	0.0
Foreign currency translation	0.0	0.0
Reallocation	15.8	15.8
Impairment	0.0
Goodwill, gross (end of period)	245.7	245.7
Accumulated impairment losses	(1.8)	(1.8)
Goodwill, net (end of period)	243.9	243.9
Hawthorne
Goodwill [Roll Forward]
Goodwill, gross (beginning of period)	444.8	400.1
Accumulated impairment losses	(94.6)	(94.6)
Goodwill, net (beginning of period)	350.2	305.5
Acquisitions and measurement-period adjustments	180.8	60.5
Foreign currency translation	(8.6)	0.0
Reallocation	(15.8)	(15.8)
Impairment	(522.4)
Goodwill, gross (end of period)	617.0	444.8
Accumulated impairment losses	(617.0)	(94.6)
Goodwill, net (end of period)	0.0	350.2
Other
Goodwill [Roll Forward]
Goodwill, gross (beginning of period)	11.1	10.5
Accumulated impairment losses	0.0	0.0
Goodwill, net (beginning of period)	11.1	10.5
Acquisitions and measurement-period adjustments	0.0	0.0
Foreign currency translation	(1.0)	0.6
Reallocation		0.0
Impairment	0.0
Goodwill, gross (end of period)	10.1	11.1
Accumulated impairment losses	0.0	0.0
Goodwill, net (end of period)	$ 10.1	$ 11.1

GOODWILL AND INTANGIBLE ASSETS, NET - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Jul. 02, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Goodwill [Line Items]
Reallocation			$ 0.0
Amortization expense		$ 37.1	30.9	$ 32.5
Goodwill		$ 254.0	605.2	544.1
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]		Impairment, restructuring and other
Noncash impairment charge		$ 35.3
Trade names
Goodwill [Line Items]
Impairment charge	$ 69.0
Noncash impairment charge		22.5
Customer relationships
Goodwill [Line Items]
Impairment charge	41.0
Noncash impairment charge		12.8
Hawthorne
Goodwill [Line Items]
Reallocation		(15.8)	(15.8)
Goodwill		0.0	350.2	305.5
Hawthorne \| Goodwill Impairment
Goodwill [Line Items]
Restructuring costs	$ 522.4	522.4
U.S. Consumer
Goodwill [Line Items]
Reallocation		15.8	15.8
Goodwill		$ 243.9	$ 243.9	$ 228.1

GOODWILL AND INTANGIBLE ASSETS, NET - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	$ 323.9	$ 323.9
Total intangible assets, net	580.2	709.6
Intangible Assets [Line Items]
Total finite-lived intangible assets, net	256.3	385.7
Trade names
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	168.2	168.2
Roundup® marketing agreement amendment
Indefinite-lived Intangible Assets [Line Items]
Total indefinite-lived intangible assets	155.7	155.7
Trade names
Intangible Assets [Line Items]
Gross Carrying Amount	318.4	293.4
Accumulated Amortization/ Impairment Charges	(174.3)	(73.3)
Total finite-lived intangible assets, net	144.1	220.1
Customer relationships
Intangible Assets [Line Items]
Gross Carrying Amount	251.1	228.3
Accumulated Amortization/ Impairment Charges	(158.4)	(91.7)
Total finite-lived intangible assets, net	92.7	136.6
Technology
Intangible Assets [Line Items]
Gross Carrying Amount	49.1	49.2
Accumulated Amortization/ Impairment Charges	(43.3)	(41.3)
Total finite-lived intangible assets, net	5.8	7.9
Other
Intangible Assets [Line Items]
Gross Carrying Amount	34.7	35.3
Accumulated Amortization/ Impairment Charges	(21.0)	(14.2)
Total finite-lived intangible assets, net	$ 13.7	$ 21.1

GOODWILL AND INTANGIBLE ASSETS, NET - Schedule of Amortization Expense (Details) $ in Millions	Sep. 30, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 27.0
2024	22.8
2025	20.0
2026	18.6
2027	$ 17.4

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS - Summary of Balance Sheet Accounts (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2020
INVENTORIES:
Finished goods	$ 926.2	$ 793.7
Raw materials	293.2	242.8
Work-in-progress	124.1	90.1
Inventories	1,343.5	1,126.6
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	1,383.9	1,359.6
Less: accumulated depreciation	(777.9)	(737.4)
Property, plant and equipment, net	606.0	622.2
OTHER ASSETS:
Operating lease right-of-use assets	288.9	293.0
Deferred tax assets	143.5	0.0
Convertible debt investments	117.0	190.3
Accrued pension, postretirement and executive retirement assets	69.6	89.9
Loans receivable	32.8	35.8	$ 66.4
Other	29.1	23.0
Other assets	680.9	632.0
OTHER CURRENT LIABILITIES:
Current lease liabilities	76.2	66.4
Advertising and promotional accruals	74.8	132.7
Payroll and other compensation accruals	44.2	91.5
Accrued taxes	29.4	31.7
Accrued interest	30.1	28.0
Other	142.3	122.9
Other current liabilities	397.0	473.2
OTHER NON-CURRENT LIABILITIES:
Non-current operating lease liabilities	223.2	234.4
Accrued pension, postretirement and executive retirement liabilities	82.1	98.2
Deferred tax liabilities	8.5	47.8
Other	45.2	29.2
Other non-current liabilities	359.0	409.6
Land and improvements
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	145.0	144.2
Buildings
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	262.2	268.5
Machinery and equipment
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	644.0	585.9
Furniture and fixtures
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	65.4	53.0
Software
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	127.9	116.2
Finance leases
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	43.9	42.4
Aircraft
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	0.0	16.6
Construction in progress
PROPERTY, PLANT AND EQUIPMENT, NET:
Property, plant and equipment, gross	$ 95.5	$ 132.8

DETAIL OF CERTAIN FINANCIAL STATEMENT ACCOUNTS - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Property, Plant and Equipment [Line Items]
Proceeds from sale of long-lived assets	$ 63.3	$ 0.2	$ 0.4
Operating expenses
Property, Plant and Equipment [Line Items]
Gains on sale of property, plant and equipment	$ (16.2)	$ 0.0	$ 0.0

MARKETING AGREEMENT - Additional Information (Details)		12 Months Ended
MARKETING AGREEMENT - Additional Information (Details)	Aug. 01, 2019 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)
Schedule of Costs Related to Purchase Obligations [Line Items]
Net sales		$ 3,924,100,000	$ 4,925,000,000	$ 4,131,600,000
Restated Marketing Agreement
Schedule of Costs Related to Purchase Obligations [Line Items]
Commission threshold, percentage of program earnings	50.00%
Annual contribution payment	$ 18,000,000.0
Third Restated Agreement
Schedule of Costs Related to Purchase Obligations [Line Items]
Minimum EBIT to avoid reduction of contribution payment	36,000,000.0
Minimum EBIT	50,000,000.0
Minimum termination fee payable	175,000,000.0
Brand decommissioning event payable	$ 375,000,000.0
Minimum termination fee payable, multiple of average program earnings, prior 3 years	4
Minimum termination fee payable, threshold	$ 186,400,000
Brand Extension Asset Purchase Agreement
Schedule of Costs Related to Purchase Obligations [Line Items]
Proceeds from sale of productive assets	112,000,000.0
Disposal group, inventory	3,500,000
Disposal group, assets	$ 111,700,000

MARKETING AGREEMENT - Net Commission Earned Under the Marketing Agreement (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Marketing Agreement [Line Items]
Contribution expenses	$ (2,891.1)	$ (3,431.3)	$ (2,768.6)
Monsanto Marketing Agreement
Marketing Agreement [Line Items]
Gross commission	83.4	94.0	90.4
Contribution expenses	(18.0)	(18.0)	(18.0)
Net commission	65.4	76.0	72.4
Reimbursements associated with Roundup® marketing agreement	67.9	70.8	61.6
Total net sales associated with Roundup® marketing agreement	$ 133.3	$ 146.8	$ 134.0

ACQUISITIONS AND INVESTMENTS - Cyco (Details) - USD ($) $ in Millions		12 Months Ended
	Apr. 28, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Goodwill		$ 254.0	$ 605.2	$ 544.1
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Maximum
Business Acquisition [Line Items]
Intangible assets amortization period		25 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 350.2	$ 305.5
Cyco
Business Acquisition [Line Items]
Maximum payout	$ 10.0
Cyco \| Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	37.3
Contingent consideration	3.1
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Inventory And Other Current Assets	1.3
Finite-lived intangible assets acquired	10.5
Goodwill	$ 25.6
Cyco \| Hawthorne \| Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	5 years
Cyco \| Hawthorne \| Maximum
Business Acquisition [Line Items]
Intangible assets amortization period	25 years

ACQUISITIONS AND INVESTMENTS - Luxx Lighting (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		12 Months Ended
	Dec. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Common shares, stated value per share (USD per share)		$ 0.01	$ 0.01
Goodwill		$ 254.0	$ 605.2	$ 544.1
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Maximum
Business Acquisition [Line Items]
Intangible assets amortization period		25 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 350.2	$ 305.5
Luxx Lighting, Inc. \| Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	$ 213.2
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	0.1
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	$ 21.0
Inventory and accounts receivable acquired	32.8
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	5.7
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities	(24.2)
Finite-lived intangible assets acquired	47.3
Goodwill	$ 151.6
Luxx Lighting, Inc. \| Hawthorne \| Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	5 years
Luxx Lighting, Inc. \| Hawthorne \| Maximum
Business Acquisition [Line Items]
Intangible assets amortization period	25 years

ACQUISITIONS AND INVESTMENTS - True Liberty Bags (Details) - USD ($) $ in Millions		12 Months Ended
	Dec. 23, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Goodwill		$ 254.0	$ 605.2	$ 544.1
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 350.2	$ 305.5
True Liberty Bags \| Hawthorne
Business Acquisition [Line Items]
Total consideration transferred	$ 10.1
Inventory and accounts receivable acquired	1.1
Finite-lived intangible assets acquired	5.8
Goodwill	$ 3.2
True Liberty Bags \| Hawthorne \| Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	15 years

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

ACQUISITIONS AND INVESTMENTS - Rhizoflora (Details) - USD ($) $ in Millions		12 Months Ended
	Aug. 13, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Goodwill		$ 254.0	$ 605.2	$ 544.1
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Maximum
Business Acquisition [Line Items]
Intangible assets amortization period		25 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 350.2	$ 305.5
Hawthorne \| Rhizoflora, Inc.
Business Acquisition [Line Items]
Total consideration transferred	$ 33.7
Inventory acquired	0.6
Finite-lived intangible assets acquired	10.9
Goodwill	$ 22.2
Hawthorne \| Rhizoflora, Inc. \| Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	5 years
Hawthorne \| Rhizoflora, Inc. \| Maximum
Business Acquisition [Line Items]
Intangible assets amortization period	25 years

ACQUISITIONS AND INVESTMENTS - The Hawthorne Collective (Details) - RIV Capital, Inc. shares in Millions, $ in Millions				3 Months Ended
	Apr. 22, 2022 USD ($) board_member nominee	Aug. 24, 2021 USD ($) board_member	Aug. 09, 2021 shares	Sep. 30, 2021 USD ($)	Apr. 22, 2022 $ / shares	Aug. 24, 2021 $ / shares
Investments in and Advances to Affiliates [Line Items]
Share ownership after conversion (in shares) \| shares			123.0
Percentage of ownership after debt conversion			42.00%
Number of members of Board of Directors that can be nominated \| board_member	9	7
Additional minority non-equity investments \| $				$ 43.1
Number of company nominees added to the board \| nominee	4
The Hawthorne Colective
Investments in and Advances to Affiliates [Line Items]
Number of members of Board of Directors that can be nominated \| board_member	3
Convertible Notes Payable
Investments in and Advances to Affiliates [Line Items]
Aggregate principal amount \| $	$ 25.0	$ 150.0
Debt term (in years)		6 years
Conversion price (in CAD per share) \| $ / shares					$ 1.65	$ 1.90
Convertible Notes Payable \| Two Percent Interest Period
Investments in and Advances to Affiliates [Line Items]
Debt term (in years)	2 years	2 years
Interest rate (percent)	2.00%	2.00%

ACQUISITIONS AND INVESTMENTS - Hydro-Logic (Details) - USD ($) $ in Millions		12 Months Ended
	Aug. 27, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Business Acquisition [Line Items]
Goodwill		$ 254.0	$ 605.2	$ 544.1
Minimum
Business Acquisition [Line Items]
Intangible assets amortization period		3 years
Maximum
Business Acquisition [Line Items]
Intangible assets amortization period		25 years
Hawthorne
Business Acquisition [Line Items]
Goodwill		$ 0.0	$ 350.2	$ 305.5
Hawthorne \| Hydro-Logic Purification Systems, Inc.
Business Acquisition [Line Items]
Total consideration transferred	$ 65.3
Inventory and accounts receivable acquired	4.5
Other assets acquired	1.6
Other liabilities assumed	2.6
Finite-lived intangible assets acquired	23.1
Goodwill	$ 38.7
Hawthorne \| Hydro-Logic Purification Systems, Inc. \| Minimum
Business Acquisition [Line Items]
Intangible assets amortization period	5 years
Hawthorne \| Hydro-Logic Purification Systems, Inc. \| Maximum
Business Acquisition [Line Items]
Intangible assets amortization period	15 years

ACQUISITIONS AND INVESTMENTS - AeroGrow (Details) - USD ($) $ / shares in Units, $ in Millions	Feb. 26, 2021	Nov. 11, 2020	Sep. 30, 2022	Sep. 30, 2021
Business Acquisition [Line Items]
Common shares, stated value per share (USD per share)			$ 0.01	$ 0.01
AeroGrow
Business Acquisition [Line Items]
Noncontrolling interest, carrying value	$ 6.7
Difference between purchase price and carrying value recognized in Common shares and capital in excess of par	$ 13.4
Common shares, stated value per share (USD per share)			$ 0.01	$ 0.01
SMG Growing Media, Inc. \| AeroGrow
Business Acquisition [Line Items]
Percent ownership	100.00%	80.50%
AeroGrow
Business Acquisition [Line Items]
Cash consideration per share (USD per share)		$ 3.00
Cash consideration		$ 20.1

INVESTMENT IN UNCONSOLIDATED AFFILIATES (Details) - USD ($) $ in Millions		3 Months Ended	12 Months Ended
	Dec. 31, 2020	Jan. 01, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Investments in and Advances to Affiliates [Line Items]
Loans receivable, carrying value	$ 66.4		$ 32.8	$ 35.8
Gain from change in fair value of loans receivable		$ 12.5
Loans receivable, fair value		$ 78.9
Investment, estimated fair value	$ 23.3
Investment in unconsolidated affiliates			193.8	207.0
Equity in income (loss) of unconsolidated affiliates			$ (12.9)	14.4	$ 0.0
Bonnie Plants, LLC
Investments in and Advances to Affiliates [Line Items]
Percent ownership	50.00%
Payments to acquire equity interest	$ 102.3
Investment in unconsolidated affiliates	$ 202.9
Distributions from equity method investment				$ 12.0

RETIREMENT PLANS - Additional Information (Details) $ in Millions	12 Months Ended
	Sep. 30, 2022 USD ($) plan	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Compensation charges \| $	$ 28.3	$ 30.1	$ 27.7
401(K) \| Company matches 200% of associates’ initial 3% contribution
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer match of employee contribution (percent)	200.00%
Employee contribution of gross pay (percent)	3.00%
401(K) \| Company matches 50% of associates' contribution up to 6%
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer match of employee contribution (percent)	50.00%
Employee contribution of gross pay (percent)	6.00%
Deferred Profit Sharing
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employee contribution of gross pay (percent)	4.00%
Defined Benefit Pension Plan \| International Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of frozen defined benefit pension plans associated with former international businesses \| plan	3
Premium payment \| $		$ 67.7
Defined Benefit Pension Plan \| U.S. Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of defined benefit plans for certain U.S. associates \| plan	2

RETIREMENT PLANS - Benefit Obligations, Plan Assets, Annual Expense, Assumptions and Other Information of the Company's Defined Benefit Pension Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	$ 69.6	$ 89.9
Non-current liabilities	(82.1)	(98.2)
International Plan \| Defined Benefit Pension Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	193.6	193.7
Interest cost	3.0	2.6
Actuarial gain	(55.1)	(2.9)
Benefits paid	(7.5)	(7.6)
Foreign currency translation	(24.8)	7.8
Projected benefit obligation (“PBO”) at end of year	109.2	193.6
Accumulated benefit obligation (“ABO”) at end of year	109.2	193.6
Change in plan assets:
Fair value of plan assets at beginning of year	221.6	209.9
Actual return on plan assets	(61.2)	2.1
Employer contribution	5.3	7.9
Benefits paid	(7.5)	(7.6)
Foreign currency translation	(29.3)	9.3
Fair value of plan assets at end of year	128.9	221.6
Unfunded status at end of year	19.7	28.0
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	11.6	16.9
Fair value of plan assets	0.0	0.0
Projected benefit obligation	11.6	16.9
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	31.3	44.9
Current liabilities	(0.8)	(0.9)
Non-current liabilities	(10.8)	(16.0)
Total amount accrued	19.7	28.0
Amounts recognized in AOCL consist of:
Actuarial loss	51.2	51.4
Prior service cost	2.1	2.7
Total amount recognized	53.3	54.1
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	(11.1)	(0.6)
Reclassification to net income	1.3	1.3
Foreign currency translation	10.6	(2.0)
Total change in other comprehensive loss	$ 0.8	$ (1.3)
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	4.96%	1.90%
U.S. Plan \| Defined Benefit Pension Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	$ 100.2	$ 109.8
Interest cost	1.7	1.5
Actuarial gain	(17.2)	(4.1)
Benefits paid	(7.0)	(7.0)
Foreign currency translation	0.0	0.0
Projected benefit obligation (“PBO”) at end of year	77.7	100.2
Accumulated benefit obligation (“ABO”) at end of year	77.7	100.2
Change in plan assets:
Fair value of plan assets at beginning of year	81.7	81.5
Actual return on plan assets	(15.8)	5.9
Employer contribution	0.2	1.3
Benefits paid	(7.0)	(7.0)
Foreign currency translation	0.0	0.0
Fair value of plan assets at end of year	59.1	81.7
Unfunded status at end of year	(18.6)	(18.5)
Information for pension plans with an ABO in excess of plan assets:
Accumulated benefit obligation	77.7	100.2
Fair value of plan assets	59.1	81.7
Projected benefit obligation	77.7	100.2
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current assets	0.0	0.0
Current liabilities	(0.2)	(0.2)
Non-current liabilities	(18.4)	(18.3)
Total amount accrued	(18.6)	(18.5)
Amounts recognized in AOCL consist of:
Actuarial loss	38.8	39.2
Prior service cost	0.0	0.0
Total amount recognized	38.8	39.2
Total change in other comprehensive loss attributable to:
Net gain (loss) during the period	(1.3)	6.6
Reclassification to net income	1.7	2.1
Foreign currency translation	0.0	0.0
Total change in other comprehensive loss	$ 0.4	$ 8.7
Weighted average assumptions used in development of projected benefit obligation:
Discount rate	5.06%	2.37%

RETIREMENT PLANS - Components of Net Periodic Benefit Cost and Weighted Average Assumptions (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
International Plan
Components of net periodic benefit cost (income):
Interest cost	$ 3.0	$ 2.6	$ 2.7
Expected return on plan assets	(5.1)	(5.5)	(6.9)
Net amortization	1.3	1.3	1.0
Net periodic benefit cost (income)	$ (0.8)	$ (1.6)	$ (3.2)
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	1.64%	1.26%	1.42%
Expected return on plan assets	2.37%	2.45%	3.39%
U.S. Plan
Components of net periodic benefit cost (income):
Interest cost	$ 1.7	$ 1.5	$ 2.6
Expected return on plan assets	(2.8)	(3.4)	(3.9)
Net amortization	1.7	2.1	1.8
Net periodic benefit cost (income)	$ 0.6	$ 0.2	$ 0.5
Weighted average assumptions used in development of net periodic benefit cost (income):
Weighted average discount rate - interest cost	1.74%	1.43%	2.44%
Expected return on plan assets	3.50%	4.25%	5.00%

RETIREMENT PLANS - Plan Asset Allocations and Expected Future Benefit Payments (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2019
International Plan
Plan asset allocations:
Expected company contributions in fiscal 2023		$ 1.1
Expected future benefit payments:
2023		5.6
2024		5.8
2025		6.1
2026		6.2
2027		6.2
2028 – 2032		$ 33.8
International Plan \| Equity securities
Plan asset allocations:
Plan asset allocations		25.00%	22.00%
International Plan \| Equity securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	25.00%
International Plan \| Debt securities
Plan asset allocations:
Plan asset allocations		44.00%	48.00%
International Plan \| Debt securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	44.00%
International Plan \| Real estate securities
Plan asset allocations:
Plan asset allocations		0.00%	0.00%
International Plan \| Real estate securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%
International Plan \| Cash and cash equivalents
Plan asset allocations:
Plan asset allocations		1.00%	0.00%
International Plan \| Cash and cash equivalents \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	1.00%
International Plan \| Insurance contracts
Plan asset allocations:
Plan asset allocations		30.00%		30.00%
International Plan \| Insurance contracts \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	30.00%
U.S. Plan
Plan asset allocations:
Expected company contributions in fiscal 2023		$ 0.2
Expected future benefit payments:
2023		7.4
2024		7.2
2025		7.0
2026		6.9
2027		6.8
2028 – 2032		$ 30.5
U.S. Plan \| Equity securities
Plan asset allocations:
Plan asset allocations		17.00%	20.00%
U.S. Plan \| Equity securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	22.00%
U.S. Plan \| Debt securities
Plan asset allocations:
Plan asset allocations		75.00%	73.00%
U.S. Plan \| Debt securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	74.00%
U.S. Plan \| Real estate securities
Plan asset allocations:
Plan asset allocations		5.00%	4.00%
U.S. Plan \| Real estate securities \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	4.00%
U.S. Plan \| Cash and cash equivalents
Plan asset allocations:
Plan asset allocations		3.00%	3.00%
U.S. Plan \| Cash and cash equivalents \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%
U.S. Plan \| Insurance contracts
Plan asset allocations:
Plan asset allocations		0.00%		0.00%
U.S. Plan \| Insurance contracts \| Scenario, Forecast
Plan asset allocations:
Plan asset allocations	0.00%

RETIREMENT PLANS - Fair Value of The Company's Pension Plan Asset (Details) - Defined Benefit Pension Plan - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
International Plan
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 128.9	$ 221.6	$ 209.9
International Plan \| Fair Value, Inputs, Level 1 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	39.8	66.9
International Plan \| Fair value, inputs, level 1 \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1.7	0.2
International Plan \| Fair value, inputs, level 3 \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	38.1	66.7
International Plan \| Total common collective trusts measured at net asset value \| Common collective trusts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	89.1	154.7
International Plan \| Total common collective trusts measured at net asset value \| Common collective trusts \| Common collective trusts—real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
International Plan \| Total common collective trusts measured at net asset value \| Common collective trusts \| Common collective trusts—equities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	32.6	48.3
International Plan \| Total common collective trusts measured at net asset value \| Common collective trusts \| Common collective trusts—fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	56.5	106.4
U.S. Plan
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	59.1	81.7	$ 81.5
U.S. Plan \| Fair Value, Inputs, Level 1 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.1	2.9
U.S. Plan \| Fair value, inputs, level 1 \| Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.1	2.9
U.S. Plan \| Fair value, inputs, level 3 \| Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
U.S. Plan \| Total common collective trusts measured at net asset value \| Common collective trusts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	57.0	78.8
U.S. Plan \| Total common collective trusts measured at net asset value \| Common collective trusts \| Common collective trusts—real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.8	3.4
U.S. Plan \| Total common collective trusts measured at net asset value \| Common collective trusts \| Common collective trusts—equities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	10.0	16.0
U.S. Plan \| Total common collective trusts measured at net asset value \| Common collective trusts \| Common collective trusts—fixed income
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 44.2	$ 59.4

ASSOCIATE MEDICAL BENEFITS - Additional Information (Details) $ in Millions	12 Months Ended
	Sep. 30, 2022 USD ($) Year	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Self-insurance per occurrence	$ 1.0
Benefits cost recognized	$ 46.6	$ 43.7	$ 34.2
Health care cost trend rate (percent)	7.50%
Ultimate trend rate (percent)	5.00%
U.S. Plan \| Postretirement Medical Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Minimum retirement age (in years) \| Year	55
Number of years of service (in years)	10 years
Net periodic benefit (income)	$ (0.2)	$ (0.2)	$ (0.1)

ASSOCIATE MEDICAL BENEFITS - Retiree Medical Plan for Domestic Associates (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Amounts recognized in the Consolidated Balance Sheets consist of:
Non-current liabilities	$ (82.1)	$ (98.2)
Postretirement Medical Benefits \| U.S. Plan
Change in projected benefit obligation:
Benefit obligation at beginning of year	20.1	22.4
Service cost	0.2	0.2
Interest cost	0.5	0.4
Plan participants’ contributions	0.4	0.4
Actuarial gain	(4.0)	(0.8)
Curtailment loss	0.6	0.0
Benefits paid	(2.1)	(2.4)
Projected benefit obligation (“PBO”) at end of year	15.7	20.1
Change in plan assets:
Fair value of plan assets at beginning of year	0.0	0.0
Employer contribution	1.7	2.0
Plan participants’ contributions	0.4	0.4
Gross benefits paid	(2.1)	(2.4)
Fair value of plan assets at end of year	0.0	0.0
Unfunded status at end of year	(15.7)	(20.1)
Amounts recognized in the Consolidated Balance Sheets consist of:
Current liabilities	(1.6)	(1.5)
Non-current liabilities	(14.1)	(18.6)
Total amount accrued	(15.7)	(20.1)
Amounts recognized in AOCL consist of:
Actuarial loss	(1.2)	2.5
Prior service credit	(0.2)	(1.4)
Total amount recognized	(1.4)	1.1
Total change in other comprehensive loss attributable to:
Gain during the period	3.4	0.8
Reclassification to net income	(0.9)	(0.8)
Total change in other comprehensive loss	$ 2.5	$ 0.0
Discount rate used in development of APBO	5.60%	2.66%

ASSOCIATE MEDICAL BENEFITS - Expected Benefit Payments Under the Plan By The Company and Retirees (Details) $ in Millions	Sep. 30, 2022 USD ($)
Gross Benefit Payments
Defined Benefit Plan Disclosure [Line Items]
2023	$ 2.2
2024	2.2
2025	2.1
2026	2.1
2027	2.2
2028 – 2032	10.5
Retiree Contribution
Defined Benefit Plan Disclosure [Line Items]
2023	0.6
2024	0.6
2025	0.5
2026	0.6
2027	0.7
2028 – 2032	3.9
Net Company Payments
Defined Benefit Plan Disclosure [Line Items]
2023	1.6
2024	1.6
2025	1.6
2026	1.5
2027	1.5
2028 – 2032	$ 6.6

DEBT - Components of Long-Term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Debt Instrument [Line Items]
Total debt	$ 2,992.1	$ 2,315.3
Finance lease obligations	28.9	33.4
Less current portions	144.3	57.8
Long-term debt	2,826.2	2,236.7
Credit Facilities \| Revolving loans
Debt Instrument [Line Items]
Total debt	300.5	0.0
Credit Facilities \| Term loans
Debt Instrument [Line Items]
Total debt	975.0	670.0
Senior Notes \| Senior Notes due 2031 – 4.000%
Debt Instrument [Line Items]
Total debt	$ 500.0	$ 500.0
Interest rate (percent)	4.00%	4.00%		4.00%
Senior Notes \| Senior Notes due 2032 – 4.375%
Debt Instrument [Line Items]
Total debt	$ 400.0	$ 400.0
Interest rate (percent)	4.375%	4.375%	4.375%
Senior Notes \| Senior Notes - 4.500%
Debt Instrument [Line Items]
Total debt	$ 450.0	$ 450.0
Interest rate (percent)	4.50%	4.50%			4.50%
Senior Notes \| Senior Notes due 2026 – 5.250%
Debt Instrument [Line Items]
Total debt	$ 250.0	$ 250.0
Interest rate (percent)	5.25%	5.25%				5.25%
Receivables facility
Debt Instrument [Line Items]
Total debt	$ 75.0	$ 0.0
Other
Debt Instrument [Line Items]
Total debt	12.7	11.9
Long-term Debt
Debt Instrument [Line Items]
Less unamortized debt issuance costs	$ 21.6	$ 20.8

DEBT - Company's Debt Maturing in Next Fiscal Years (Details) $ in Millions	Sep. 30, 2022 USD ($)
Debt Disclosure [Abstract]
2023	$ 137.7
2024	50.0
2025	50.0
2026	50.0
2027	1,325.5
Thereafter	1,350.0
Total debt	$ 2,963.2

- Definition

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

DEBT - Credit Facilities (Details) $ in Millions	Jun. 08, 2022 USD ($)	Apr. 08, 2022 USD ($)	Jul. 05, 2018 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2021	Sep. 30, 2020
Debt Instrument [Line Items]
Debt, weighted average interest rate (percentage)				3.60%	3.70%	4.30%
Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Maximum leverage ratio				6.50
Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Maximum leverage ratio				6.25
Debt Instrument, Redemption, Period Four
Debt Instrument [Line Items]
Maximum leverage ratio				5.50
Debt Instrument, Redemption, Period Five
Debt Instrument [Line Items]
Maximum leverage ratio				4.50
Fifth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity			$ 2,300.0
Leverage ratio				6.01
Interest coverage ratio				4.83
Fifth Amended And Restated Senior Secured Credit Agreement \| Minimum
Debt Instrument [Line Items]
Interest coverage ratio				3.00
Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity		$ 2,500.0
Outstanding debt				$ 2,875.5
Sixth Amended And Restated Senior Secured Credit Agreement \| Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Maximum leverage ratio				6.25
Credit Facilities
Debt Instrument [Line Items]
Senior secured credit facilities, available borrowing capacity				$ 1,185.5
Credit Facilities \| Fifth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Debt, maturity period (in years)			5 years
Credit Facilities \| Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Debt, maturity period (in years)		5 years
Revolving loans
Debt Instrument [Line Items]
Debt, weighted average interest rate (percentage)				2.80%	1.90%	3.30%
Revolving loans \| Sixth Amended And Restated Senior Secured Credit Agreement, Amendment One
Debt Instrument [Line Items]
Interest rate, increase (decrease)	35
Annual facility fee rate increase (decrease)	15
Maximum leverage ratio	4.75
Cash dividends, annual maximum	$ 225.0
Maximum other dividends and distributions	$ 25.0
Letter of Credit \| Credit Facilities
Debt Instrument [Line Items]
Aggregate face amount of letters of credit outstanding				$ 14.1
Revolving loans \| Fifth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity			$ 1,500.0
Revolving loans \| Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity		$ 1,500.0
Letters of credit		100.0
Additional committed credit		500.0
Secured Term Loan \| Fifth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity			800.0
Letters of credit			$ 75.0
Secured Term Loan \| Sixth Amended And Restated Senior Secured Credit Agreement
Debt Instrument [Line Items]
Senior secured credit facilities, maximum borrowing capacity		$ 1,000.0
Secured Term Loan \| Sixth Amended And Restated Senior Secured Credit Agreement, Amendment One
Debt Instrument [Line Items]
Interest rate, increase (decrease)	50

DEBT - Senior Notes - 6.000% (Details) - Senior Notes – 6.000% - USD ($) $ in Millions	Oct. 23, 2019	Sep. 30, 2021	Dec. 28, 2019	Oct. 13, 2015
Debt Instrument [Line Items]
Repayments of debt	$ 412.5
Accrued interest	0.5
Redemption premium	12.0
Outstanding principal	$ 400.0
Senior Notes
Debt Instrument [Line Items]
Interest rate (percent)		6.00%		6.00%
Unamortized debt issuance costs			$ 3.1

DEBT - Senior Notes - 5.250% (Details) - Senior Notes - Senior Notes due 2026 – 5.250% - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021	Dec. 15, 2016
Debt Instrument [Line Items]
Aggregate principal amount			$ 250.0
Interest rate (percent)	5.25%	5.25%	5.25%

DEBT - Senior Notes - 4.500% (Details) - Senior Notes - Senior Notes - 4.500% - USD ($) $ in Millions	Oct. 22, 2019	Sep. 30, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt	$ 450.0
Interest rate (percent)	4.50%	4.50%	4.50%

DEBT - Senior Notes - 4.000% (Details) - Senior Notes - Senior Notes due 2031 – 4.000% - USD ($) $ in Millions	Mar. 17, 2021	Sep. 30, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt	$ 500.0
Interest rate (percent)	4.00%	4.00%	4.00%

DEBT - Senior Notes - 4.375% (Details) - Senior Notes - Senior Notes due 2032 – 4.375% - USD ($) $ in Millions	Aug. 13, 2021	Sep. 30, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Proceed from issuance of unsecured debt	$ 400.0
Interest rate (percent)	4.375%	4.375%	4.375%

DEBT - Receivables Facility (Details) $ in Millions	Apr. 07, 2017 USD ($) customer	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)
Debt Instrument [Line Items]
Borrowings or receivables pledged as collateral		$ 2,992.1	$ 2,315.3
Receivables facility
Debt Instrument [Line Items]
Borrowings or receivables pledged as collateral		75.0	0.0
Amendments
Debt Instrument [Line Items]
Number of customers \| customer	3
Maximum aggregate amount	$ 400.0
Committed up to limit under agreement	$ 160.0
Receivables facility \| Asset Pledged as Collateral
Debt Instrument [Line Items]
Allowance for credit loss		$ 79.8	$ 0.0

DEBT - Interest Rate Swap Agreements (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Interest Rate Swap, Instrument 3
Derivative [Line Items]
Notional amount	$ 100.0
Fixed rate (percentage)	1.36%
Interest Rate Swap, Instrument 4
Derivative [Line Items]
Notional amount	$ 300.0
Fixed rate (percentage)	1.34%
Interest Rate Swap, Instrument 5
Derivative [Line Items]
Notional amount	$ 200.0
Fixed rate (percentage)	1.37%
Interest Rate Swap, Instrument 6
Derivative [Line Items]
Notional amount	$ 200.0
Fixed rate (percentage)	0.58%
Interest Rate Swap, Instrument 7
Derivative [Line Items]
Notional amount	$ 200.0
Fixed rate (percentage)	0.85%
Designated as Hedging Instruments \| Interest rate swap agreements
Derivative [Line Items]
Notional amount	$ 800.0	$ 600.0

DEBT - Weighted Average Interest Rate (Details)	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Debt Disclosure [Abstract]
Debt, weighted average interest rate (percentage)	3.60%	3.70%	4.30%

EQUITY - Schedule of Authorized and Issued Shares (Details) - $ / shares	Sep. 30, 2022	Sep. 30, 2021
Preferred shares, no par value:
Authorized (in shares)	200,000	200,000
Issued (in shares)	0.0	0.0
Common shares, no par value, $0.01 stated value per share:
Authorized (in shares)	100,000,000.0	100,000,000.0
Issued (in shares)	68,100,000	68,100,000
Common shares, stated value per share (USD per share)	$ 0.01	$ 0.01

EQUITY - Additional Information (Details) - Miracle-Gro	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Ownership of outstanding common shares (percent)	26.00%
Condition for ownership of voting stock (percent)	49.00%
Tender offer for ownership of voting power (as a percent)	100.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Condition for ownership of voting stock (percent)	50.00%

EQUITY - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Other comprehensive income (loss) before reclassifications	$ (96.4)	$ 35.1	$ (22.1)
Amounts reclassified from accumulated other comprehensive net income (loss)	2.6	7.7	11.2
Income tax benefit (expense)	15.6	(10.0)	5.7
Net current period other comprehensive income (loss)	(78.2)	32.8	(5.2)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(66.4)	(99.1)	(93.9)
Equity ending balance	(144.6)	(66.4)	(99.1)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(1.7)	(6.2)	(17.4)
Other comprehensive income (loss) before reclassifications	(27.2)	4.5	10.5
Amounts reclassified from accumulated other comprehensive net income (loss)	0.0	0.0	0.8
Income tax benefit (expense)	0.0	0.0	0.0
Net current period other comprehensive income (loss)	(27.2)	4.5	11.3
Equity ending balance	(28.9)	(1.7)	(6.2)
Net Unrealized Gain (Loss) On Derivative Instruments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	10.2	(15.1)	(8.1)
Other comprehensive income (loss) before reclassifications	40.1	26.8	(19.7)
Amounts reclassified from accumulated other comprehensive net income (loss)	(9.1)	7.3	10.1
Income tax benefit (expense)	(7.9)	(8.9)	2.5
Net current period other comprehensive income (loss)	23.1	25.2	(7.1)
Equity ending balance	33.3	10.2	(15.1)
Net Unrealized Loss On Securities
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(2.3)	0.0	0.0
Other comprehensive income (loss) before reclassifications	(102.0)	(3.1)	0.0
Amounts reclassified from accumulated other comprehensive net income (loss)	0.0	0.0	0.0
Income tax benefit (expense)	24.6	0.8	0.0
Net current period other comprehensive income (loss)	(77.4)	(2.3)	0.0
Equity ending balance	(79.7)	(2.3)	0.0
Net Unrealized Gain (Loss) in Pension and Other Post- Retirement Benefits
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Equity beginning balance	(72.5)	(77.8)	(68.4)
Other comprehensive income (loss) before reclassifications	(7.3)	6.9	(12.9)
Amounts reclassified from accumulated other comprehensive net income (loss)	11.7	0.4	0.3
Income tax benefit (expense)	(1.1)	(1.9)	3.2
Net current period other comprehensive income (loss)	3.3	5.4	(9.4)
Equity ending balance	$ (69.3)	$ (72.5)	$ (77.8)

EQUITY - Dividends (Details) - $ / shares					3 Months Ended	12 Months Ended
EQUITY - Dividends (Details) - $ / shares	Jul. 30, 2021	Sep. 10, 2020	Jul. 27, 2020	Jul. 30, 2019	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Dividends Payable [Line Items]
Dividends declared (USD per share)	$ 0.66		$ 0.62	$ 0.58		$ 2.64	$ 2.52	$ 7.36
Dividends paid (USD per share)					$ 0.66
Special Cash Dividend
Dividends Payable [Line Items]
Dividends declared (USD per share)			$ 5.00
Dividends paid (USD per share)		$ 5.00

EQUITY - Share Repurchases (Details) - USD ($) shares in Millions	1 Months Ended	6 Months Ended	12 Months Ended			68 Months Ended
	Aug. 31, 2014	Mar. 28, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020	Mar. 28, 2020	Feb. 06, 2020	Aug. 03, 2016
Accelerated Share Repurchases [Line Items]
Number of common shares repurchased (in shares)			1.1	0.6
Value of common shares repurchased to be held in treasury			$ 175,000,000.0	$ 113,100,000
Tax withholding			$ 82,900,000	$ 16,300,000	$ 4,900,000
August 11, 2014 Program
Accelerated Share Repurchases [Line Items]
Stock repurchase authorization	$ 500,000,000.0							$ 1,000,000,000
Share repurchase period (in years)	5 years
Additional shares authorized repurchase								$ 500,000,000.0
Number of common shares repurchased (in shares)		0.4				8.7
Value of common shares repurchased to be held in treasury		$ 48,200,000				$ 762,800,000
February 6, 2020 Program
Accelerated Share Repurchases [Line Items]
Stock repurchase authorization							$ 750,000,000.0

EQUITY - Share-Based Awards, Additional Information (Details) - USD ($) shares in Millions, $ in Millions	2 Months Ended	12 Months Ended
	Nov. 22, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Common share available for issue under share-based plan (in shares)		5.0
Common shares were available to underlie the grant of new share-based award (in shares)		3.4
Tax benefit realized from tax deduction associated with exercise of stock options and vesting of restricted share awards		$ 14.8	$ 18.3	$ 5.8
Treasury Shares
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Treasury shares reissued (in shares)		1.5	0.5	0.4
Share-Based Compensation Awards and Employee Stock Purchase Plan \| Treasury Shares
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Treasury shares reissued (in shares)		0.9	0.4	0.4
Restricted Stock Units, Performance Shares, And Stock Options \| Subsequent Event
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Options and equity instruments other than options, grants in period (in shares)	1.6
Options and equity instruments other than options, grants in period, fair value	$ 51.8

EQUITY - Share-Based Compensation Awards Granted (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based awards (in shares)	354,329	265,565	213,499
Aggregate fair value at grant dates	$ 41.2	$ 30.2	$ 21.5
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	248,573
Performance units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	105,756
Employees \| Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	0	183,553	37,255
Employees \| Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	228,558	70,936	119,726
Employees \| Performance units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	105,756	1,903	37,570
Non-Employee Directors \| Restricted and deferred stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation awards granted, other than options (in shares)	20,015	9,173	18,948

EQUITY - Schedule of Share-Based Compensation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Equity [Abstract]
Share-based compensation	$ 30.3	$ 40.6	$ 57.9
Related tax benefit recognized	$ 4.9	$ 7.4	$ 14.6

EQUITY - Schedule of Aggregate Stock Option Activity (Details) - Options	12 Months Ended
	Sep. 30, 2022 $ / shares shares
No. of Options
Beginning balance (shares) \| shares	568,191
Forfeited (shares) \| shares	(39,720)
Ending balance (shares) \| shares	528,471
Exercisable (shares) \| shares	388,002
Wtd. Avg. Exercise Price
Beginning balance (USD per share) \| $ / shares	$ 118.38
Forfeited (in USD per share) \| $ / shares	236.53
Ending balance (USD per share) \| $ / shares	110.86
Exercisable (USD per share) \| $ / shares	$ 65.36

EQUITY - Stock Options, Additional Information (Details) - USD ($)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Intrinsic value of stock options exercised		$ 41,800,000	$ 21,900,000
Cash received from exercise of stock options	$ 3,300,000	$ 15,200,000	$ 17,600,000
Options
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Compensation costs not yet recognized, net	$ 1,400,000
Expected weighted average period for unrecognized compensation cost (in years)	1 year 3 months 18 days

EQUITY - Summary of Certain Information Pertaining to Stock Option Awards Outstanding and Exercisable (Details) - Options - $ / shares	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Awards Outstanding
No. of Options (in shares)	528,471	568,191
Wtd. Avg. Remaining Life (in years)	4 years 4 months 20 days
WTD. Avg. Exercise Price (USD per share)	$ 110.86	$ 118.38
Awards Exercisable
No. of Options (in shares)	388,002
Wtd. Avg. Remaining Life (in years)	2 years 11 months 12 days
WTD. Avg. Exercise Price (USD per share)	$ 65.36
$59.62 - $64.55
Range of Exercise Price
Exercise Price, minimum (USD per share)	59.62
Exercise Price, maximum (USD per share)	$ 64.55
Awards Outstanding
No. of Options (in shares)	380,932
Wtd. Avg. Remaining Life (in years)	2 years 10 months 6 days
WTD. Avg. Exercise Price (USD per share)	$ 62.18
Awards Exercisable
No. of Options (in shares)	380,932
Wtd. Avg. Remaining Life (in years)	2 years 10 months 6 days
WTD. Avg. Exercise Price (USD per share)	$ 62.18
$236.53 - $236.53
Range of Exercise Price
Exercise Price, minimum (USD per share)	236.53
Exercise Price, maximum (USD per share)	$ 236.53
Awards Outstanding
No. of Options (in shares)	147,539
Wtd. Avg. Remaining Life (in years)	8 years 4 months 6 days
WTD. Avg. Exercise Price (USD per share)	$ 236.53
Awards Exercisable
No. of Options (in shares)	7,070
Wtd. Avg. Remaining Life (in years)	8 years 4 months 6 days
WTD. Avg. Exercise Price (USD per share)	$ 236.53

EQUITY - Schedule of Intrinsic Value of Stock Option Awards Outstanding and Exercisable (Details) $ in Millions	Sep. 30, 2022 USD ($)
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$ 0.0

EQUITY - Restricted Share-Based Award Activity (Details) - Restricted Stock Units (RSUs)	12 Months Ended
	Sep. 30, 2022 $ / shares shares
No. of Shares
Beginning Balance (in shares) \| shares	375,825
Granted (in shares) \| shares	248,573
Vested (in shares) \| shares	(246,846)
Forfeited (in shares) \| shares	(56,977)
Ending Balance (in shares) \| shares	320,575
Wtd. Avg. Grant Date Fair Value per Share
Beginning Balance (USD per share) \| $ / shares	$ 124.50
Granted (USD per share) \| $ / shares	109.10
Vested (USD per share) \| $ / shares	75.38
Forfeited (USD per share) \| $ / shares	165.01
Ending Balance (USD per share) \| $ / shares	$ 143.19

EQUITY - Restricted Share-Based Awards, Additional Information (Details) - Restricted Stock Units (RSUs) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Compensation costs net yet recognized, restricted units, net	$ 10.0
Expected weighted average period for unrecognized compensation cost (in years)	1 year 8 months 12 days
Total fair value of share-based payment awards vested	$ 28.2	$ 41.8	$ 15.2

EQUITY - Performance-Based Award Activity (Details) - Performance-Based Units	12 Months Ended
	Sep. 30, 2022 $ / shares shares
No. of Units
Beginning Balance (in shares) \| shares	572,557
Granted (in shares) \| shares	105,756
Vested (in shares) \| shares	(533,441)
Forfeited (in shares) \| shares	(31,616)
Ending Balance (in shares) \| shares	113,256
Wtd. Avg. Grant Date Fair Value per Unit
Beginning Balance (USD per share) \| $ / shares	$ 95.09
Granted (USD per share) \| $ / shares	132.74
Vested (USD per share) \| $ / shares	93.22
Forfeited (USD per share) \| $ / shares	124.15
Ending Balance (USD per share) \| $ / shares	$ 130.94
Shares vested (as a percentage of shares granted)	228.00%

EQUITY - Performance-Based Awards, Additional Information (Details) - Performance units - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Schedule of Share based Compensation Arrangements by Share based Payment Award, Equity Instruments, Other Than Options, Restricted Stock Units [Line Items]
Compensation costs net yet recognized, restricted units, net	$ 3.6
Expected weighted average period for unrecognized compensation cost (in years)	2 years 1 month 6 days
Total fair value of share-based payment awards vested	$ 182.5	$ 11.9	$ 3.9

EARNINGS PER COMMON SHARE - Schedule of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Earnings Per Share [Abstract]
Income (loss) from continuing operations	$ (437.5)	$ 517.3	$ 386.9
Net income attributable to noncontrolling interest	0.0	(0.9)	(1.2)
Income (loss) attributable to controlling interest from continuing operations	(437.5)	516.4	385.7
Income (loss) from discontinued operations, net of tax	0.0	(3.9)	1.7
Net income (loss) attributable to controlling interest	$ (437.5)	$ 512.5	$ 387.4
Basic income (loss) per common share:
Weighted-average Common Shares outstanding during the period (in shares)	55.5	55.7	55.7
Income from continuing operations (USD per share)	$ (7.88)	$ 9.27	$ 6.92
Income (loss) from discontinued operations (USD per share)	0	(0.07)	0.04
Basic net income (loss) per common share (USD per share)	$ (7.88)	$ 9.20	$ 6.96
Diluted income (loss) per common share:
Weighted-average Common Shares outstanding during the period (in shares)	55.5	55.7	55.7
Dilutive potential Common Shares (in shares)	0.0	1.5	1.2
Weighted-average number of Common Shares outstanding and dilutive potential Common Shares (in shares)	55.5	57.2	56.9
Income from continuing operations (USD per share)	$ (7.88)	$ 9.03	$ 6.78
Income (loss) from discontinued operations (USD per share)	0	(0.07)	0.03
Diluted net income (loss) per common share (USD per share)	$ (7.88)	$ 8.96	$ 6.81

EARNINGS PER COMMON SHARE - Additional Information (Details) - shares shares in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted average number of shares outstanding, diluted (in shares)	55.5	57.2	56.9
Dilutive potential Common Shares (in shares)	0.0	1.5	1.2
Number of common shares covered by out-of-the-money stock options (in shares)	0.6
Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of common shares covered by out-of-the-money stock options (in shares)	0.2	0.1	0.0

INCOME TAXES - Provision (Benefit) For Income Taxes Allocated to Continuing Operation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Current:
Federal	$ 22.8	$ 113.7	$ 104.3
State	9.3	31.6	25.3
Foreign	8.7	2.7	0.3
Total Current	40.8	148.0	129.9
Deferred:
Federal	(125.5)	9.1	(1.6)
State	(23.3)	1.5	(2.0)
Foreign	(12.6)	1.2	(2.6)
Total Deferred	(161.4)	11.8	(6.2)
Provision (benefit) for income taxes	$ (120.6)	$ 159.8	$ 123.7

INCOME TAXES - Domestic and Foreign Components of Income From Continuing Operations Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Domestic	$ (427.3)	$ 670.2	$ 483.7
Foreign	(130.8)	6.9	26.9
Income (loss) from continuing operations before income taxes	$ (558.1)	$ 677.1	$ 510.6

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 20
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(8))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

INCOME TAXES - Reconciliation of The Federal Corporate Income Tax Rate and The Effective Tax Rate (Details)	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Statutory income tax rate	21.00%	21.00%	21.00%
Effect of foreign operations	(2.50%)	(0.10%)	(0.70%)
State taxes, net of federal benefit	2.60%	3.90%	3.50%
Effect of other permanent differences	2.80%	(1.10%)	0.00%
Research and Experimentation and other federal tax credits	0.20%	(0.20%)	(0.30%)
Effect of tax contingencies	(1.80%)	0.00%	0.10%
Other	(0.70%)	0.10%	0.60%
Effective income tax rate	21.60%	23.60%	24.20%

INCOME TAXES - Additional Information (Details) $ in Millions	12 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)
Investments, Owned, Federal Income Tax Note [Line Items]
Statutory income tax rate	21.00%	21.00%	21.00%
Valuation allowance for net operating losses	$ 40.7	$ 32.3
Foreign tax credit carryovers	15.0	14.9
Deferred tax assets subject to limitation	10.7	10.8
Gross unrecognized tax benefits	35.8	24.1	$ 30.2	$ 29.5
Unrecognized tax benefits that would have an impact on the effective tax rate	31.5	19.9	25.9
Unrecognized tax benefits accrued payment of interest	3.2	2.7	2.8
Unrecognized tax benefits accrued payment of penalties	$ 1.6	1.6	1.6
Discrete item, foreign income tax, increase (decrease) in basis points	340
Discrete item, increase (decrease) in basis points	260
Deferred Tax Assets, Net of Valuation Allowance	$ 298.0	163.7
Deferred Tax Liabilities, Net		(47.8)
Impairment, restructuring and other	693.1	4.3	0.8
Income Tax Expense (Benefit)	120.6	(159.8)	(123.7)
Operating expenses \| Goodwill and intangible asset impairments
Investments, Owned, Federal Income Tax Note [Line Items]
Impairment, restructuring and other	668.3	0.0	0.0
Impairment, Restructuring, And Other
Investments, Owned, Federal Income Tax Note [Line Items]
Income Tax Expense (Benefit)	148.3
Goodwill, Non-Deductible Impact	18.8
Other assets
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Assets, Net of Valuation Allowance	143.5
Other liabilities
Investments, Owned, Federal Income Tax Note [Line Items]
Deferred Tax Liabilities, Net	(8.5)
AeroGrow International Inc.
Investments, Owned, Federal Income Tax Note [Line Items]
Statutory tax benefit of net operating loss carryovers and related valuation allowances	10.5
Foreign Country
Investments, Owned, Federal Income Tax Note [Line Items]
Valuation allowance for net operating losses	2.9
Foreign net operating losses	3.7	1.8
Foreign tax credit carryovers	15.0	14.9
U.S. state and local tax authorities
Investments, Owned, Federal Income Tax Note [Line Items]
Valuation allowance for net operating losses	4.8
Foreign tax credit carryovers	1.4	1.4
State net operating losses carryforward	$ 7.3	1.7
State net operating losses carryforward period, minimum	5 years
State net operating losses carryforward period, maximum	20 years
Valuation allowance for state credits	$ 1.2
Discontinued Operations
Investments, Owned, Federal Income Tax Note [Line Items]
Gross unrecognized tax benefits	0.2	$ 0.2	$ 6.4
State Administration of Taxation, China \| Foreign Country
Investments, Owned, Federal Income Tax Note [Line Items]
Valuation allowance for net operating losses	$ 6.3

INCOME TAXES - Components of Deferred Income Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
DEFERRED TAX ASSETS
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities	$ 80.8	$ 65.6
Lease liabilities	70.7	71.0
Intangible assets	60.8	0.0
Inventories	43.2	16.8
Convertible debt investments	25.3	0.0
Net operating loss carryovers	21.7	14.2
Foreign tax credit carryovers	15.0	14.9
Accounts receivable	8.7	8.5
Other	12.5	5.0
Gross deferred tax assets	338.7	196.0
Valuation allowance	(40.7)	(32.3)
Total deferred tax assets	298.0	163.7
DEFERRED TAX LIABILITIES
Intangible assets	0.0	(73.3)
Lease right-of-use assets	(68.6)	(69.6)
Property, plant and equipment	(65.8)	(55.8)
Outside basis difference in equity investments	(14.8)	(7.2)
Derivative contracts	(10.5)	0.0
Other	(3.3)	(5.6)
Total deferred tax liabilities	(163.0)	(211.5)
Net deferred tax asset (liability)	$ 135.0
Net deferred tax asset (liability)		$ (47.8)

INCOME TAXES - Reconciliation of the Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 24.1	$ 30.2	$ 29.5
Additions for tax positions of the current year	11.3	0.3	0.3
Additions for tax positions of prior years	2.2	6.1	4.5
Reductions for tax positions of prior years	(2.5)	(5.9)	(2.4)
Settlements with tax authorities	1.3	0.2	0.3
Expiration of statutes of limitation	(0.6)	(6.8)	(2.0)
Balance at end of year	$ 35.8	$ 24.1	$ 30.2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Derivatives not designated as Hedging Instruments \| Currency forward contracts
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amount	$ 178.6	$ 180.3
Designated as Hedging Instruments \| Interest rate swap agreements
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Notional amount	800.0	$ 600.0
Interest rate gain amount expected to be reclassified to earnings during the next 12 months	9.7
Designated as Hedging Instruments \| Commodity hedging instruments
Derivative Instruments and Hedging Activities Disclosure [Line Items]
Commodity gain amount expected to be reclassified to earnings during the next 12 months	$ 9.5

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Outstanding Commodity Contracts that Hedge Forecasted Purchases (Details)	12 Months Ended
	Sep. 30, 2022 T gal	Sep. 30, 2021 T gal
Urea
Derivative [Line Items]
Outstanding commodity contracts, mass \| T	54,000	94,500
Diesel
Derivative [Line Items]
Outstanding commodity contracts, volume	3,150,000	5,880,000
Heating Oil
Derivative [Line Items]
Outstanding commodity contracts, volume	1,218,000	2,268,000

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair Values of the Company's Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	$ 37.2	$ 13.5
Designated as Hedging Instruments \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	33.4	9.0
Designated as Hedging Instruments \| Interest rate swap agreements \| Other assets
Derivatives, Fair Value [Line Items]
Derivative asset	18.2	3.3
Designated as Hedging Instruments \| Interest rate swap agreements \| Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	12.8	0.0
Designated as Hedging Instruments \| Interest rate swap agreements \| Other current liabilities \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	0.0	(5.7)
Designated as Hedging Instruments \| Interest rate swap agreements \| Other liabilities \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	0.0	(2.5)
Designated as Hedging Instruments \| Commodity hedging instruments \| Prepaid and other current assets \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative asset	2.4	13.9
Derivatives not designated as Hedging Instruments \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Total derivatives instruments	3.8	4.5
Derivatives not designated as Hedging Instruments \| Commodity hedging instruments \| Prepaid and other current assets
Derivatives, Fair Value [Line Items]
Derivative asset	0.4	1.3
Derivatives not designated as Hedging Instruments \| Currency forward contracts \| Prepaid and other current assets \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative asset	3.4	3.4
Derivatives not designated as Hedging Instruments \| Currency forward contracts \| Other current liabilities \| Fair value, inputs, level 2
Derivatives, Fair Value [Line Items]
Derivative liability	$ 0.0	$ (0.2)

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of Derivative Instruments on OCI and the Condensed, Consolidated Statements of Operations (Details) - Fair value, inputs, level 2 - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Derivatives not designated as Hedging Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ 28.4	$ 0.3
Derivatives not designated as Hedging Instruments \| Currency forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ 17.9	$ (4.2)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Operating Income (Expense), Net	Other Operating Income (Expense), Net
Derivatives not designated as Hedging Instruments \| Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Statement of Operations	$ 10.5	$ 4.5
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales	Cost of sales
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	$ 29.9	$ 19.8
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	6.8	(5.4)
Cash Flow Hedging \| Interest rate swap agreements
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	24.1	3.4
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	$ (2.1)	$ (7.7)
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Interest expense	Interest expense
Cash Flow Hedging \| Commodity hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in AOCI	$ 5.8	$ 16.4
Amount of Gain/(Loss) Reclassified From AOCI Into Statement of Operations	$ 8.9	$ 2.3
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of sales	Cost of sales

FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Aug. 13, 2021	Mar. 17, 2021	Oct. 22, 2019	Dec. 15, 2016
Senior Notes \| Senior Notes due 2031 – 4.000%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.00%	4.00%		4.00%
Senior Notes \| Senior Notes due 2032 – 4.375%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.375%	4.375%	4.375%
Senior Notes \| Senior Notes - 4.500%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	4.50%	4.50%			4.50%
Senior Notes \| Senior Notes due 2026 – 5.250%
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate (percent)	5.25%	5.25%				5.25%
Convertible debt investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost basis of investment	$ 222.1	$ 193.4
Unrealized loss on investment	(105.1)	(3.1)
Total realized / unrealized gains included in net earnings	$ 3.7	$ 0.3

FAIR VALUE MEASUREMENTS - Summary of Fair Value of Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021	Aug. 13, 2021	Mar. 17, 2021	Sep. 30, 2020	Oct. 22, 2019	Dec. 15, 2016
Senior Notes \| Senior Notes due 2031 – 4.000%
Liabilities
Interest rate (percent)	4.00%	4.00%		4.00%
Senior Notes \| Senior Notes due 2032 – 4.375%
Liabilities
Interest rate (percent)	4.375%	4.375%	4.375%
Senior Notes \| Senior Notes - 4.500%
Liabilities
Interest rate (percent)	4.50%	4.50%				4.50%
Senior Notes \| Senior Notes due 2026 – 5.250%
Liabilities
Interest rate (percent)	5.25%	5.25%					5.25%
Reported Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2031 – 4.000%
Liabilities
Long-term debt	$ 500.0	$ 500.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2032 – 4.375%
Liabilities
Long-term debt	400.0	400.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes - 4.500%
Liabilities
Long-term debt	450.0	450.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2026 – 5.250%
Liabilities
Long-term debt	250.0	250.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Receivables facility
Liabilities
Long-term debt	75.0	0.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Credit Facilities \| Revolving loans
Liabilities
Long-term debt	300.5	0.0
Reported Value Measurement \| Fair value, inputs, level 2 \| Credit Facilities \| Term loans
Liabilities
Long-term debt	975.0	670.0
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2031 – 4.000%
Liabilities
Long-term debt	350.6	498.8
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2032 – 4.375%
Liabilities
Long-term debt	284.0	402.0
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes - 4.500%
Liabilities
Long-term debt	325.7	466.9
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Senior Notes \| Senior Notes due 2026 – 5.250%
Liabilities
Long-term debt	230.0	258.1
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Receivables facility
Liabilities
Long-term debt	75.0	0.0
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Credit Facilities \| Revolving loans
Liabilities
Long-term debt	300.5	0.0
Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Credit Facilities \| Term loans
Liabilities
Long-term debt	975.0	670.0
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 1
Assets
Cash equivalents	64.3	222.5
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 1 \| Investment securities in non-qualified retirement plan assets
Assets
Other	38.4	45.0
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 2 \| Other Long-term Debt
Liabilities
Long-term debt	12.7	11.9
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 3 \| Convertible debt investments
Assets
Convertible debt investments	117.0	190.3
Fair Value, Measurements, Recurring \| Reported Value Measurement \| Fair value, inputs, level 3 \| Loans receivable
Assets
Other	32.8	35.8
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 1
Assets
Cash equivalents	64.3	222.5
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 1 \| Investment securities in non-qualified retirement plan assets
Assets
Other	38.4	45.0
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 2 \| Other Long-term Debt
Liabilities
Long-term debt	12.7	11.9
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 3 \| Convertible debt investments
Assets
Convertible debt investments	117.0	190.3			$ 0.0
Fair Value, Measurements, Recurring \| Estimate of Fair Value Measurement \| Fair value, inputs, level 3 \| Loans receivable
Assets
Other	$ 32.8	$ 35.8

FAIR VALUE MEASUREMENTS - Rollforward (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Purchases	$ 25.0	$ 193.1
Total realized / unrealized losses included in OCI	(96.4)	35.1	$ (22.1)
Net Unrealized Loss On Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total realized / unrealized losses included in OCI	(102.0)	(3.1)	0.0
Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Total realized / unrealized gains included in net earnings	3.7	0.3
Fair value, inputs, level 3 \| Estimate of Fair Value Measurement \| Fair Value, Measurements, Recurring \| Convertible debt investments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair value at beginning of year	190.3	0.0
Fair value at end of year	$ 117.0	$ 190.3	$ 0.0

LEASES - Narrative (Details) - USD ($) $ in Millions	Sep. 21, 2022	Sep. 30, 2022	Sep. 30, 2021
Lessee, Lease, Description [Line Items]
Total lease liabilities		$ 299.4	$ 300.8
Residual value of leased asset		3.9
Net proceeds	$ 44.7
Carrying value	36.7
Gain (loss) on transaction	$ 8.0
Sale leaseback term	3 years
Not Yet Commenced
Lessee, Lease, Description [Line Items]
Total lease liabilities		$ 49.8

LEASES - (Supplemental Balance Sheet Information Schedule) (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Operating lease right-of-use assets	$ 288.9	$ 293.0
Current lease liabilities	76.2	66.4
Non-current operating lease liabilities	223.2	234.4
Total operating lease liabilities	299.4	300.8
Finance lease right-of-use assets	26.4	31.3
Finance lease current lease liabilities	6.4	5.9
Finance lease non-current lease liabilities	22.5	27.5
Total finance lease liabilities	$ 28.9	$ 33.4
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets	Other assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other Liabilities, Current	Other Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, plant and equipment, net	Property, plant and equipment, net
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Current portion of debt	Current portion of debt
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt	Long-term debt

LEASES - (Components of Lease Cost Schedule) (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Operating lease cost	$ 86.7	$ 70.3
Variable lease cost	35.9	29.4
Amortization of right-of-use assets	6.4	6.0
Interest on lease liabilities	1.2	1.4
Total finance lease cost	7.6	7.4
Operating lease amortization of ROU assets	75.3	62.3
Short-term lease expense	$ 19.1	$ 22.8

LEASES - (Supplemental Cash Flow Information and Non-Cash Activity Schedule) (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Lease, Cost [Abstract]
Operating cash flows from operating leases, net	$ 83.9	$ 66.9
Operating cash flows from finance leases	1.2	1.4
Financing cash flows from finance leases	5.9	5.3
Right-of-use assets obtained in exchange for lease obligations, operating leases	71.9	200.0
Right-of-use assets obtained in exchange for lease obligations, finance leases	$ 1.5	$ 2.6

LEASES - (Weighted-Average Remaining Lease Term and Discount Rate Schedule) (Details)	Sep. 30, 2022
Leases [Abstract]
Operating leases, weighted average remaining term (in years)	4 years 10 months 24 days
Finance leases, weighted average remaining term (in years)	7 years 3 months 18 days
Operating leases, weighted average discount rate (percent)	3.50%
Finance leases, weighted average discount rate (percent)	4.30%

LEASES - (Maturities of Lease Liabilities by Fiscal Year Schedule) (Details) - USD ($) $ in Millions	Sep. 30, 2022	Sep. 30, 2021
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2023	$ 85.2
2024	78.0
2025	61.2
2026	42.2
2027	18.9
Thereafter	40.5
Total lease payments	326.0
Less: Imputed interest	(26.6)
Total lease liabilities	299.4	$ 300.8
Finance Lease, Liability, Payment, Due [Abstract]
2023	7.5
2024	7.5
2025	3.3
2026	2.2
2027	1.9
Thereafter	11.8
Total lease payments	34.2
Less: Imputed interest	(5.3)
Total lease liabilities	$ 28.9	$ 33.4

COMMITMENTS (Details) $ in Millions	Sep. 30, 2022 USD ($)
Unrecorded Unconditional Purchase Obligation, Fiscal Year Maturity [Abstract]
2023	$ 547.2
2024	358.6
2025	201.1
2026	147.7
2027	128.8
Thereafter	84.8
Unrecognized unconditional purchase obligations due	$ 1,468.2

CONTINGENCIES (Details) $ in Millions	Sep. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Accrued liabilities related to other regulatory matters which are accounted for in the Other liabilities	$ 2.4

SEGMENT INFORMATION - Additional Information (Details)	12 Months Ended
SEGMENT INFORMATION - Additional Information (Details)	Sep. 30, 2022 segment
Segment Reporting [Abstract]
Number of reportable segments	3

SEGMENT INFORMATION - Segment Financial Information (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Segment Reporting Information [Line Items]
Net sales	$ 3,924.1	$ 4,925.0	$ 4,131.6
Intangible asset amortization	(37.1)	(30.9)	(32.5)
Impairment, restructuring and other	(693.1)	(4.3)	(0.8)
Equity in income (loss) of unconsolidated affiliates	(12.9)	14.4	0.0
Interest expense	(118.1)	(78.9)	(79.6)
Other non-operating income, net	6.9	18.6	20.1
Depreciation and amortization	105.2	93.8	94.7
Capital expenditures	113.5	106.9	62.7
Assets	4,296.8	4,800.0
Corporate
Segment Reporting Information [Line Items]
Depreciation and amortization	7.6	7.9	7.5
Assets	583.8	814.5
U.S. Consumer
Segment Reporting Information [Line Items]
Net sales	2,928.8	3,197.7	2,883.5
Depreciation and amortization	55.8	48.6	48.0
Capital expenditures	97.4	78.3	52.3
U.S. Consumer \| Operating Segments
Segment Reporting Information [Line Items]
Assets	2,454.4	2,333.1
Hawthorne
Segment Reporting Information [Line Items]
Net sales	716.2	1,424.2	1,023.1
Depreciation and amortization	34.8	30.3	31.7
Capital expenditures	12.4	25.0	7.8
Hawthorne \| Operating Segments
Segment Reporting Information [Line Items]
Assets	1,061.5	1,442.8
Other
Segment Reporting Information [Line Items]
Net sales	279.1	303.1	225.0
Depreciation and amortization	7.0	7.0	7.5
Capital expenditures	3.7	3.6	2.6
Other \| Operating Segments
Segment Reporting Information [Line Items]
Assets	197.1	209.6
Continuing Operations
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(558.1)	677.1	510.6
Intangible asset amortization	(37.1)	(30.9)	(32.5)
Impairment, restructuring and other	(852.2)	(29.0)	(16.8)
Equity in income (loss) of unconsolidated affiliates	(12.9)	14.4	0.0
Costs related to refinancing	0.0	0.0	(15.1)
Interest expense	(118.1)	(78.9)	(79.6)
Other non-operating income, net	6.9	18.6	20.1
Continuing Operations \| Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	567.7	932.6	817.9
Continuing Operations \| Corporate
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(112.4)	(149.7)	(183.4)
Continuing Operations \| U.S. Consumer \| Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	568.6	726.7	694.3
Continuing Operations \| Hawthorne \| Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	(21.1)	163.8	111.9
Continuing Operations \| Other \| Operating Segments
Segment Reporting Information [Line Items]
Income from continuing operations before income taxes	$ 20.2	$ 42.1	$ 11.7

SEGMENT INFORMATION - Net Sales by Product Category (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Revenue from External Customer [Line Items]
Net sales	$ 3,924.1	$ 4,925.0	$ 4,131.6
U.S. Consumer \| Growing media and mulch
Revenue from External Customer [Line Items]
Net sales	1,192.6	1,286.7	1,164.0
U.S. Consumer \| Lawn care
Revenue from External Customer [Line Items]
Net sales	973.6	1,060.6	943.3
U.S. Consumer \| Controls
Revenue from External Customer [Line Items]
Net sales	382.2	402.4	383.7
U.S. Consumer \| Roundup marketing agreement
Revenue from External Customer [Line Items]
Net sales	132.3	145.2	132.7
U.S. Consumer \| Other, primarily gardening
Revenue from External Customer [Line Items]
Net sales	248.1	302.8	259.8
Hawthorne
Revenue from External Customer [Line Items]
Net sales	716.2	1,424.2	1,023.1
Hawthorne \| Lighting
Revenue from External Customer [Line Items]
Net sales	200.0	452.4	328.7
Hawthorne \| Nutrients
Revenue from External Customer [Line Items]
Net sales	148.0	324.7	250.1
Hawthorne \| Growing environment
Revenue from External Customer [Line Items]
Net sales	143.7	264.0	154.2
Hawthorne \| Growing media
Revenue from External Customer [Line Items]
Net sales	119.0	192.6	148.9
Hawthorne \| Other, primarily hardware
Revenue from External Customer [Line Items]
Net sales	105.5	190.5	141.2
Other
Revenue from External Customer [Line Items]
Net sales	279.1	303.1	225.0
Other \| Lawn care
Revenue from External Customer [Line Items]
Net sales	92.9	99.2	73.7
Other \| Growing media
Revenue from External Customer [Line Items]
Net sales	96.6	116.7	90.6
Other \| Other, primarily gardening and controls
Revenue from External Customer [Line Items]
Net sales	$ 89.6	$ 87.2	$ 60.7

SEGMENT INFORMATION - Concentrations of Credit Risk (Details) - Customer Concentration Risk	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Net Sales \| Home Depot
Revenue, Major Customer [Line Items]
Concentration risk (percent)	28.00%	24.00%	26.00%
Net Sales \| Lowe's
Revenue, Major Customer [Line Items]
Concentration risk (percent)	15.00%	15.00%	18.00%
Net Accounts Receivable \| Two Largest Customers
Revenue, Major Customer [Line Items]
Concentration risk (percent)	46.00%	42.00%

SEGMENT INFORMATION - Net sales and long-lived assets by geographic area (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 3,924.1	$ 4,925.0	$ 4,131.6
Long-lived assets	862.3	1,007.9
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3,554.6	4,507.0	3,773.4
Long-lived assets	753.3	868.8
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	369.5	418.0	$ 358.2
Long-lived assets	$ 109.0	$ 139.1

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Allowance for doubtful accounts
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ 16.8	$ 7.5	$ 4.2
Reserves Acquired	0.0	0.0	0.0
Additions Charged to Expense	5.8	11.1	7.2
Deductions Credited and Write-Offs	(8.2)	(1.8)	(3.9)
Balance at End of Period	14.4	16.8	7.5
Income tax valuation allowance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	32.3	33.8	35.8
Reserves Acquired	0.0	0.0	0.0
Additions Charged to Expense	9.0	3.0	0.5
Deductions Credited and Write-Offs	(0.6)	(4.5)	(2.5)
Balance at End of Period	$ 40.7	$ 32.3	$ 33.8